在下文中,將參考實例更詳細地描述本發明,但本發明之技術範疇不限於此等實例。在整個說明書中,除非特定地指出,否則單數表述應理解為以複數形式涵蓋其概念。因此,除非特定地指出,否則單數物品(例如,在英語之情況下「一(a/an)」、「該」及其類似物)亦應理解為以複數形式涵蓋其概念。此外,除非特定地指出,否則本文所用之術語應理解為用於本領域中常用的意義。因此,除非定義,否則本文所用之所有術語及科學技術均具有與涉及本發明之熟習此項技術者所通常理解的術語相同的含義。在矛盾之情況下,本說明書(包括定義)優先採用。胺基甲酸酯化合物或其鹽
本發明提供由式(1)表示之胺基甲酸酯化合物或其鹽以用於農業及園藝。其中R1
、R2
、R3
、R4
、R5
、R6
、R7
、R8
、X、X1
、Y、Z、l、m及n如上文所定義。 隨後,下文描述本發明書中之術語。 在本發明書中,若基團為可取代的且為一個或複數個,則由「視情況經取代」或「經取代」定義之基團之取代基數目不受特定限制。另外,除非另外指示,否則亦在基團為其他基團之一部分或其上取代基時應用各基團之描述。 「C1 - 6
烷基」意謂具有一至六個碳原子之直鏈或支鏈飽和烴基。 「C2 - 6
烯基」意謂具有二至六個碳原子且含有1至3個雙鍵之直鏈或支鏈不飽和烴基。 「C2 - 6
炔基」意謂具有二至六個碳原子且含有一個三鍵之直鏈或支鏈不飽和烴基。 「C3 - 8
環烷基」意謂具有三至八個碳原子之環烷基,且包括具有部分橋連結構之彼等環烷基。 「C1 - 6
烷氧基」係指「C1 - 6
烷氧基」,且「C1 - 6
烷基」部分與上文所描述之「C1 - 6
烷基」定義相同。 「芳基」意謂單環或多環芳族烴。 「雜環」意謂在環中具有氮、氧、磷及/或硫原子中之至少一者且可在任何可取代之位置鍵結的飽和、不飽和或芳族雜環基。 「雜芳基」意謂在環中具有氮、氧及/或硫原子中之至少一者且可在任何可取代之位置鍵結的芳族雜環基,其中雜芳基之環成員原子除碳原子之外包括1、2、3或4個選自N、O及S之雜原子。 下文展示如本說明書中所用各基團之具體實例。 鹵素之實例包括但不特別限制於氟、氯、溴、碘及其類似鹵素。 C1 - 6
烷基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷基,諸如甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、正戊基、正己基及其類似基團。 C1 - 6
鹵烷基之實例包括但不特別限制於經1至9個、較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷基,諸如氟甲基、氯甲基、溴甲基、碘甲基、二氟甲基、2,2-二氟乙基、三氟甲基、2,2,2-三氟乙基、五氟乙基、3,3,3-三氟丙基、4,4,4-三氟丁基、七氟異丁基及其類似基團。 C1 - 6
烷氧基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷氧基,諸如甲氧基、乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基及其類似基團。 C1 - 6
鹵烷氧基之實例包括但不特別限制於經1至9個、較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷氧基,諸如氟甲氧基、氯甲氧基、溴甲氧基、碘甲氧基、二氟甲氧基、三氟甲氧基、2,2,2-三氟乙氧基、五氟乙氧基、3,3,3-三氟丙氧基、4,4,4-三氟丁氧基、七氟異丁氧基及其類似基團。 C1 - 6
烷氧基C1 - 6
烷基之實例包括不特別限制於C1 - 6
直鏈或支鏈烷基經C1 - 6
直鏈或支鏈烷氧基取代之烷氧基烷基,諸如甲氧基甲基、乙氧基甲基、正丙氧基甲基、異丙氧基甲基、正丁氧基甲基、異丁氧基甲基、第二丁氧基甲基、第三丁氧基甲基、甲氧基乙基、乙氧基乙基、甲氧基-正丙基、甲氧基-正丁基及其類似基團。 C1 - 6
鹵烷氧基C1 - 6
烷基之實例包括但不特別限制於經1至9個、較佳1至5個鹵素原子取代之直鏈或支鏈烷氧基烷基,諸如氟甲氧基甲基、氯甲氧基甲基、溴甲氧基甲基、碘甲氧基甲基、二氟甲氧基甲基、三氟甲氧基甲基、2,2,2-三氟乙氧基甲基及其類似基團。 C3 - 8
環烷基之實例包括但不特別限制於環丙基、環丁基、環戊基、環己基、環庚基、環辛基及其類似基團。 C3 - 8
環烷基C1 - 6
烷基之實例包括但不特別限制於環丙基甲基、環丁基乙基、環戊基甲基、環己基甲基及其類似基團。 C1 - 6
烷基羰基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷基羰基,諸如甲基羰基(乙醯基)、乙基羰基(丙醯基)、正丙基羰基(丁醯基)、異丙基羰基(異丁醯基)、正丁基羰基(戊醯基)、異丁基羰基(異戊醯基)、第二丁基羰基、第三丁基羰基及其類似基團。 C1 - 6
鹵烷基羰基之實例包括但不特別限制於經1至9個、且較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷基羰基,諸如氟甲基羰基、氯甲基羰基、溴甲基羰基、碘甲基羰基、二氯甲基羰基、三氯甲基羰基、二氟甲基羰基、三氟甲基羰基、氯二氟甲基羰基、溴二氟甲基羰基、二氯氟甲基羰基、2,2,2-三氯乙基羰基、2,2,2-三氟乙基羰基、五氟乙基羰基及其類似基團。 C1 - 6
烷氧羰基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷氧羰基,諸如甲氧基羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、正丁氧基羰基、異丁氧基羰基、第二丁氧基羰基、第三丁氧基羰基及其類似基團。 C1 - 6
鹵烷氧羰基之實例包括但不特別限制於經1至9個、較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷氧羰基,諸如氟甲氧基羰基、氯甲氧基羰基、溴甲氧基羰基、碘甲氧基羰基、二氯甲氧基羰基、三氯甲氧基羰基、二氟甲氧基羰基、三氟甲氧基羰基、2,2,2-三氟乙氧基甲基、五氟乙氧基羰基、3,3,3-三氟丙氧基羰基、4,4,4-三氟丁氧基羰基、七氟異丙氧基羰基及其類似基團。 氰基C1 - 6
烷基之實例包括但不特別限制於經氰基取代之C1 - 6
直鏈或支鏈烷基,諸如氰基甲基、氰基乙基、氰基-正丙基、氰基-異丙基、氰基-正丁基、氰基-異丁基、氰基-第二丁基、氰基-第三丁基、氰基-正己基及其類似基團。 氰基C1 - 6
烷氧基之實例包括經氰基取代之C1 - 6
直鏈或支鏈烷氧基,諸如氰基甲氧基、氰基乙氧基、氰基-正丙氧基、氰基-異丙氧基、氰基-正丁氧基、氰基-異丁氧基、氰基-第二丁氧基、氰基-第三丁氧基、氰基-己氧基及其類似基團。 C2 - 6
烯基之實例包括但不特別限制於乙烯基、烯丙基、2-丁烯基、3-丁烯基、1-甲烯丙基及其類似基團。 C2 - 6
鹵烯基之實例包括但不特別限制於2,2-二氯乙烯基、2,2-二溴乙烯基、2,2-二氟乙烯基、3,3-二氟-2-烯丙基、4,4-二氟-3-丁烯基、4,4,4-三氟-2-丁烯基及其類似基團。 C2 - 6
炔基之實例包括但不特別限制於乙炔基、2-丙炔基(炔丙基)、1-甲基-2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基及其類似基團。 C2 - 6
鹵炔基之實例包括但不特別限制於氟乙炔基、溴乙炔基、氯乙炔基、碘乙炔基、3,3,3-三氟-1-丙炔基及其類似基團。 氰基C2 - 6
烯基之實例包括但不特別限制於2-氰基乙烯基、2,2-二氰基乙烯基、3-氰基-2-烯丙基、3,3-二氰基-2-烯丙基、4-氰基-3-丁烯基、4,4-二氰基-3-丁烯基、4,4,4-三氰基-2-丁烯基及其類似基團。 氰基C2 - 6
炔基之實例包括但不特別限制於氰基乙炔基、3-氰基-1-丙炔基及其類似基團。 C1 - 6
烷磺醯基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷磺醯基,諸如甲磺醯基、乙磺醯基、正丙磺醯基、異丙磺醯基、正丁磺醯基、異丁磺醯基、第二丁磺醯基、第三丁磺醯基及其類似基團。 C1 - 6
鹵烷磺醯基之實例包括但不特別限制於氟甲磺醯基、氯甲磺醯基、溴甲磺醯基、碘甲磺醯基、二氯甲磺醯基、三氯甲磺醯基、二氟甲磺醯基、三氟甲磺醯基、氯二氟甲磺醯基、溴二氟甲磺醯基、二氯氟甲磺醯基、2,2,2-三氯乙磺醯基、2,2,2-三氟乙磺醯基、五氟乙磺醯基以及如經1至9個、且較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷磺醯基。 C1 - 6
烷基亞磺醯基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷基亞磺醯基,諸如甲基亞磺醯基、乙基亞磺醯基、正丙基亞磺醯基、異丙基亞磺醯基、正丁基亞磺醯基、異丁基亞磺醯基、第二丁基亞磺醯基、第三丁基亞磺醯基及其類似基團。 C1 - 6
鹵烷基亞磺醯基之實例包括但不特別限制於經1至9個、且較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷基亞磺醯基,諸如氟甲基亞磺醯基、氯甲基亞磺醯基、溴甲基亞磺醯基、碘甲基亞磺醯基、二氯甲基亞磺醯基、三氯甲基亞磺醯基、二氟甲基亞磺醯基、三氟甲基亞磺醯基、氯二氟甲基亞磺醯基、溴二氟甲基亞磺醯基、二氯氟甲基亞磺醯基、2,2,2-三氯乙基亞磺醯基、2,2,2-三氟乙基亞磺醯基、五氟乙基亞磺醯基及其類似基團。 C1 - 6
烷硫基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷硫基,諸如甲硫基、乙硫基、正丙硫基、異丙硫基、正丁硫基、異丁硫基、第二丁硫基、第三丁硫基及其類似基團。 C1 - 6
鹵烷硫基之實例包括但不特別限制於經1至9個、且較佳1至5個鹵素原子取代之C1 - 6
直鏈或支鏈烷硫基,諸如氟甲硫基、氯甲硫基、溴甲硫基、碘甲硫基、二氯甲硫基、三氯甲硫基、二氟甲硫基、三氟甲硫基、氯二氟甲硫基、溴二氟甲硫基、二氯氟甲硫基、2,2,2-三氯乙硫基、2,2,2-三氟乙硫基、五氟乙硫基及其類似基團。 C3 - 8
環烷磺醯基之實例包括但不特別限制於環丙磺醯基、環丁磺醯基、環戊磺醯基、環己磺醯基及其類似基團。 C3 - 8
環烷基亞磺醯基之實例包括但不特別限制於環丙基亞磺醯基、環丁基亞磺醯基、環戊基亞磺醯基、環己基亞磺醯基及其類似基團。 C3 - 8
環烷硫基之實例包括但不特別限制於環丙硫基、環丁硫基、環戊硫基、環己硫基及其類似基團。 C3 - 8
環烷基C1 - 6
烷磺醯基之實例包括但不特別限制於環丙基甲磺醯基、2-環丙基乙磺醯基、3-環丙基丙磺醯基、環己基甲磺醯基及其類似基團。 C3 - 8
環烷基C1 - 6
烷基亞磺醯基之實例包括但不特別限制於環丙基甲基亞磺醯基、2-環丙基乙基亞磺醯基、3-環丙基丙基亞磺醯基、環己基甲基亞磺醯基及其類似基團。 C3 - 8
環烷基C1 - 6
烷硫基之實例包括但不特別限制於環丙基甲硫基、2-環丙基乙硫基、3-環丙基丙硫基、環己基甲硫基及其類似基團。 C1 - 6
烷氧基C1 - 6
烷硫基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷硫基經C1 - 6
直鏈或支鏈烷氧基取代之烷氧基烷硫基,諸如甲氧基甲硫基、乙氧基甲硫基、正丙氧基甲硫基、異丙氧基甲硫基、正丁氧基甲硫基、第二丁氧基甲硫基、第三丁氧基甲硫基、2-甲氧基乙硫基及其類似基團。 C2 - 6
烯氧基之實例包括但不特別限制於乙烯氧基、1-丙烯氧基、異丙烯氧基、烯丙氧基、2-丁烯氧基、3-丁烯氧基、1-甲基烯丙氧基及其類似基團。 C2 - 6
鹵烯氧基之實例包括但不特別限制於2,2-二氯乙烯氧基、2,2-二溴乙烯氧基、2,2-二氟乙烯氧基、3,3-二氟-2-烯丙氧基、4,4-二氟-3-丁烯氧基、4,4,4-三氟-2-丁烯氧基及其類似基團。 C2 - 6
炔氧基之實例包括但不特別限制於乙炔氧基、2-丙炔氧基、1-甲基-2-丙炔氧基、1,1-二甲基-2-丙炔氧基、1-丁炔氧基、2-丁炔氧基、3-丁炔氧基及其類似基團。 C2 - 6
鹵炔氧基之實例包括但不特別限制於氟乙炔氧基、溴乙炔氧基、氯乙炔氧基、碘乙炔氧基、3,3,3-三氟-1-丙炔氧基及其類似基團。 C1 - 6
烷基磺醯氧基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷磺醯基,諸如甲基磺醯氧基、乙基磺醯氧基、正丙基磺醯氧基、異丙基磺醯氧基、正丁基磺醯氧基、異丁基磺醯氧基、第二丁基磺醯氧基、第三丁基磺醯氧基及其類似基團。 C1 - 6
烷基亞磺醯氧基之實例包括但不特別限制於C1 - 6
直鏈或支鏈烷基亞磺醯氧基,諸如甲基亞磺醯氧基、乙基亞磺醯氧基、正丙基亞磺醯氧基、異丙基亞磺醯氧基、正丁基亞磺醯氧基、異丁基亞磺醯氧基、第二丁基亞磺醯氧基、第三丁基亞磺醯氧基及其類似基團。 經取代或未經取代之胺基之實例包括但不特別限制於胺基、單烷胺基、二烷胺基、單醯胺基及其類似基團。 烷基之實例包括上文提及之C1 - 6
烷基及其類似基團。 醯基之實例包括上文提及之C1 - 6
烷氧羰基、鹵烷氧羰基、芳基羰基及其類似基團。 芳基之實例包括但不特別限制於苯基、1-萘基、2-萘基及其類似基團。 芳基C1 - 6
烷基之實例包括但不特別限制於苯甲基、苯乙基、苯基-正丙基及其類似基團。此等芳基C1 - 6
烷基在烷基以及芳基兩個部分可進一步經取代。 芳氧基之實例包括但不特別限制於苯氧基、1-萘氧基、2-萘氧基及其類似基團。 芳基C1 - 6
烷氧基之實例包括但不特別限制於苯甲氧基、苯基乙氧基、苯基-正丙氧基、苯基-正丁氧基、1-萘甲氧基、2-萘甲氧基及其類似基團。 雜芳氧基之實例包括但不特別限制於吡啶氧基、嘧啶氧基、吡唑氧基及其類似基團。 雜芳基C1 - 6
烷氧基之實例包括但不特別限制於吡啶基甲氧基、吡啶基乙氧基、嘧啶基乙氧基、吡唑基甲氧基及其類似基團。 芳磺醯基之實例包括但不特別限制於苯磺醯基、1-萘磺醯基、2-萘磺醯基及其類似基團。 芳基亞磺醯基之實例包括但不特別限制於苯基亞磺醯基、1-萘基亞磺醯基、2-萘基亞磺醯基及其類似基團。 芳硫基之實例包括但不特別限制於苯硫基、1-萘硫基、2-萘硫基及其類似基團。 芳基磺醯氧基之實例包括但不特別限制於苯基磺醯氧基、1-萘基磺醯氧基、2-萘基磺醯氧基及其類似基團。 芳基亞磺醯氧基之實例包括但不特別限制於苯基亞磺醯氧基、1-萘基亞磺醯氧基、2-萘基亞磺醯氧基及其類似基團。 芳基C1 - 6
烷硫基之實例包括但不特別限制於苯甲硫基、苯乙硫基、苯基-正丙硫基、苯基-正丁硫基、1-萘甲硫基、2-萘甲硫基及其類似基團。 雜芳基之實例包括但不特別限制於噻吩基、呋喃基、吡咯基、噁唑基、異噁唑基、噻唑基、異噻唑基、吡唑基、咪唑基、噁二唑基、噻二唑基、三唑基、四唑基、吡啶基、噠嗪基、嘧啶基、吡嗪基、三嗪基、四嗪基、吲哚基、異吲哚基、吲唑基、喹唑啉基、咔唑基、苯并噁唑基、苯并異噁唑基、苯并噻唑基、苯并異噻唑基、苯并咪唑基、喹啉基、異喹啉基、吡啶并吲哚基、噌啉基、酞嗪基、喹喏啉基、嘌呤基、啡噻嗪基呋喃基、苯并呋喃基、𠳭烷基、苯并噻吩基及其類似基團。 上文提及之所有芳基及雜芳基可視情況進一步經取代。取代基之數目之實例包括但不特別限制於1至20個(較佳1至10個,且更佳為1至5個)。 雜環基之實例包括但不特別限制於噻吩基、呋喃基、四氫呋喃基、二氧戊環基、二氧雜環己烷基、吡咯基、吡咯啉基、吡咯烷基、噁唑基、異噁唑基、噁唑啉基、噁唑啶基、異噁唑啉基、噻唑基、異噻唑基、噻唑啉基、噻唑啶基、異噻唑啉基、吡唑基、吡唑啶基、咪唑基、二氫咪唑基、四氫咪唑基、噁二唑基、噁二唑啉基、噻二唑啉基、三唑基、三唑啉基、三唑啶基、四唑基、四唑啉基、吡啶基、二氫吡啶基、四氫吡啶基、哌啶基、噁嗪基、二氫噁嗪基、N-嗎啉基、噻嗪基、二氫噻嗪基、噻N-嗎啉基、噠嗪基、二氫噠嗪基、四氫噠嗪基、六氫噠嗪基、噁二嗪基、二氫噁二嗪基、四氫噁二嗪基、噻二唑基、噻二嗪基、二氫噻二嗪基、四氫噻二嗪基、嘧啶基、二氫嘧啶基、四氫嘧啶基、六氫嘧啶基、吡嗪基、二氫吡嗪基、四氫吡嗪基、哌嗪基、三嗪基、二氫三嗪基、四氫三嗪基、六氫三嗪基、四嗪基、二氫四嗪基、吲哚基、二氫吲哚基、異吲哚基、吲唑基、喹唑啉基、二氫喹唑基、四氫喹唑基、咔唑基、苯并噁唑基、苯并噁唑啉基、苯并異噁唑基、苯并異唑啉基、苯并噻唑基、苯并異噻唑基、苯并異噻唑啉基、苯并咪唑基、吲唑啉基、喹啉基、二氫喹啉基、四氫喹啉基、異喹啉基、二氫異喹啉基、四氫異喹啉基、吡啶并吲哚基、四氫苯并噁嗪基、噌啉基、二氫噌啉基、四氫噌啉基、酞嗪基、二氫酞嗪基、四氫酞嗪基、喹喏啉基、二氫喹喏啉基、四氫喹喏啉基、嘌呤基、二氫苯并三嗪基、二氫苯并四嗪基、啡噻嗪基呋喃基、苯并呋喃基、𠳭烷基、苯并噻吩基及其類似基團。 此等雜環基包括在任何可取代位置處用側氧基或硫酮基經取代之彼等。 上文提及之所有雜環族化合物可視情況進一步經取代。取代基之數目之實例包括但不特別限制於1至20個(較佳1至10個,且更佳為1至5個)。 「經取代」或「取代基」之實例包括但不特別限制於:鹵素、硝基、氰基、羥基、甲醯基、C1 - 6
烷基、C1 - 6
鹵烷基、C1 - 6
烷氧基、C1 - 6
鹵烷氧基、C1 - 6
烷氧基C1 - 6
烷基、C1 - 6
鹵烷氧基、C1 - 6
烷基、C3 - 8
環烷基、C3 - 8
環烷基C1 - 6
烷基、C1 - 6
烷基羰基、C1 - 6
鹵烷基羰基、芳基羰基、芳氧基羰基、C1 - 6
烷氧羰基、C1 - 6
鹵烷氧羰基、C1 - 6
氰基烷基、C1 - 6
氰基烷氧基、C2 - 6
烯基、C2 - 6
鹵烯基、C2 - 6
炔基、C2 - 6
鹵炔基、C1 - 6
烷磺醯基、C1 - 6
鹵烷磺醯基、C1 - 6
烷基亞磺醯基、C1 - 6
鹵烷基亞磺醯基、C1 - 6
烷硫基、C1 - 6
鹵烷硫基、C3 - 8
環烷磺醯基、C3 - 8
環烷基亞磺醯基、C3 - 8
環烷硫基、C3 - 8
環烷基C1 - 6
烷磺醯基、C3 - 8
環烷基C1 - 6
烷基亞磺醯基、C3 - 8
環烷基C1 - 6
烷硫基、C1 - 6
烷氧基C1 - 6
烷磺醯基、C1 - 6
烷氧基C1 - 6
烷基亞磺醯基、C1 - 6
烷氧基C1 - 6
烷硫基、C2 - 6
烯氧基、C2 - 6
鹵烯氧基、C2 - 6
炔氧基、C2 - 6
鹵炔氧基、C1 - 6
烷基磺醯氧基、C1 - 6
鹵烷基磺醯氧基、C1 - 6
烷基亞磺醯氧基、C1 - 6
鹵烷基亞磺醯氧基、OCN、SCN、SF5
、經取代或未經取代之胺基、芳基、芳基C1 - 6
烷基、芳氧基、芳基C1 - 6
烷氧基、芳磺醯基、芳基亞磺醯基、芳硫基、芳基C1 - 6
烷磺醯基、芳基C1 - 6
烷基亞磺醯基、芳基C1 - 6
烷硫基、雜環、雜環C1 - 6
烷基、雜環氧基及其類似基團。在此等中,較佳取代基為鹵素、硝基、氰基、C1 - 6
烷基、C1 - 6
鹵烷基、C1 - 6
烷氧基、C1 - 6
鹵烷氧基、C1 - 6
烷磺醯基、C1 - 6
鹵烷磺醯基、C1 - 6
烷基亞磺醯基、C1 - 6
鹵烷基亞磺醯基、C1 - 6
烷硫基、C1 - 6
鹵烷硫基、經取代或未經取代之胺基、芳基及雜環,且更佳取代基為氟、氯、硝基、甲基、乙基、三氟甲基、甲氧基及三氟甲氧基。 較佳經取代之芳基為經鹵素取代之芳基、經C1 - 6
烷基取代之芳基、經C1 - 6
鹵烷基取代之芳基、經鹵素及C1 - 6
鹵烷基取代之芳基、經C1 - 6
烷氧基取代之芳基、經C1 - 6
鹵烷氧基取代之芳基及經C1 - 6
烷硫基取代之芳基。更佳經取代之芳基為經氯取代之芳基、經氟取代之芳基、經三氟甲基取代之芳基、經氯及三氟甲基取代之芳基、經三氟甲氧基取代之芳基及經甲氧基取代之芳基及經甲硫基取代之芳基。 較佳經取代之雜芳基為經鹵素取代之雜芳基、經C1 - 6
烷基取代之雜芳基、經C1 - 6
鹵烷基取代之雜芳基、經鹵素及C1 - 6
鹵烷基取代之雜芳基、經C1 - 6
烷氧基取代之雜芳基、經C1 - 6
鹵烷氧基取代之雜芳基及經C1 - 6
烷硫基取代之雜芳基。更佳經取代之雜芳基為經氯取代之雜芳基、經氟取代之雜芳基、經三氟甲基取代之雜芳基、經氯及三氟甲基取代之雜芳基、經三氟甲氧基取代之雜芳基及經甲氧基取代之雜芳基及經甲硫基取代之雜芳基。 較佳經取代之雜環基為經鹵素取代之雜環、經C1 - 6
烷基取代之雜環、經C1 - 6
鹵烷基取代之雜環、經C1 - 6
烷氧基取代之雜環、經C1 - 6
鹵烷氧基取代之雜環及經C1 - 6
烷硫基取代之雜環。更佳經取代之雜環基為經氯取代之雜環、經氟取代之雜環、經三氟甲基取代之雜環、經三氟甲氧基取代之雜環、經甲氧基取代之雜環及經甲硫基取代之雜環。 由式(1)表示之化合物之鹽可為任何類型之鹽,只要其為農業上可接受的。鹽之實例包括:無機酸鹽,諸如鹽酸鹽、硫酸鹽、硝酸鹽及其類似鹽;有機酸鹽,諸如乙酸鹽、甲烷磺酸鹽及其類似鹽;鹼金屬鹽,諸如鈉鹽、鉀鹽及其類似鹽;鹼土金屬鹽,諸如鎂鹽、鈣鹽及其類似鹽;四級銨鹽,諸如二甲基銨、三乙基銨及其類似銨鹽;及類似鹽。 在一實施例中,X及X1
表示氧或硫; Y表示氧或硫; Z表示氧或硫; l為整數0至2; m為整數0至3;且 n為整數0至4。 在本發明之化合物(1)中,較佳化合物為其中R1
為以下之化合物:氫、鹵素、硝基、C1 - 6
烷基、C1 - 6
鹵烷基、C1 - 6
烷基羰基、氰基C1 - 6
烷基、視情況經取代之芳基,且更佳化合物(1)為其中R1
為以下之化合物:氫、氯、溴、甲基、氯甲基、三氟甲基、甲氧羰基、乙氧羰基或氰基甲基。 在本發明之化合物(1)中,較佳化合物為其中R2
為氫或C1 - 6
烷基之化合物,且更佳化合物(1)為其中R2
為甲基之化合物。 在本發明之化合物(1)中,較佳化合物為其中R3
為氫、鹵素或C1 - 6
烷基之化合物,且更佳化合物(1)為其中R3
為氫之化合物。 在本發明之化合物(1)中,較佳化合物為其中R4
為氫或C1 - 6
烷基之化合物,且更佳化合物(1)為其中R4
為氫之化合物。 在本發明之化合物(1)中,較佳化合物為其中R5
為氫或C1 - 6
烷基之化合物,且更佳化合物(1)為其中R5
為氫之化合物。 在本發明之化合物(1)中,較佳化合物為其中R6
為氫、鹵素、C1 - 6
烷基或C1 - 6
烷氧基之化合物,且更佳化合物(1)為其中R6
為氫、氯、甲基或甲氧基之化合物。 在本發明之化合物(1)中,較佳化合物為其中R7
為氫、C1 - 6
烷基或C1 - 6
烷基羰基之化合物,且更佳化合物(1)為其中R7
為以下之化合物:氫、甲基、乙基、異丙基、乙醯基、丙醯基或異丁醯基。 在本發明之化合物(1)中,較佳化合物為其中R8
為C1 - 6
烷基之化合物,且更佳化合物(1)為其中R8
為甲基之化合物。 在本發明之化合物(1)中,較佳化合物為其中X為氧或硫之化合物,且更佳化合物(1)為其中X為氧之化合物。 在本發明之化合物(1)中,較佳化合物為其中X1
為氧或硫之化合物,且更佳化合物(1)為其中X1
為氧之化合物。 在本發明之化合物(1)中,較佳化合物為其中Y氧或硫之化合物,且更佳化合物(1)為其中Y為氧之化合物。 在本發明之化合物(1)中,較佳化合物為其中Z為氧或硫之化合物,且更佳化合物(1)為其中Z為硫之化合物。 在此等中,本發明之更佳化合物為以下之化合物或其鹽,其中 R1
為氫、鹵素、硝基、C1 - 6
烷基、C1 - 6
鹵烷基、C1 - 6
烷基羰基或氰基C1 - 6
烷基; R2
為氫或C1 - 6
烷基; R3
為氫、鹵素或C1 - 6
烷基; R4
為氫或C1 - 6
烷基; R5
為氫或C1 - 6
烷基; R6
為氫、鹵素、C1 - 6
烷基或C1 - 6
烷氧基; R7
為氫、C1 - 6
烷基或C1 - 6
烷基羰基; R8
為C1 - 6
烷基; X及X1
獨立地表示氧或硫; Y表示氧或硫; Z表示氧或硫; l為0至2之整數; m為0至3之整數;且 n為0至4之整數。 本發明之更更尤其較佳化合物為以下之化合物或其鹽,其中 R1
為氫、鹵素、C1 - 6
烷基或C1 - 6
鹵烷基; R2
為氫或甲基; R3
為氫; R4
為氫; R5
為氫; R6
為氫、氯、甲基或甲氧基; R7
為氫、甲基、乙基、異丙基、乙醯基、丙醯基或異丁醯基; R8
為甲基; X及X1
獨立地表示氧; Y表示氧; Z表示氧; l為0至2之整數; m為0至3之整數;且 n為0至4之整數。 本發明亦提供一種製備由式(1)表示之胺基甲酸酯或其鹽之方法。其中R1
、R2
、R3
、R4
、R5
、R6
、R7
、R8
、X、X1
、Y、Z、l、m及n如上文所定義。 由式(1)表示之胺基甲酸酯化合物可根據以下反應流程1至流程4容易地製備,但不限於此等方法。 由式(1D)表示之胺基甲酸酯化合物可藉由使2-經取代之五員雜環化合物(2a)與硼化合物(3)在如反應流程1中所提及的催化劑、鹼及溶劑存在下反應來製備: 反應流程1其中R1
、R2
、R3
、R4
、R5
、R6
、R8
、X、X1
、Y、Z、l、m及n如上文所定義。 A表示鹵素、甲烷磺醯基氧基、對甲苯磺醯基氧基或三氟甲烷磺醯基氧基。 R9
表示氫、C1 - 6
烷基(取代基可形成具有兩個相鄰R9
之-CH2
CH2
-、-C(CH3
)2
-C(CH3
)2
-或-CH2
-CH2
-CH2
-)。 前述反應可在過渡金屬催化劑存在下進行。作為過渡金屬催化劑,可廣泛地使用通常已知之過渡金屬催化劑,且過渡金屬催化劑之實例包括鈀化合物,諸如乙酸鈀(II)、肆(三苯膦)鈀(0)、二氯化雙(三苯膦)鈀(II)、三(二苯亞甲基丙酮)二鈀及[1,1'-雙(二苯膦基)二茂鐵]二氯鈀(II)與二氯甲烷之錯合物;及其類似物,較佳為肆(三苯膦)鈀(0)。 待使用之鈀催化劑之量通常為每1 mol化合物(3)為0.01至1.0 mol、較佳為0.05至0.1 mol。 待使用之化合物(2a)之量通常為每1 mol化合物(3)為0.5至5 mol、較佳1.0至2.0 mol。 前述反應可在不存在或存在鹼下進行。在以上中,反應較佳在鹼存在下進行。作為鹼,可廣泛地使用通常已知鹼,且鹼之實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及其類似物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀及其類似物;無機鹼,諸如鹼金屬氫化物,諸如氫化鈉及氫化鉀及其類似物;鹼金屬醇鹽,諸如甲醇鈉、乙醇鈉、第三丁醇鉀及其類似物;有機鹼,諸如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲胺吡啶、哌啶及其類似物;及其類似物,較佳為碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及氫化鈉。使用此等鹼中之任一者或其兩種或更多種類型之組合。 待使用之鹼之量通常為每1 mol化合物(3)為1.0至5.0 mol、較佳為1.0至2.0 mol。 前述反應在適當溶劑中或在無任何溶劑情況下進行。當前述反應在溶劑中進行時,只要溶劑相對於前述反應為非活性的,即可對溶劑無限制。 該種溶劑之實例包括:基於脂肪酸或脂環烴之溶劑,諸如正己烷、環己烷、正庚烷及其類似物;基於芳族烴之溶劑,諸如苯、氯苯、甲苯、二甲苯及其類似物;基於鹵化烴之溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿及四氯化碳及其類似物;基於醚之溶劑,諸如乙醚、四氫呋喃(THF)、1,4-二噁烷、二甲氧基乙烷及其類似物;酯溶劑,諸如乙酸甲酯、乙酸乙酯及其類似物;乙腈;基於醯胺之溶劑,諸如N,N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮及其類似物;及基於亞碸之溶劑,諸如二甲亞碸、環丁碸及其類似物;H2
O;乙酸,優選為二甲氧基乙烷及乙醇-H2
O及甲苯-H2
O之混合溶劑。可單獨使用此等溶劑中之任一者,或必要時可使用其兩種或超過兩種類型之組合。 待使用之溶劑之量通常為每1 mol化合物(3)為1.0至20公升、較佳1.0至10公升。 前述反應之反應溫度不受特定限制,且通常處於-10℃與所用溶劑之沸點之間的範圍內,且較佳為0至120℃。 反應時間視例如反應溫度而變化,且反應通常在大約0.5至24小時內結束。 由式(1E)表示之胺基甲酸酯化合物可藉由使5-經取代之五員雜環化合物(2b)與硼化合物(3)在如反應流程2中所提及的催化劑、鹼及溶劑存在下反應來製備: 反應流程2其中R1
、R2
、R3
、R4
、R5
、R6
、R8
、X、X1
、Y、Z、l、m及n如上文所定義。 A表示鹵素、甲烷磺醯基氧基、對甲苯磺醯基氧基或三氟甲烷磺醯基氧基。 R9
表示氫、C1 - 6
烷基(取代基可形成具有兩個相鄰R9
之-CH2
CH2
-、-C(CH3
)2
-C(CH3
)2
-或-CH2
-CH2
-CH2
-)。 前述反應可在過渡金屬催化劑存在下進行。作為過渡金屬催化劑,可廣泛地使用通常已知之過渡金屬催化劑,且過渡金屬催化劑之實例包括鈀化合物,諸如乙酸鈀(II)、肆(三苯膦)鈀(0)、二氯化雙(三苯膦)鈀(II)、三(二苯亞甲基丙酮)二鈀及[1,1'-雙(二苯膦基)二茂鐵]二氯鈀(II)與二氯甲烷之錯合物;及其類似物,較佳為肆(三苯膦)鈀(0)。 待使用之鈀催化劑之量通常為每1 mol化合物(3)為0.01至1.0 mol、較佳為0.05至0.1 mol。 待使用之化合物(2b)之量通常為每1 mol化合物(3)為0.5至5 mol、較佳1.0至2.0 mol。 前述反應可在不存在或存在鹼下進行。在以上中,反應較佳在鹼存在下進行。作為鹼,可廣泛地使用通常已知鹼,且鹼之實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及其類似物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀及其類似物;無機鹼,諸如鹼金屬氫化物,諸如氫化鈉及氫化鉀及其類似物;鹼金屬醇鹽,諸如甲醇鈉、乙醇鈉、第三丁醇鉀及其類似物;有機鹼,諸如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲胺吡啶、哌啶及其類似物;及其類似物,較佳為碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及氫化鈉。使用此等鹼中之任一者或其兩種或更多種類型之組合。 待使用之鹼之量通常為每1 mol化合物(3)為1.0至5.0 mol、較佳1.0至2.0 mol。 前述反應在適當溶劑中或在無任何溶劑情況下進行。當前述反應在溶劑中進行時,只要溶劑相對於前述反應為非活性的,即可對溶劑無限制。 該種溶劑之實例包括:基於脂肪酸或脂環烴之溶劑,諸如正己烷、環己烷、正庚烷及其類似物;基於芳族烴之溶劑,諸如苯、氯苯、甲苯、二甲苯及其類似物;基於鹵化烴之溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿及四氯化碳及其類似物;基於醚之溶劑,諸如乙醚、四氫呋喃(THF)、1,4-二噁烷、二甲氧基乙烷及其類似物;酯溶劑,諸如乙酸甲酯、乙酸乙酯及其類似物;乙腈;基於醯胺之溶劑,諸如N,N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮及其類似物;及基於亞碸之溶劑,諸如二甲亞碸、環丁碸及其類似物;H2
O;乙酸,優選為二甲氧基乙烷及乙醇-H2
O及甲苯-H2
O之混合溶劑。可單獨使用此等溶劑中之任一者,或必要時可使用其兩種或超過兩種類型之組合。 待使用之溶劑之量通常為每1 mol化合物(3)為1.0至20公升、較佳1.0至10公升。 前述反應之反應溫度不受特定限制,且通常處於-10℃與所用溶劑之沸點之間的範圍內,且較佳為0至120℃。 反應時間視例如反應溫度而變化,且反應通常在大約0.5至24小時內結束。 由式(1F)表示之胺基甲酸酯化合物可藉由使4-經取代之五員雜環化合物(2c)與硼化合物(3)在如反應流程3中所提及的催化劑、鹼及溶劑存在下反應來製備: 反應流程3其中R1
、R2
、R3
、R4
、R5
、R6
、R8
、X、X1
、Y、Z、l、m及n如上文所定義。 A表示鹵素、甲烷磺醯基氧基、對甲苯磺醯基氧基或三氟甲烷磺醯基氧基。 R9
表示氫、C1 - 6
烷基(取代基可形成具有兩個相鄰R9
之-CH2
CH2
-、-C(CH3
)2
-C(CH3
)2
-或-CH2
-CH2
-CH2
-)。 前述反應可在過渡金屬催化劑存在下進行。作為過渡金屬催化劑,可廣泛地使用通常已知之過渡金屬催化劑,且過渡金屬催化劑之實例包括鈀化合物,諸如乙酸鈀(II)、肆(三苯膦)鈀(0)、二氯化雙(三苯膦)鈀(II)、三(二苯亞甲基丙酮)二鈀及[1,1'-雙(二苯膦基)二茂鐵]二氯鈀(II)與二氯甲烷之錯合物;及其類似物,較佳為肆(三苯膦)鈀(0)。 待使用之鈀催化劑之量通常為每1 mol化合物(3)為0.01至1.0 mol、較佳為0.05至0.1 mol。 待使用之化合物(2c)之量通常為每1 mol化合物(3)為0.5至5 mol、較佳1.0至2.0 mol。 前述反應可在不存在或存在鹼下進行。在以上中,反應較佳在鹼存在下進行。作為鹼,可廣泛地使用通常已知鹼,且鹼之實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及其類似物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀及其類似物;無機鹼,諸如鹼金屬氫化物,諸如氫化鈉及氫化鉀及其類似物;鹼金屬醇鹽,諸如甲醇鈉、乙醇鈉、第三丁醇鉀及其類似物;有機鹼,諸如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲胺吡啶、哌啶及其類似物;及其類似物,較佳為碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及氫化鈉。使用此等鹼中之任一者或其兩種或更多種類型之組合。 待使用之鹼之量通常為每1 mol化合物(3)為1.0至5.0 mol、較佳1.0至2.0 mol。 前述反應在適當溶劑中或在無任何溶劑情況下進行。當前述反應在溶劑中進行時,只要溶劑相對於前述反應為非活性的,即可對溶劑無限制。 該種溶劑之實例包括:基於脂肪酸或脂環烴之溶劑,諸如正己烷、環己烷、正庚烷及其類似物;基於芳族烴之溶劑,諸如苯、氯苯、甲苯、二甲苯及其類似物;基於鹵化烴之溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿及四氯化碳及其類似物;基於醚之溶劑,諸如乙醚、四氫呋喃(THF)、1,4-二噁烷、二甲氧基乙烷及其類似物;酯溶劑,諸如乙酸甲酯、乙酸乙酯及其類似物;乙腈;基於醯胺之溶劑,諸如N,N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮及其類似物;及基於亞碸之溶劑,諸如二甲亞碸、環丁碸及其類似物;H2
O;乙酸,優選為二甲氧基乙烷及乙醇-H2
O及甲苯-H2
O之混合溶劑。可單獨使用此等溶劑中之任一者,或必要時可使用其兩種或超過兩種類型之組合。 待使用之溶劑之量通常為每1 mol化合物(3)為1.0至20公升、較佳1.0至10公升。 前述反應之反應溫度不受特定限制,且通常處於-10℃與所用溶劑之沸點之間的範圍內,且較佳為0至120℃。 反應時間視例如反應溫度而變化,且反應通常在大約0.5至24小時內結束。 此步驟中所用化合物(3)可根據已知方法(例如,本方法描述於WO2016/114165、WO2016/114164、WO2016/114162及WO2016/114161中)製造。 由式(1)表示之胺基甲酸酯化合物可藉由使試劑(4)與化合物(1G)在如反應流程4中所提及之催化劑、鹼及溶劑存在下反應來製備: 反應流程4其中R1
、R2
、R3
、R4
、R5
、R6
、R7
、R8
、X、X1
、Y、Z、l、m及n如上文所定義,且G表示脫離基。 反應中所用化合物(1G)與試劑(4)之間的比率不受特定限制,且可恰當地選自廣泛範圍。待使用之試劑(4)之量通常為每1 mol化合物(1G)為1.0至5.0 mol、較佳1.0至2.0 mol。 前述反應可在不存在或存在鹼下進行。在以上中,反應較佳在鹼存在下進行。作為鹼,可廣泛地使用通常已知鹼,且鹼之實例包括:鹼金屬碳酸鹽,諸如碳酸鈉、碳酸鉀、碳酸銫、碳酸氫鉀、碳酸氫鈉及其類似物;鹼金屬氫氧化物,諸如氫氧化鈉、氫氧化鉀及其類似物;無機鹼,諸如鹼金屬氫化物,諸如氫化鈉及氫化鉀及其類似物;鹼金屬醇鹽,諸如甲醇鈉、乙醇鈉、第三丁醇鉀及其類似物;有機鹼,諸如吡啶、三乙胺、二乙胺、二甲胺、甲胺、咪唑、苯并咪唑、二異丙基乙胺、4-二甲胺吡啶、哌啶及其類似物;及其類似物,較佳為鹼金屬碳酸鹽及鹼金屬氫化物,更優選為碳酸鈉、碳酸鉀、碳酸氫鉀、碳酸氫鈉及氫化鈉。使用此等鹼中之任何獨立的一者或其兩種或更多種類型之組合。 待使用之鹼之量通常為每1 mol化合物(1G)為1.0至5.0 mol、較佳1.0至3.0 mol。 前述反應可藉由進一步添加自由基引發劑進行。自由基引發劑之實例包括但不特別限制於亞硫酸加合物,諸如亞硫酸、亞硫酸鹽、Rongalite (化合物名稱,甲醛次硫酸鈉)及其類似物。鹼及自由基引發劑可以組合使用。 當使用自由基引發劑時,作為其添加量,待使用之自由基引發劑之量通常為每1 mol化合物(1G)為0.1至10.0 mol、較佳0.1至5.0 mol。 前述反應在適當溶劑中進行。溶劑之實例包括:基於脂肪酸或脂環烴之溶劑,諸如正己烷、環己烷、正庚烷及其類似物;基於芳族烴之溶劑,諸如苯、氯苯、甲苯、二甲苯及其類似物;基於鹵化烴之溶劑,諸如二氯甲烷、1,2-二氯乙烷、氯仿、四氯化碳及其類似物;基於醚之溶劑,諸如乙醚、THF、1,4-二噁烷及其類似物;基於酯之溶劑,諸如乙酸甲酯、乙酸乙酯及其類似物;基於醯胺之溶劑,諸如乙腈;DMF、N,N-二甲基乙醯胺、N-甲基-2-吡咯啶酮及其類似物;二甲亞碸及其類似物,基於亞碸之溶劑;極性溶劑,諸如基於醇之溶劑,諸如環丁碸、甲醇、乙醇、異丙醇及其類似物;水;及其類似物。可單獨使用此等溶劑中之任一者,或必要時可使用其兩種或超過兩種類型之組合。 待使用之溶劑之量通常為每1 mol化合物(1G)為1.0至20公升、較佳1.0至10公升。 反應溫度視起始化合物、試劑、溶劑及其類似物而變化,但在反應體系中其通常為-40℃至回流溫度,較佳為0至100℃。 反應時間視化合物、試劑、溶劑及反應溫度以及其類似物而變化,但通常為5分鐘至48小時,較佳為10分鐘至24小時。 藉由流程1至4中所示的本方法所獲得之由式(1)表示之化合物易於從反應混合物中分離,且可藉由使用典型分離方式及純化方式(例如過濾、溶劑萃取、蒸餾、再結晶、管柱層析等)來純化。 儘管用於本發明化合物之形式可為本發明化合物自身,但本發明化合物通常藉由使本發明化合物與固體載劑、液體載劑、氣體載劑、界面活性劑及其他混合來製備,且必要時添加黏著劑、分散劑及穩定劑以調配成可濕潤散劑、水分散性顆粒、可流動物、顆粒、乾燥可流動物、可乳化濃縮物、水溶液、油溶液、煙霧劑、霧劑、微膠囊及其他,在此等調配物中,通常含有0.1至99重量%、較佳0.2至90重量%範圍內之本發明化合物。 固體載劑之實例包括呈細粉或微粒形式之黏土(例如,高嶺土、矽藻土、合成的水合二氧化矽、Fubasami黏土、膨潤土及酸黏土)、滑石或其他無機礦物(例如,絹雲母、石英粉末、硫粉末、活性炭、碳酸鈣及水合二氧化矽),且液體載劑之實例包括水、醇類(例如,甲醇及乙醇)、酮類(例如,丙酮及甲基乙基酮)、芳族烴類(例如,苯、甲苯、二甲苯、乙苯及甲萘)、脂族烴類(例如,正己烷、環己烷及煤油)、酯類(例如,乙酸乙酯及乙酸丁酯)、腈類(例如,乙腈及異丁腈)、醚類(例如,二噁烷及二異丙基醚)、醯胺類(例如,N,N-二甲基甲醯胺(DMF)及二甲基乙醯胺)、鹵化碳氫化合物類(例如,二氯乙烷三氯乙烯及四氯化碳)及其他。 界面活性劑之實例包括烷基硫酸鹽、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚及其聚氧乙烯化之化合物、聚乙二醇醚、多元醇酯及糖醇衍生物。 用於調配物之其他輔助劑之實例包括黏著劑、分散劑及穩定劑,具體言之酪蛋白、明膠、多糖(例如,澱粉、阿拉伯膠(gum arabic)、纖維素衍生物及褐藻酸)、木質素衍生物、膨潤土、糖、水溶性合成的聚合物(例如,聚乙烯醇、聚乙烯吡咯啶酮及聚丙烯酸)、PAP (酸性磷酸異丙酯)、BHT (2,6-二-第三丁基-4-甲苯酚)、BHA (2-第三丁基-4-甲氧基苯酚與3-第三丁基-4-甲氧基苯酚之混合物)、植物油、礦物油、脂肪酸或其脂肪酸酯及其他。 施用本發明化合物之本方法不受特定限制,只要施用形式為可藉由該形式施用本發明化合物的形式,且包括例如對植物的施用,諸如葉施用;對用於培育植物的領域的施用,諸如浸沒處理;及對污染的施用,諸如種子滅菌。 施用劑量視天氣條件、劑型、施用時序、施用方法、待施用面積、目標疾病及目標作物等而變化,但通常在每1,000 m2
之待施用的面積1至500 g、且較佳2至200 g範圍內。可乳化濃縮物、可濕潤散劑或懸浮濃縮物等通常藉由用水使其稀釋來施用。在此情況下,本發明化合物之濃度在稀釋後通常在0.0005至2重量%、且較佳在0.005至1重量%範圍內。粉塵調配物或粒狀調配物等通常以自身而不使其稀釋來施用。在施用於種子中,本發明化合物之量通常在每1 kg種子0.001至100 g、且較佳在0.01至50 g範圍內。 本文中,害蟲存活的場所之實例包括稻田、田、茶園、果園、非農田、住宅、育苗盤、育苗盒、育苗土壤及育苗床。 此外,在另一實施例中,例如,本發明化合物可向下文提及之脊椎動物之內部(身體內部)或外部(身體表面)投與以全身性或非全身性消滅寄生在脊椎動物上的活物或寄生蟲。內部藥物之方法之實例包括經口投與、肛門投與、移殖、藉由皮下、肌肉內或靜脈內注射投與。外部藥物方法之實例包括經皮投與。此外,本發明化合物可由家畜動物攝入,從而消滅在動物排泄物中出現之衛生昆蟲(sanitary insect)。 當本發明化合物施用於動物(諸如害蟲寄生於其上之家畜動物及寵物)時,劑量視投與方法等而變化,但一般而言期望投與本發明化合物以使得活性成分(本發明化合物或其鹽)之劑量大體上在每1 kg動物體重0.1 mg至2,000 mg、且較佳在0.5 mg至1,000 mg範圍內。 本發明化合物可用作控制農田中(諸如田、稻田、草坪、果園)之植物疾病的藥劑。本發明之化合物可控制農田中或用於培育以下「植物」之其他田中出現的疾病。 作物:玉米、稻穀、小麥、大麥、粗麥、燕麥、高樑、棉、大豆、花生、蕎麥、甜菜、菜籽、向日葵、甘蔗、菸草及其他;蔬菜:茄果類蔬菜(solanaceous vegetable) (例如,茄子、番茄、甜椒、胡椒及馬鈴薯)、葫蘆科蔬菜(cucurbitaceous vegetable) (例如,胡瓜、南瓜、西葫蘆(zucchini)、西瓜及甜瓜)、十字花科蔬菜(cruciferous vegetable) (例如,日本蘿蔔(Japanese radish)、白蕪菁、辣根、球莖甘藍、大白菜(Chinese cabbage)、甘藍菜、雪里紅(leaf mustard)、椰菜、花椰菜(cauliflower))、紫菀科蔬菜(asteraceous vegetable) (例如,牛蒡、茼蒿(crown daisy)、朝鮮薊及萵苣)、百合科蔬菜(liliaceous vegetable) (例如,小洋蔥(green onion)、洋蔥、大蒜及蘆筍)、傘狀花科蔬菜(ammiaceous vegetable) (例如,胡蘿蔔、歐芹、芹菜及防風草)、藜科蔬菜(chenopodiaceous vegetable) (例如,菠菜及紅頭菜(Swiss chard))、唇形科蔬菜(lamiaceous vegetable) (例如,紫蘇(Perilla frutescens)、薄荷及羅勒(basil)、草莓、甜馬鈴薯、日本薯蕷(Dioscorea japonica)、芋頭(colocasia)及其他;花:觀賞植物葉植物:水果:梨果類(pomaceous)水果(例如,蘋果、梨、日本梨、木瓜(Chinese quince)及柑橘)、核果(例如,桃、李、油桃、梅(Prunus mume)、櫻桃水果、杏及乾果李(prune))、柑橘屬(citrus)水果(例如,溫州蜜柑(Citrus unshiu)、橙、檸檬、青檸(lime)及葡萄柚(grapefruit))、堅果(例如,栗子、胡桃、榛子、杏仁、開心果、腰果(cashew nut)及澳洲胡桃(macadamia nut))、漿果類水果(例如,越桔、蔓越橘、黑莓及樹莓)、葡萄、柿子(kaki persimmon)、橄欖、日本李、香蕉、咖啡、椰棗(date palm)、椰子及其他;除水果樹木外之樹木:茶桑椹、開花植物、行道樹(roadside tree) (例如,白蠟木(ash)、樺樹(birch)、山茱萸(dogwood)、桉樹、銀杏(Ginkgo biloba)、雪青(lilac)、楓樹(maple)、櫟屬(Quercus)、白楊(poplar)、紫荊樹(Judas tree)、楓香樹(Liquidambar formosana)、懸鈴樹(plane tree)、櫸樹(zelkova)、日本柏(Japanese arborvitae)、冷杉木(fir wood)、鐵杉(hemlock)、杜松(juniper)、松(Pinus)、雲杉(Picea)、及東北紅豆杉(Taxus cuspidata));及其他。 上文所提及之「植物」包括經基因修飾之作物。 本發明化合物對其有控制功效之害蟲包括植物病原體,諸如絲狀真菌(filamentous fungus),以及有害節肢動物,諸如有害昆蟲及有害蟎蟲,及線蟲(nemathelminth),諸如線蟲(nematodes),且具體言之包括但不限於以下實例。 稻穀疾病:稻瘟病(blast) (稻瘟菌(Magnaporthe grisea))、褐斑病(brown spot) (水稻旋孢腔菌(Cochliobolus miyabeanus))、紋枯病(sheath blight) (立枯絲核菌(Rhizoctonia solani))、水稻惡苗病(bakanae disease) (赤黴菌(Gibberella fujikuroi))及霜黴病(downy mildew) (大孢指疫黴(Sclerophthora macrospora)); 小麥疾病:白粉病(powdery mildew) (禾白粉菌(Erysiphe graminis))、鐮刀枯萎病(fusarium blight) (禾穀鐮刀菌(Fusarium graminearum)、燕麥鐮孢菌(F. avenaceum)、大刀鐮孢菌(F. culmorum)、雪黴葉枯病(Microdochium nivale))、銹病(rust) (條銹病(Puccinia striiformis)、桿銹病(P. graminis)、葉銹病(P. recondita))、雪疫病(snow mould) (雪腐鐮刀黴(Micronectriella nivale))、斑疹傷寒疫病(typhulasnow blight) (斑疹傷寒菌(Typhula sp.))、散黑穗病(loose smut) (小麥散黑穗病(Ustilago tritici))、腥黑穗病(stinking smut) (小麥腥黑穗病菌(Tilletia caries)、小麥矮腥黑穗病(T. controversa))、小麥紋枯病(eyespot) (小麥基腐病菌(Pseudocercosporella herpotrichoides))、葉皰(leaf blotch) (小麥殼針孢(Septoria tritici))、稃枯病(glume blotch) (小麥葉斑病真菌(Stagonospora nodorum))、褐斑病(tan spot) (小麥黃斑葉枯病菌(Pyrenophora tritici-repentis))、絲核菌種子疫病(rhizoctonia seeding blight) (立枯絲核菌)及呈現所有疾病(小麥全蝕病菌(Gaeumannomyces graminis)); 大麥疾病:白粉病(禾白粉菌)、鐮刀枯萎病(禾穀鐮刀菌、燕麥鐮孢菌、大刀鐮孢菌、雪黴葉枯病)、銹病(條銹病、桿銹病、大麥對銹病(P. hordei))、散黑穗病(大麥散黑粉菌(Ustilago nuda))、褐變病(scald) (大麥雲紋病菌(Rhynchosporium secalis))、網斑病(net blotch) (圓核腔菌(Pyrenophora teres))、斑枯(spot blotch) (禾旋孢腔菌(Cochliobolus sativus))、葉條紋病(leaf stripe) (麥類核腔菌(Pyrenophora graminea))、柱隔孢菌病(Ramularia disease) (柱隔孢葉斑病(Ramularia collo-cygni))及絲核菌種子疫病(立枯絲核菌); 玉米疾病:銹病(玉米柄鏽菌(Puccinia sorghi))、南方銹病(southern rust) (玉米南方銹病(Puccinia polysora))、北方葉枯病(玉米大斑病菌(Setosphaeria turcica))、南方葉枯病(異旋孢腔菌(Cochliobolus heterostrophus))、炭疽病(禾生炭疽病菌(Colletotrichum graminicola))、灰色葉斑病(gray leaf spot) (玉蜀黍尾孢菌(Cercospora zeae-maydis))、小麥紋枯病(玉米秋梗孢(Kabatiella zeae))及噬菌體葉斑病(phaeosphaeria leaf spot) (噬菌體玉米小斑病菌(Phaeosphaeria maydis)); 棉疾病:炭疽病(炭疽病棉)、灰色黴菌(白斑柱隔孢(Ramularia areola))、黑斑病(alternaria leaf spot) (棉黑斑病菌(Alternaria macrospora)、棉鈴蟲(A. gossypii)); 咖啡疾病:銹病(咖啡駝孢鏽菌(Hemileia vastatrix)); 油菜籽疾病:黃瓜菌核病(sclerotinia rot) (向日葵核盤菌(Sclerotinia sclerotiorum))、植物黑斑病(black spot) (甘藍交鏈孢菌(Alternaria brassicae))及黑脛病(black leg) (油菜根枯病菌(Phoma lingam)); 柑橘屬疾病:黑變病(melanose) (柑桔間座殼菌(Diaporthe citri))、瘡痂病(scab) (柑橘痂囊腔菌(Elsinoe fawcettii))及果腐病(fruit rot) (指狀青黴菌(Penicillium digitatum)、柑橘青黴病菌(P. italicum)); 蘋果疾病:花枯病(blossom blight) (鏈核盤菌(Monilinia mali))、潰瘍病(canker) (梨腐爛病菌(Valsa ceratosperma))、白粉病(蘋果白粉病(Podosphaera leucotricha))、蠶豆蘭格苞葉斑病(alternaria leaf spot) (斑點落葉病菌(Alternaria alternata apple pathotype))、瘡痂病(scab) (蘋果黑星病菌(Venturia inaequalis))及苦腐病(bitter rot) (尖孢炭疽菌(Colletotrichum acutatum)); 梨疾病:瘡痂病(日本梨黑星病菌(Venturia nashicola)、梨黑星病(V. pirina))、植物黑斑病(交鏈孢屬赤星病菌日本梨病變形(Alternaria alternata Japanese pear pathotype))及銹病(梨銹病(Gymnosporangium haraeanum)); 桃疾病:褐腐病(brown rot) (桃褐腐病菌(Monilinia fructicola))、瘡痂病(嗜果枝孢黴(Cladosporium carpophilum))及蝴蝶蘭腐病(Phomopsis rot) (擬莖點黴屬(Phomopsis sp.)); 葡萄疾病:炭疽病(葡萄黑痘病菌(Elsinoe ampelina))、成熟腐爛病(ripe rot) (圍小叢殼菌(Glomerella cingulata))、白粉病(葡萄白粉病菌(Uncinula necator))、銹病(葡萄層鏽菌(Phakopsora ampelopsidis))、黑腐病(black rot) (葡萄球座菌(Guignardia bidwellii))及霜黴病(downy mildew) (葡萄生單軸黴(Plasmopara viticola)); 日本柿子之疾病:炭疽病(柿盤長孢(Gloeosporium kaki))及葉斑病(柿角斑病(Cercospora kaki)、納瓦黴(Mycosphaerella nawae)); 葫蘆家族之疾病:炭疽病(瓜類炭疽病菌(Colletotrichum lagenarium))、白粉病(單絲殼白粉菌(Sphaerotheca fuliginea))、蔓枯病(gummy stem blight) (蔓枯病菌(Didymella bryoniae))、靶斑病(target spot) (多主棒孢黴(Corynespora cassiicola))、鐮刀菌萎蔫病(fusarium wilt) (尖鐮孢菌(Fusarium oxysporum)、霜黴病(downy mildew) (黃瓜霜黴病原菌(Pseudoperonospora cubensis))、大豆疫腐病(phytophthora rot) (疫黴(Phytophthora sp.))及猝倒病(damping-off) (腐黴菌(Pythium sp.)); 番茄疾病:早疫病(early blight) (交鏈孢菌(Alternaria solani))、葉黴病(leaf mold) (黃枝孢黴(Cladosporium fulvum)、葉黴病(假尾孢菌(Pseudocercospora fuligena))及晚疫病(late blight) (致病疫黴(Phytophthora infestan)); 茄子疾病:褐斑病(茄褐紋病菌(Phomopsis vexans))及白粉病(二孢白粉菌(Erysiphe cichoracearum)); 十字花科蔬菜之疾病:交鏈孢菌葉斑病(山茶交鏈孢菌(Alternaria japonica))、白斑病(white spot) (短尾尾球藻(Cercosporella brassicae))、根瘤病(clubroot) (根腫病菌(Plasmodiophora parasitica))、霜黴病(寄生霜黴(Peronospora parasitica)); 大蔥疾病:銹病(蔥柄鏽菌(Puccinia allii)); 大豆疾病:紫斑病(purple stain) (菊池尾孢菌)、痂圓孢屬瘡痂病(sphaceloma scad) (大豆瘡痂病菌(Elsinoe glycines))、豆莢及莖疫病(大豆黑點病菌(Diaporthe phaseolorum var. sojae))、銹病(大豆鏽菌)、靶斑病(多主棒孢黴)、炭疽病(大豆炭疽病菌(Colletotrichum glycines/C. truncatum)、紋枯病(Rhizoctonia aerial blight) (立枯絲核菌)、殼針孢屬褐斑病(septoria brown spot)(大豆褐紋殼針孢)及灰斑病(frog eye leaf spot) (大豆灰斑病菌); 菜豆疾病:炭疽病(菜豆炭疽病菌); 花生疾病:早期葉斑病(落花生黑澀病菌(Cercospora personata))、晚期葉斑病(落花生褐斑病菌(Cercospora arachidicola))及白絹病(southern blight) (白絹病菌(Sclerotium rolfsii)); 豌豆疾病:白粉病(白粉病菌); 馬鈴薯疾病:早疫病(馬鈴薯夏疫病菌(Alternaria solani))、晚疫病(馬鈴薯腐疫病菌)及半身凋萎病(verticillium wilt) (半身凋萎病菌(verticillium albo-atrum)、大麗輪枝菌(V. dahliae)、變黑輪枝菌(V. nigrescens)); 草莓疾病:白粉病(草莓白粉病菌); 茶樹疾病:網皰狀疫病(net blister blight) (網狀外擔菌(Exobasidium reticulatum))、白痂病(white scab) (茶瘡痂病菌(Elsinoe leucospila))、灰疫病(gray blight) (擬盤多毛孢屬(Pestalotiopsis sp.))及炭疽病(茶炭疽病菌(Colletotrichum theae-sinensis)); 菸草疾病:褐斑病(長柄鏈隔孢菌)、白粉病(二孢白粉菌)、炭疽病(菸草炭疽病菌)、露菌病(downy mildew) (菸草霜黴菌(Peronospora tabacina))及黑梗病(菸草疫黴菌(Phytophthora nicotianae)); 甜菜疾病:尾孢菌葉斑病(甜菜尾孢菌)、葉枯病(稻紋枯病菌(Thanatephorus cucumeris))、根腐病(Thanatephorus cucumeris) (稻紋枯病菌)及絲囊屬根腐病(甜菜黑腐絲囊黴菌(Aphanomyces cochlioides)); 薔薇疾病:黑點病(薔薇雙盤菌(Diplocarpon rosae))及白粉病(薔薇類白粉病菌(Sphaerotheca pannosa)); 菊花疾病:葉枯病(野菊花殼針孢菌(Septoria chrysanthemi-indici))及白銹病(堀柄鏽菌(Puccinia horiana)); 洋蔥疾病:葡萄孢屬葉枯病(灰色葡萄孢菌、菌絲性腐敗病菌(B. byssoidea)、小菌核性腐敗病菌(B. squamosa))、灰黴頸腐病(灰色腐敗病菌(Botrytis allii))及小菌核腐病(小菌核性腐敗病菌(Botrytis squamosa); 各種作物疾病:灰黴病(灰色葡萄孢菌)及核盤菌屬腐病(sclerotinia rot) (核盤菌); 日本蘿蔔之疾病:交鏈孢屬葉斑病(甘藍交鏈孢菌(Alternaria brassicicola)); 草皮草疾病:幣斑病(dollar spot) (同果核盤菌(Sclerotinia homoeocarpa))、褐斑及大斑(立枯絲核菌);及 香蕉疾病:香蕉葉斑病(Sigatoka disease) (斐濟球腔菌、芭蕉生球腔菌)。 半翅目:稻虱科(Delphacidae) (例如灰飛虱(Laodelphax striatellus)、褐飛虱或白背飛虱);角頂葉蟬亞科(Deltocephalinae) (例如偽黑尾葉蟬或二點黑尾葉蟬);蚜蟲科(例如棉蚜、桃蚜、菜蚜、大戟長管蚜(Macrosiphum euphorbiae)、馬鈴薯長鬚蚜、禾穀縊管蚜、桔蚜(Toxoptera citricidus));蝽科(Pentatomidae) (例如南方稻綠蝽、條蜂緣蝽(Riptortus clavatus)、中華稻緣蝽(Leptocorisa chinensis)、尖角二星蝽(Eysarcoris parvus)、茶翅蝽(Halyomorpha mista)或牧草盲蝽(Lygus lineolaris));粉虱科(Aleyrodidae) (例如溫室白粉虱(Trialeurodes vaporariorum)或銀葉粉虱(Bemisia argentifolii));介殼蟲總科(Coccoidea) (例如橘紅腎圓盾介殼蟲(Aonidiella aurantii)、梨圓介殼蟲(Comstockaspis perniciosa)、桔矢尖介殼蟲(Unaspis citri)、紅蠟介殼蟲(Ceroplastes rubens)或吹綿介殼蟲(Icerya purchasi));網椿科(Tingidae),木虱科(Psyllidae);床虱(Bed bugs) (溫帶臭蟲(Cimex lectularius))及其他。 鱗翅目:螟蛾科(例如二化螟(Chilo suppressalis)、三化螟(Tryporyza incertulas)、瘤野螟(Cnaphalocrocis medinalis)、棉大卷葉野螟(Notarcha derogata)、印度穀螟(Plodia interpunctella)、亞洲玉米螟(Ostrinia furnacalis)、菜心螟(Hellula undalis)、蘭草螟蛾(Pediasia teterrellus))、夜蛾科(例如斜紋夜蛾(Spodoptera litura)、甜菜夜蛾(Spodoptera exigua)、黏秘夜蛾(Pseudaletia separata)、甘藍夜蛾(Mamestra brassicae)、小地老虎(Agrotis ipsilon)、黑點銀紋夜蛾(Plusia nigrisigna)、粉紋夜蛾屬(Trichoplusia spp.)、實夜蛾屬(Heliothis spp.)或棉鈴蟲蛾屬(Helicoverpa spp.);粉蝶科(Pieridae) (例如紋白蝶(Pieris rapae))、卷葉蛾科(Tortricidae)(例如褐帶卷蛾屬(Adoxophyes spp.)、桃折心蟲(Grapholita molesta)、蘋果蠹蛾(Cydia pomonella)、大豆食心蟲(Leguminivora glycinivorella)、日豆小卷蛾(Matsumuraeses azukivora)、茶小卷葉蛾(Adoxophyes orana fasciata)、褐帶卷蛾屬(Adoxophyes sp.)、茶長卷葉蛾(Homona magnanima)、杏黃卷蛾(Archips fuscocupreanus)、蘋果蠹蛾(Cydia pomonella));細蛾科(Gracillariidae) (例如茶細蛾(Caloptilia theivora)、金紋細蛾(Phyllonorycter ringoniella));蛀果蛾科(Carposinidae) (例如桃蛀果蛾(Carposina niponensis));潛蛾科(Lyonetiidae) (例如潛蛾屬(Lyonetia spp.);毒蛾科(Lymantriidae) (例如毒蛾(Lymantria spp.)或黃毒蛾屬(Euproctis spp.));巢蛾科(Yponomeutidae) (例如小菜蛾Plutella xylostella);麥蛾科(Gelechiidae) (例如紅鈴蟲(Pectinophora gossypiella)或馬鈴薯塊莖蛾(Phthorimaea operculella));燈蛾科 (例如美國白蛾(Hyphantria cunea));大蛾科(Tineidae) (例如衣蛾(Tinea translucens)或穀蛾(Tineola bisselliella));及其他; 纓翅目(Thysanoptera):纓翅目(例如苜蓿薊馬(Frankliniella occidentalis)、南黃薊馬(Thrips palmi)、小黃薊馬(Scirtothrips dorsalis)、菸薊馬(Thrips tabaci)、臺灣花薊馬(Frankliniella intonsa)、菸褐花薊馬(Frankliniella fusca)); 雙翅目:家蠅(Musca domestica)、淡色庫蚊(Culex pipiens pallens)、三角虻(Tabanus trigonus)、蔥種蠅(Hylemya antiqua)、灰地種蠅(Hylemya platura)、中華瘧蚊(Anopheles sinensis)、稻潛蠅(Agromyza oryzae)、水稻潛葉蠅(Hydrellia griseola)、稻稈潛蠅(Chlorops oryzae)、瓜實蠅(Dacus cucurbitae)、地中海實蠅(Ceratitis capitata)、非洲斑潛蠅(Liriomyza trifolii)及其他; 鞘翅目:茄二十八星瓢蟲(Epilachna vigintioctopunctata)、黃守瓜(Aulacophora femoralis)、黃條葉蚤(Phyllotreta striolata)、稻負泥蟲(Oulema oryzae)、稻象鼻蟲(Echinocnemus squameus)、稻水象甲(Lissorhoptrus oryzophilus)、棉鈴象甲(Anthonomus grandis)、綠豆象(Callosobruchus chinensis)、結縷草象甲(Sphenophorus venatus)、日本麗金龜(Popillia japonica)、古銅異麗金龜(Anomala cuprea)、根螢葉甲屬(Diabrotica spp.)、馬鈴薯甲蟲(Leptinotarsa decemlineata)、叩甲屬(Agriotes spp.)、菸甲蟲(Lasioderma serricorne)、小園皮蠹(Anthrenus verbasci)、擬榖盜(Tribolium castaneum)、褐粉蠹(Lyctus brunneus)、馬拉白星天牛(Anoplophora malasiaca)、縱坑切梢小蠹(Tomicus piniperda))及其他; 直翅目:飛蝗(Locusta migratoria)、非洲螻蛄(Gryllotalpa africana)、小翅稻蝗(Oxya yezoensis)、日本稻蝗(Oxya japonica)及其他; 膜翅目:紅角菜葉蜂(Athalia rosae)、頂切葉蟻屬(Acromyrmex spp.)、火蟻屬(Solenopsis spp.)及其他; 線蟲:貝西滑刃線蟲(Aphelenchoides besseyi)、草莓芽線蟲(Nothotylenchus acris)、大豆異皮線蟲(Heterodera glycines)、根瘤線蟲(Meloidogyne incognita)、草地墊刃線蟲屬(Pratylenchus)、假根瘤線蟲(Nacobbus aberrans)及其他; 蜚蠊目(Blattariae):德國小蠊(Blattella germanica)、黑褐家蠊(Periplaneta fuliginosa)、美洲家蠊(Periplaneta americana)、棕色家蠊(Periplaneta brunnea)、東方蜚蠊(Blatta orientalis)及其他; 蜱蟎目:葉蟎(Tetranychidae) (例如棉葉蟎(Tetranychus urticae)、橘全爪蟎(Panonychus citri)或小爪蟎屬(Oligonychus spp.));節蜱科(Eriophyidae) (例如桔刺皮節蜱(Aculops pelekassi));跗線蟎科(Tarsonemidae) (例如多食跗線蟎(Polyphagotarsonemus latus));細鬚蟎科(Tenuipalpidae);杜克葉蟎科(Tuckerellidae);粉蟎科(Acaridae) (例如腐食酪蟎(Tyrophagus putrescentiae));塵蟎科(Pyroglyphidae) (例如粉塵蟎(Dermatophagoides farinae)或屋塵蟎(Dermatophagoides pteronyssinus));肉食蟎科(Cheyletidae) (例如普通肉食蟎(Cheyletus eruditus)、馬六甲肉食蟎(Cheyletus malaccensis)或穆氏肉食蟎(Cheyletus moorei));皮刺蟎科(Dermanyssidae);及其他。 包含本發明化合物或其鹽之調配物亦可在有關治療家畜疾病或家畜工業之領域中使用,且例如可消滅寄生在脊椎動物(諸如人類、母牛、綿羊、豬、家禽、狗、貓及魚)之內部及/或外部上的活物或寄生蟲,從而保持公共衛生。 害蟲之實例包括硬蜱屬(Ixodes spp.) (例如肩突硬蜱(Ixodes scapularis))、牛蜱屬(Boophilus spp.) (例如微小牛蜱(Boophilus microplus))、花蜱屬(Amblyomma spp.)、璃眼蜱屬(Hyalomma spp.)、扇頭蜱屬(Rhipicephalus spp.) (例如血紅扇頭蜱(Rhipicephalus sanguineus))、血蜱屬(Haemaphysalis spp.) (例如長角血蜱(Haemaphysalis longicornis))、革蜱屬(dermacentor spp.)、鈍緣蜱屬(Ornithodoros spp.) (例如喙蜱(Ornithodoros moubata))、雞皮刺蟎(Dermanyssus gallinae)、林禽刺蟎(Ornithonyssus sylviarum)、疥蟎屬(Sarcoptes spp.) (例如疥蟎(Sarcoptes scabiei))、癢蟎屬(Psoroptes spp.)、皮蟎屬(Chorioptes spp.)、蠕形蟎屬(Demodex spp.)、真恙蟎亞屬(Eutrombicula spp.)、伊蚊屬(Ades spp.) (例如白紋伊蚊(Aedes albopictus))、瘧蚊屬(Anopheles spp.)、庫蚊屬(Culex spp.)、庫蠓屬(Culicoides spp.)、家蠅屬(Musca spp.)、牛蠅屬(Hypoderma spp.)、馬蠅屬(Gasterophilus spp.)、角蠅屬(Haematobia spp.)、牛虻屬(Tabanus spp.)、蚋屬(Simulium spp.)、 錐鼻蟲屬(Triatoma spp.)、毛虱目(Phthiraptera) (例如畜虱屬(Damalinia spp.))、顎虱屬(Linognathus spp.)、血虱屬(Haematopinus spp.)、 櫛頭蚤屬(Ctenocephalides spp.) (例如貓櫛頭蚤屬(Ctenocephalides felis))、鼠蚤屬(Xenopsylla spp.)、廚蟻(monomorium pharaonis)及線蟲(nematodes/hairworm) (例如巴西日圓線蟲(Nippostrongylus brasiliensis)、艾氏毛圓線蟲(Trichostrongylus axei)、蛇形毛圓線蟲(Trichostrongylus colubriformis))、旋毛蟲屬(Trichinella spp.) (例如旋毛蟲(Trichinella spiralis))、撚轉胃蟲(Haemonchus contortus)、細頸屬(Nematodirus spp.) (例如巴氏細頸線蟲(Nematodirus battus))、普通奧斯特他線蟲(Ostertagia circumcincta)、古柏線蟲屬(Cooperia spp.)、包膜蟲屬(Hymenolepis nana)及其他。 將本發明之胺基甲酸酯(1)用作例如殺真菌劑之活性成分。 本發明之胺基甲酸酯(1)可藉由製成期望形式(諸如油、乳液、可濕潤散劑、可流動製劑、顆粒、散劑、霧劑、熏劑或其類似形式)使用。在此情況下,本發明之胺基甲酸酯(1)之含量不受限制且可根據各種條件適合地選自廣泛範圍,該等條件諸如製劑形式、待治療之疾病種類、植物種類、疾病嚴重性、施用場所、施用時間、施用方法、以組合使用之化學品(殺昆蟲劑、殺線蟲劑、殺蟎劑(acaricide)、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤調節劑等)、肥料之量及種類等等。按殺真菌製劑之總量計,含量通常為約0.01至約95重量%。 含有本發明之胺基甲酸酯(1)作為活性成分之殺真菌製劑可根據已知方法製造。舉例而言,本發明之胺基甲酸酯(1)可與載劑(諸如固體載劑、液體載劑、氣態載劑或其類似載劑)混合。 視情況可添加界面活性劑及用於製備之其他佐劑。 適用載劑可為通常用於此領域中之已知載劑中之任一種。 適用固體載劑之實例為黏土之細粒或顆粒 (高嶺黏土、矽藻土、合成的水合二氧化矽、膨潤土、fubasami黏土、酸黏土及其類似物)、滑石、陶瓷、其他無機礦物鈰矽石、石英、硫、活性碳、碳酸鈣、水合二氧化矽等)等等。 適用液體載劑為例如,水、醇類(諸如甲醇、乙醇等)、酮類(諸如丙酮、甲基乙基酮、等)、芳族烴類(諸如苯、甲苯、二甲苯、乙苯、甲基萘等)、脂族烴類(諸如己烷、環己烷、煤油、輕質油等)、酯類(諸如乙酸乙酯、乙酸丁酯等)、腈類(諸如乙腈、異丁腈等)、醚類(諸如二異丙基醚、二噁烷等)、醯胺類(諸如N,N-二甲基甲醯胺、N,N-二甲基乙醯胺等)、鹵化烴(諸如二氯甲烷、三氯乙烷、四氯化碳等)、二甲基甲醯胺、大豆油、棉子油、植物油等等。 適用氣態載劑(推進劑)之實例為丁烷氣體、LPG (液化石油氣)、二甲醚、二氧化碳等。 適用界面活性劑之實例為烷基酯硫酸鹽、烷基磺酸鹽、烷基芳基磺酸鹽、烷基芳基醚、其聚氧乙烯化產物、聚乙二醇醚、多元醇酯、糖醇化合物等。 用於製備之適用佐劑之實例為固定劑,諸如酪蛋白、明膠、多糖(澱粉粉末、阿拉伯膠、纖維素化合物、褐藻酸等)、木質素化合物、膨潤土、醣類、合成的水溶性聚合物(聚乙烯醇、聚乙烯吡咯啶酮、聚丙烯酸等)及其類似物;穩定劑,諸如PAP (酸性磷酸異丙酯)、BBH (2,6-二-第三丁基-4-甲苯酚)、BHA (2-第三丁基-4-甲氧基苯酚與3-第三丁基-4-甲氧基苯酚之混合物)、植物油、礦物油、脂肪酸、其酯及其類似物。 由此獲得之本發明之殺真菌製劑可按原樣或用水稀釋來使用。製劑可藉由與殺蟲劑、殺線蟲劑、殺蟎劑(acaricide)、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤調節劑等中之任一種混合製備。本發明之製劑可與其他製劑同時施用。 當本發明之製劑用作在農業及園藝中使用的殺真菌劑時,本發明之製劑之量不受限制且可根據各種條件適合地選自廣泛範圍,該等條件諸如活性成分濃度、製劑形式、待治療之疾病種類、植物種類、疾病或蟎嚴重性、施用時間、施用方法、以組合使用之化學品(殺昆蟲劑、殺線蟲劑、殺蟎劑(miticide)、殺真菌劑、除草劑、植物生長控制劑、增效劑、土壤調節劑等)、肥料之量及種類等等。該量通常為每100 m2
面積約0.001至約100 g。當使用用水稀釋之乳液、可濕潤散劑、可流動製劑或其類似物時,殺真菌或殺蟎製劑之濃度為約0.1至約1000 ppm,較佳為約1至500 ppm。按原樣而不稀釋來施用顆粒、微粒或其類似物。 本發明之化合物之特徵為具有極佳殺真菌活性及廣泛範圍活性。化合物可用於控制歸屬於病原性真菌及耐藥性病原性真菌之植物疾病。該病原性真菌之實例包括造成或耐受治療以下疾病之殺真菌劑之彼等:稻穀植物稻瘟病、稻穀植物紋枯病、番茄上之灰黴病、蘋果白粉病、蘋果交鏈孢屬皰、柿子白粉病、葡萄白粉病、大麥白粉病、小麥白粉病、胡瓜白粉病、胡瓜灰黴病、番茄晚疫病、馬鈴薯枯萎病及其類似物。 實例 本發明將更詳細地描述關於製備實例、調配實例及測試實例。 本發明更詳細地描述關於以下參考實例、製造實例、調配實例及測試實例。然而,本發明不限於此等實例。另外,可在不脫離本發明之範疇之範疇內進行變化。 製備實例1製備(2-((2-甲基-4-(4-(三氟甲基)噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-1) (1) 1-(2-硝基苯甲氧基)-4-溴-2-甲苯 在氮氣氛圍下向4-溴-2-甲苯酚(0.93 g,5.0 mmol)及(2-硝苯基)甲醇(1.0 g,6.5 mmol)於無水THF (10 ml)中之冷卻溶液中添加三苯膦(1.9 g,7.5 mmol),隨後緩慢添加偶氮二甲酸二乙酯(0.78 g,7.5 mmol)。隨後將所得混合物在室溫下攪拌12 h。隨後將反應混合物傾入冷蒸餾水中且用乙酸乙酯 (3 × 70 mL)萃取。將經合併之有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到粗殘餘物。殘餘物隨後藉由管柱層析(乙酸乙酯:正己烷=1:9純化),獲得標題化合物。1
H NMR (CDCl3
): δ 8.18 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 7.6 Hz, 1H), 7.70 (t, J = 8.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 1H), 7.31-7.30 (m, 1H), 7.27-7.24 (m, 1H), 6.74 (d, J = 8.4 Hz, 1H), 5.46 (s, 2H), 2.30 (s, 3H)。 (2) 2-((4-溴-2-甲基苯氧基)甲基)苯胺 將氯化亞銅(0.74 g,7.5 mmol)添加至1-(2-硝基苯甲氧基)-4-溴-2-甲苯(1.2 g,3.7 mmol)於甲醇(10 ml)中之冷卻溶液中。隨後向此混合物中逐份添加硼氫化鈉(0.69 g,18.7 mmol)。隨後將所得混合物在室溫下攪拌2 h。將反應混合物隨後藉由飽和氯化銨溶液淬滅,且用乙酸乙酯(100 mL)稀釋。將有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到呈淡黃色固體狀之標題化合物(0.90 g,粗產物)。隨後其不經進一步純化即用於下一步驟。1
H NMR (DMSO-d6
): δ 7.33-7.30 (m, 2H), 7.18-7.17 (m, 1H), 7.04-7.00 (m, 2H), 6.68-6.66 (m, 1H), 6.55 (t, J = 7.2 Hz, 1H), 5.06 (bs, 2H), 4.95 (s, 2H), 2.16 (s, 3H)。 (3) 2-((4-溴-2-甲基苯氧基)甲基)苯基胺基甲酸甲酯 向2-((4-溴-2-甲基苯氧基)甲基)苯胺(0.90 g,3.1 mmol)於氯仿(10 ml)中之冷卻溶液中添加吡啶(0.74 g,9.3 mmol)。隨後向此混合物中緩慢添加氯甲酸甲酯(0.43 g,4.6 mmol)。隨後將所得混合物在室溫下攪拌12 h。隨後將反應混合物傾入冷水中,且用二氯甲烷萃取(3 × 80 ml)。將經合併之有機層用蒸餾水洗滌、經硫酸鈉乾燥、過濾且在減壓下濃縮,得到粗產物。將粗產物隨後藉由管柱層析純化(乙酸乙酯:正己烷=1:4),獲得呈白色固體狀之標題化合物(0.75 g,產率:69%)。1
H NMR (DMSO-d6
): δ 9.01 (bs, 1H), 7.49-7.45 (m, 2H), 7.36-7.30 (m, 3H), 7.18 (t, J = 7.6 Hz, 1H), 6.93 (d, J = 8.4 Hz, 1H), 5.12 (s, 2H), 3.65 (s, 3H), 2.17 (s, 3H)。 (4) 2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基胺基甲酸甲酯 在氮氣氛圍下向2-((4-溴-2-甲基苯氧基)甲基)苯基胺基甲酸甲酯(0.75 g,2.1 mmol)及乙酸鉀(0.42 g,4.3 mmol)於1,4-二噁烷(5.0 ml)中之混合物中添加[1,1'-雙(二苯膦基)二茂鐵]二氯鈀(II)與二氯甲烷(0.09 g,0.10 mmol)之錯合物,隨後添加雙(頻哪醇根基)二硼(0.81 g,3.2 mmol)。隨後使所得混合物回流3 h。隨後用乙酸乙酯稀釋反應混合物。將有機層隨後用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到呈淡黃色殘餘物狀之標題化合物(0.4 g,粗產物)。其隨後不經任何進一步純化即用於下一步驟中。1
H NMR (CDCl3
): δ 8.01 (bs, 1H), 7.66-7.59 (m, 3H), 7.39-7.35 (m, 1H), 7.30-7.29 (m, 1H), 7.10-7.06 (m, 1H), 6.96 (d, J = 8.0 Hz, 1H), 5.11 (s, 2H), 3.74 (s, 3H), 2.25 (s, 3H), 1.33 (s, 12H)。 (5) (2-((2-甲基-4-(4-(三氟甲基)噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-1) 在氮氣氛圍下向2-溴-4-(三氟甲基)噻唑(0.058 g,0.25 mmol)及碳酸鉀(0.070 g,0.5 mmol)於1,4-二噁烷(5 ml)中之混合物中添加肆(三苯膦)鈀(0) (0.014 g,0.01 mmol),隨後添加2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.1 g,0.25 mmol)。隨後使所得混合物回流3 h。隨後用乙酸乙酯(50 mL)稀釋反應混合物。隨後將有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到粗產物。將粗產物隨後藉由管柱層析純化(乙酸乙酯:正己烷=1:3),獲得呈白色固體狀之標題化合物(0.060 g,產率:47%)。1
H NMR (CDCl3
): δ 8.00 (bs, 1H), 7.81-7.77 (m, 2H), 7.66 (s, 1H), 7.51 (bs, 1H), 7.39 (t, J = 7.2 Hz, 1H), 7.33 (d, J = 7.6 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.00 (d, J = 8.8 Hz, 1H), 5.16 (s, 2H), 3.77 (s, 3H), 2.31 (s, 3H)。 製備實例2 製備2-((4-(4-氯噻唑-2-基)-2-甲基苯氧基)甲基)苯基胺基甲酸甲酯(1A-2) 在氮氣氛圍下向2,4-二氯噻唑(0.06 g,0.39 mmol)及碳酸鉀(0.11 g,0.78 mmol)於1,4-二噁烷(5.0 ml)中之混合物中添加肆(三苯膦)鈀(0) (22 mg,0.02 mmol),隨後添加2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)))苯基胺基甲酸甲酯(0.15 g,0.39 mmol)。隨後使所得混合物回流3 h。隨後用乙酸乙酯(50 mL)稀釋反應混合物。隨後將有機層用蒸餾水洗滌,經硫酸鈉乾燥,過濾且在減壓下濃縮,得到粗產物。粗產物隨後藉由管柱層析純化(乙酸乙酯:正己烷=1:3),獲得呈白色固體狀之2-((4-(4-氯噻唑-2-基)-2-甲基苯氧基)甲基)苯基胺基甲酸甲酯(0.050 g,產率:33%)。1
H NMR (CDCl3
): δ 7.99 (bs, 1H), 7.77 (s, 1H), 7.75-7.72 (m, 1H), 7.53 (bs, 1H), 7.41-7.37 (m, 1H), 7.32 (d, J = 7.6 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.01-6.98 (m, 2H), 5.14 (s, 2H), 3.77 (s, 3H), 2.30 (s, 3H)。 製備實例3 製備(3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-39) (1) 2-(4-甲氧基-3-甲基苯基)-4-甲基噻唑 在氮氣氛圍下向2-溴-4-甲基噻唑(1.0 g,5.6 mmol)於DMF:H2
O (10:1,3.0 ml)中之溶液中添加碳酸鈉(1.19 g,0.0112莫耳),之後添加二氯化1,1'-雙(二苯膦基)二茂鐵-鈀(II)二氯甲烷(0.457 g,5.6 mmol)。將4-甲氧基-3-甲基苯基酸(1.38 g,8.41 mmol)添加至反應混合物中,且隨後將其在100℃下攪拌12 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 50 mL)洗滌,經硫酸鈉乾燥且蒸發至乾。粗產物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-(4-甲氧基-3-甲基苯基)-4-甲基噻唑(0.80 g,產率:65%)。1
H NMR (CDCl3
): δ 7.73-7.71 (m, 2H), 6.84 (d, J = 9.2 Hz, 1H), 6.79-6.78 (m, 1H), 3.87 (s, 3H), 2.48 (s, 3H), 2.26 (s, 3H)。 (2) 2-甲基-4-(4-甲基噻唑-2-基)苯酚 使2-(4-甲氧基-3-甲基苯基)-4-甲基噻唑(0.8 g,3.6 mmol)於HBr水溶液(10 ml)及乙酸(5.0 ml)中之溶液在120℃下回流24 h。反應完成後,將反應混合物用飽和碳酸氫鈉溶液處理,直至pH變為約10。將其用乙酸乙酯(3 × 50 mL)萃取,用水(3 × 50 mL)洗滌,經硫酸鈉乾燥,且蒸發至乾,獲得呈淡黃色固體狀之標題化合物(0.70 g,產率93%)。其隨後不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.73 (s, 1H), 7.64-7.62 (m, 1H), 6.80-6.78 (m, 2H), 5.07 (bs, 1H), 2.48 (s, 3H), 2.29 (s, 3H)。 (3) 2-(溴甲基)-1-氯-3-硝基苯 向1-氯-2-甲基-3-硝基苯(1.0 g,5.8 mmol))於四氯化碳(30 ml)中之溶液中添加N-溴丁二醯亞胺(1.03 g,5.8 mmol),隨後添加過氧化苯甲醯(0.071 g,0.29 mmol)。使反應混合物在80℃回流6 h。隨後將反應混合物冷卻至室溫且過濾。將反應混合物用二氯甲烷(50 mL)稀釋,且用水(3 × 50 mL)洗滌,經硫酸鈉乾燥且蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-(溴甲基)-1-氯-3-硝基苯(0.60 g,產率:41%)。1
H NMR (CDCl3
): δ 7.87-7.85 (m, 1H), 7.70-7.68 (m, 1H), 7.43 (t, J = 8.0 Hz, 1H), 4.87 (s, 2H)。 (4) 2-(4-((2-氯-6-硝基苯甲氧基)-3-甲基苯基)-4-甲基噻唑 向2-甲基-4-(4-甲基噻唑-2-基)苯酚(0.7 g,3.4 mmol)於乙腈(10 ml)中之溶液中添加碳酸鉀(0.7 g,5.1 mmol),隨後添加2-(溴甲基)-1-氯-3-硝基苯(0.85 g,3.4 mol),且使反應混合物在80℃下回流3 h。將反應混合物用乙酸乙酯(70 mL)稀釋,且用水(3 × 100 mL)洗滌,經硫酸鈉乾燥且蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色固體狀之2-(4-(2-氯-6-硝基苯甲氧基)-3-甲基苯基)-4-甲基噻唑(0.80 g,產率:62%)。1
H NMR (CDCl3
): δ 7.75-7.72 (m, 3H), 7.70-7.67 (m, 1H), 7.47 (t, J = 8.0 Hz, 1H), 6.93 (d, J = 9.2 Hz, 1H), 6.79-6.78 (m, 1H), 5.49 (s, 2H), 2.48 (s, 3H), 2.17 (s, 3H)。 (5) 3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯胺 在0℃下向2-(4-(2-氯-6-硝基苯甲氧基)-3-甲基苯基)-4-甲基噻唑(0.80 g,2.1 mmol)於甲醇(20 ml)中之溶液中添加氯化亞銅(0.63 g,6.3 mmol),隨後添加硼氫化鈉(0.24 g,6.4 mmol)。在室溫下攪拌反應混合物3 h。將反應混合物過濾,且用乙酸乙酯(100 mL)稀釋,且用水(3 × 60 ml)洗滌,經硫酸鈉乾燥且在減壓下蒸發至乾,獲得呈淡黃色固體狀之標題化合物(0.60 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.75-7.71 (m, 2H), 7.09-7.04 (m, 2H), 6.83-6.79 (m, 2H), 6.61 (d, J = 8.0 Hz, 1H), 5.34 (s, 2H), 4.27 (bs, 2H), 2.48 (s, 3H), 2.16 (s, 3H)。 (6) (3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-39) 向3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯胺(0.60 g,1.7 mmol)於二氯甲烷(10 ml)中之溶液中添加吡啶(0.20 g,2.5 mmol),隨後添加氯甲酸甲酯(0.20 g,2.1 mmol)。在室溫下攪拌反應混合物3 h。將反應混合物用二氯甲烷(70 mL)稀釋,且用水(3 × 50 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色固體狀之3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.50 g,產率:71%)。1
H NMR (CDCl3
): δ 7.96 (d, J = 8.0 Hz, 1H), 7.90 (bs, 1H), 7.77 (s, 1H), 7.74-7.71 (m, 1H), 7.29 (t, J = 8.4 Hz, 1H), 7.16-7.14 (m, 1H), 7.05 (d, J = 8.8 Hz, 1H), 6.80 (d, J = 1.2 Hz, 1H), 5.40 (s, 2H), 3.77 (s, 3H), 2.49 (s, 3H), 2.30 (s, 3H)。 製備實例4製備3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基(甲基)胺基甲酸甲酯(化合物1A-43) 在0℃下向(3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(70 mg,0.17 mmol)於二氯甲烷(2.0 mL)中之溶液中添加氫化鈉(6.0 mg,0.26 mmol)。10分鐘後,將碘代甲烷(37 mg,0.26 mmol)添加至反應混合物中。在室溫下攪拌反應混合物3 h。將反應混合物用乙酸乙酯(40 mL)稀釋,且用水(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基(甲基)胺基甲酸甲酯(40 mg,產率:55%)。1
H NMR (CDCl3
): δ 7.75-7.73 (m, 2H), 7.45-7.43 (m, 1H), 7.36 (t, J = 8.0 Hz, 1H), 7.15-7.11 (m, 1H), 6.98 (d, J = 9.2 Hz, 1H), 6.79 (d, J = 1.2 Hz, 1H), 5.12 (d, J = 10.0 Hz, 1H), 5.03 (d, J= 10.0 Hz, 1H), 3.76-3.22 (m, 6H), 2.49 (s, 3H), 2.20 (s, 3H)。 製備實例5 製備 (3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲基乙醯酯(化合物1A-46) 在0℃下向3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(90 mg,0.22 mmol)於DMF (5.0 ml)中之溶液中添加氫化鈉(8 mg,0.33 mmol)。10分鐘後,將乙醯氯(22 mg,0.30 mmol)添加至反應混合物中,且隨後將其在室溫下攪拌3 h。將反應混合物用乙酸乙酯(30 mL)稀釋,且用水(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之(3-氯-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲基乙醯酯(50 mg,產率:50%)。1
H NMR (CDCl3
): δ 7.75-7.74 (m, 1H), 7.71-7.69 (m, 1H), 7.50 (d, J = 7.6 Hz, 1H), 7.38 (t, J = 8.0 Hz, 1H), 7.06 (d, J = 8.0 Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 6.79 (s, 1H), 3.53 (s, 3H), 2.61 (s, 3H), 2.48 (s, 3H), 2.20 (s, 3H)。 製備實例6 製備2-((2-甲基-4-(噻唑-5-基)苯氧基)甲基)苯基胺基甲酸甲酯(化合物1B-1) 在氮氣氛圍下向5-溴噻唑(0.15 g,0.91 mmol)於1,4-二噁烷:H2
O (5:1,6.0 mL)中之溶液中添加磷酸鉀(0.38 g,1.8 mmol),隨後添加肆(三苯膦)鈀(50 mg,0.04 mmol)。將2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.65 g,1.6 mmol)添加至反應混合物中,且隨後將其在100℃下攪拌12 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 40 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-((2-甲基-4-(噻唑-5-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.20 g,產率:62%)。1
H NMR (DMSO-d6
): δ 8.70 (s, 1H), 8.01-7.96 (m, 2H), 7.62 (bs, 1H), 7.41-7.37 (m, 3H), 7.32 (d, J = 7.2 Hz, 1H), 7.12 (t, J = 7.2 Hz, 1H), 6.99-6.96 (m, 1H), 5.13 (s, 2H), 2.99 (s, 3H), 2.30 (s, 3H)。 製備實例7 製備2-((2-甲基-4-(噻唑-4-基)苯氧基)甲基)苯基胺基甲酸甲酯(化合物1C-1) 在氮氣氛圍下向4-溴噻唑(0.1 g,0.61 mmol)於1,4-二噁烷:H2
O (5:1,6 mL)中之溶液中添加磷酸鉀(0.26 g,1.2 mmol),隨後添加肆(三苯膦)鈀(35 mg,0.031 mmol)。將2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.38 g,0.97 mmol)添加至反應混合物中,且隨後將其在100℃下攪拌12 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 25 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-((2-甲基-4-(噻唑-4-基)苯氧基)甲基)苯基胺基甲酸甲酯(0.15 g,產率:69%)。1
H NMR (DMSO-d6
): δ 9.14 (s, 1H), 9.03 (bs, 1H), 7.97 (s, 1H), 7.80-7.77 (m, 1H), 7.50 (d, J = 8.0 Hz, 2H), 7.41-7.30 (m, 2H), 7.20-7.17 (m, 1H), 7.04 (d, J = 8.4 Hz, 1H), 5.18 (s, 2H), 3.66 (s, 3H), 2.24 (s, 3H)。 製備實例8 製備2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(化合物1A-38) (1) 2-(溴甲基)-1-甲氧基-3-硝基苯 向1-甲氧基-2-甲基-3-硝基苯(2 g,12.0 mmol))於四氯化碳(20 ml)中之溶液中添加N-溴丁二醯亞胺(2.56 g,14.4 mmol),隨後添加過氧化苯甲醯(0.14 g,0.6 mmol)。使反應混合物在80℃回流6 h。將反應混合物冷卻至室溫且過濾。將濾液用二氯甲烷(80 mL)稀釋,且用水(3 × 30 mL)洗滌,經硫酸鈉乾燥且蒸發至乾。粗產物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-(溴甲基)-1-甲氧基-3-硝基苯(1.6 g,產率:83%)。1
H NMR (CDCl3
): δ 7.74-7.72 (m, 1H), 7.61-7.58 (m, 1H), 7.12 (t, J = 8.0 Hz, 1H), 4.91 (s, 2H), 4.01 (s, 3H)。 (2) 1-(2-甲氧基-6-硝基苯甲氧基)-4-溴-2-甲苯 向4-溴-2-甲苯酚(1.0 g,5.3 mmol)於乙腈(10 ml)中之溶液中添加碳酸鉀(1.1 g,6.4 mmol),隨後添加2-(溴甲基)-1-甲氧基-3-硝基苯(1.58 g,6.4 mol),且使反應混合物在80℃下回流3 h。將反應混合物用乙酸乙酯稀釋,且用水洗滌,經硫酸鈉乾燥且在減壓下蒸發至乾。粗產物藉由管柱層析純化,獲得呈黃色黏稠油狀物之1-(2-甲氧基-6-硝基苯甲氧基)-4-溴-2-甲苯(1.2 g,產率:83.8%)。1
H NMR (CDCl3
): δ 7.47-7.39 (m, 2H), 7.24-7.21 (m, 2H), 7.16-7.14 (m, 1H), 6.79 (d, J = 9.2 Hz, 1H), 5.34 (s, 2H), 3.93 (s, 3H), 2.07 (s, 3H)。 (3) 2-((4-溴-2-甲基苯氧基)甲基)-3-甲氧基苯胺 在0℃下向1-(2-甲氧基-6-硝基苯甲氧基)-4-溴-2-甲苯(0.5 g,1.4 mmol)於甲醇(10 ml)中之溶液中添加氯化亞銅(0.21 g,2.1 mmol),隨後添加硼氫化鈉(0.18 g,5.0 mmol),且在室溫下攪拌反應混合物3 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 30 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得標題化合物(0.2 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.24-7.22 (m, 2H), 7.09 (t, J = 8.4 Hz, 1H), 6.95 (d, J = 9.2 Hz, 1H), 6.35-6.33 (m, 2H), 5.20 (s, 2H), 4.13 (bs, 2H), 3.83 (s, 3H), 2.17 (s, 3H)。 (4) 2-((4-溴-2-甲基苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯 向2-((4-溴-2-甲基苯氧基)甲基)-3-甲氧基苯胺(0.2 g,0.62 mmol)於二氯甲烷(5.0 ml)中之溶液中添加吡啶(98 mg,1.2 mmol),隨後添加氯甲酸甲酯(70 mg,0.74 mmol)。在室溫下攪拌反應混合物3 h。將反應混合物用二氯甲烷(30 mL)稀釋,且用水(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗產物藉由管柱層析純化,獲得呈黃色固體狀之2-((4-溴-2-甲基苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(0.14 g,產率:59%)。1
H NMR (CDCl3
): δ 7.82 (bs, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.29 (t, J = 8.4 Hz, 1H), 7.27-7.22 (m, 2H), 6.91 (d, J = 8.4 Hz, 1H), 6.65 (d, J = 8.4 Hz, 1H), 5.28 (s, 2H), 3.86 (s, 3H), 3.76 (s, 3H), 2.21 (s, 3H)。 (5) 2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯 在氮氣氛圍下向2-((4-溴-2-甲基苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(0.15 g,0.4 mmol)及乙酸鉀(77 mg,0.8 mmol)於1,4-二噁烷:H2
O (5:1,6 ml)中之混合物中添加肆(三苯膦)鈀(45 mg,0.04 mmol),隨後添加雙(頻哪醇根基)二硼(0.15 g,0.6 mmol)。隨後使反應在85℃下回流12 h。冷卻至室溫後,將反應混合物用乙酸乙酯(70 mL)稀釋,且用水(3 × 50 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈黃色黏稠油狀物之2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(0.09 g,產率:53%)。1
H NMR (CDCl3
): δ 7.88 (bs, 1H), 7.64-7.60 (m, 3H), 7.28 (t, J = 8.4 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 5.30 (s, 2H), 3.86 (s, 3H), 3.74 (s, 3H), 2.24 (s, 3H), 1.26 (s, 9H)。 (6) 2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(化合物1A-38) 在氮氣氛圍下向2-溴-4-甲基噻唑(0.041 g,0.23 mmol)於1,4-二噁烷:H2
O (4:1,6 ml)中之溶液中依序添加碳酸鈉(50 mg,0.50 mmol)、二氯化1,1'-雙(二苯膦基)二茂鐵-鈀(II)二氯甲烷錯合物(19 mg,0.02 mmol)及2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(0.10 g,0.2 mmol)。在100℃下攪拌反應物12 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈灰白色固體狀之2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(49 mg,產率:53.4%)。1
H NMR (CDCl3
): δ 7.85 (bs, 1H), 7.73 (s, 1H), 7.71-7.68 (m, 1H), 7.65 (d, J= 8.0 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.08 (d, J = 8.4 Hz, 1H), 6.79 (d, J = 1.2 Hz, 1H), 6.66 (d, J = 8.0 Hz, 1H), 5.33 (s, 2H), 3.88 (s, 3H), 3.76 (s, 3H), 2.48 (s, 3H), 2.29 (s, 3H)。 製備實例9 製備(3-甲基-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-15) (1) (2-甲基-6-硝苯基)甲醇 在0℃下向2-甲基-6-硝基苯甲酸(2.0 g,12.0 mmol))於二氯甲烷(20 ml)中之溶液中逐滴添加乙二醯氯(3.47 g,30.0 mmol),隨後添加二甲基甲醯胺(0.2 mL)。在室溫下攪拌反應混合物1 h。將反應混合物在減壓下蒸發至乾。在0℃下將無水THF添加至其中製備澄清溶液,隨後添加硼氫化鈉(1.2 g,36.0 mmol)。在室溫下攪拌反應混合物1 h。其用水淬滅,且用乙酸乙酯(3 × 50 mL)萃取,用NH4
Cl溶液(3 × 30 mM)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得呈灰白色固體狀之2-甲基-6-硝苯基)甲醇(1.65 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.69 (d, J = 8.0 Hz 1H), 7.45 (d, J = 7.60 Hz 1H 1H), 7.34 (t, J = 8.0 Hz, 1H), 4.69 (d, J = 7.2 Hz, 2H), 2.64 (t, J = 7.6 Hz 1H), 2.55 (s, 3H) (2) (2-胺基-6-甲基苯基)甲醇 在0℃下向2-甲基-6-硝苯基)甲醇(1.0 g,5.0 mmol)於甲醇(10 ml)中之溶液中依序添加氯化亞銅(1.7 g,15.0 mmol)及硼氫化鈉(1.8 g,40.0 mmol)。在0℃下攪拌反應混合物1 h。將反應混合物用乙酸乙酯(60 mL)稀釋,且用水(3 × 30 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得呈淺棕色固體狀之(2-胺基-6-甲基苯基)甲醇(0.70 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.01 (t, J = 7.6 Hz, 1H), 6.58 (t, J = 7.6 Hz 2H), 4.76 (s, 2H), 233 (s, 3H)。(3) (2-(羥甲基)-3-甲基苯基)胺基甲酸甲酯向2-胺基-6-甲基苯基)甲醇(0.70 g,0.62 mmol)於二氯甲烷(5.0 ml)中之溶液中依序添加吡啶(20 mg,0.32 mmol)及氯甲酸甲酯(48 mg,0.32 mmol)。在室溫下攪拌反應混合物1 h。將反應混合物用二氯甲烷(30 mL)稀釋,且用1N HCl (3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得呈白色固體狀之(2-(羥甲基)-3-甲基苯基)胺基甲酸甲酯(0.50 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.59 (s, 1H), 7.56 (d, J = 8.4 Hz, 1H), 7.20 (t, J = 8 Hz, 1H), 6.96 (d, J = 7.6 Hz, 1H), 4.74 (d, J = 5.2 Hz, 2H), 3.78 (s, 3H), 2.40 (s, 3H)。 (4) (2-(溴甲基)-3-甲基苯基)胺基甲酸甲基酯 在0℃下向(2-(羥甲基)-3-甲基苯基)胺基甲酸酯(0.50 g,0.62 mmol )於二氯甲烷(5 mL)中之溶液中添加三溴化磷(1.0 g,0.95 mmol)。在0℃下攪拌反應混合物1 h。將反應混合物用二氯甲烷(30 mL)稀釋,且用硫代硫酸鈉溶液(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得呈白色固體狀之(2-(溴甲基)-3-甲基苯基)胺基甲酸甲酯(0.55 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.57 (bs, 1H), 7.22 (d, J = 8 Hz, 1H), 6.99 (d, J = 7.6 Hz, 1H), 6.68 (s, 1H), 4.54 (s, 2H), 3.80 (s, 3H), 2.41 (s, 3H)。 (5) (2-((4-溴-2-甲基苯氧基)甲基)-3-甲基苯基)胺基甲酸甲酯在0℃下向4-溴-2-甲苯酚(0.40 g,5.3 mmol)於乙腈(10 ml)中之溶液中依序添加碳酸鉀(0.59 g,10.6 mmol)及(2-(溴甲基)-3-甲基苯基)胺基甲酸甲酯(0.55 g,5.3 mmol)。使反應混合物在80℃回流3 h。在室溫下冷卻後,將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 30 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾,獲得呈灰白色固體狀之(2-((4-溴-2-甲基苯氧基)甲基)-3-甲基苯基)胺基甲酸甲酯(0.54 g,粗產物)。其不經任何進一步純化即按原樣用於下一步驟中。1
H NMR (CDCl3
): δ 7.75 (bs, 1H), 7.39 (bs, 1H), 7.30-7.26 (m, 3H), 7.03-6.97 (m, 1H), 6.85 (t, J = 4.8, 1H), 5.06 (s, 2H), 3.74 (s, 3H), 2.38 (s, 3H), 2.18 (s, 3H)。 (6) (3-甲基-2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯 在氮氣氛圍下向(2-((4-溴-2-甲基苯氧基)甲基)-3-甲基苯基)胺基甲酸甲酯(0.150 g,0.4 mmol)及乙酸鉀(77 mg,0.8 mmol)於1,4-二噁烷:H2
O (5:1,6 ml)中之混合物中添加肆(三苯膦)鈀(45 mg,0.04 mmol),隨後添加雙(頻哪醇根基)二硼(0.15 g,0.6 mmol)。隨後使反應在85℃下回流12 h。冷卻至室溫後,將反應混合物用乙酸乙酯(70 mL)稀釋,且用水(3 × 50 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈灰白色固體狀之(3-甲基-2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(0.09 g,產率:53%)。1
H NMR (CDCl3
): δ 7.76 (d, J = 5.6 Hz 1H), 7.68 (d, J = 8.4 Hz 1H), 7.64 (s, 1H), 7.47 (bs, 1H), 7.28-7.24 (m, 1H), 6.99 (t, J = 8.4 Hz, 2H), 5.11 (s, 2H), 3.72 (s, 3H), 2.39 (s, 3H), 2.21 (s, 3H), 1.34 (s, 12H)。 (7) (3-甲基-2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(化合物1A-15) 在氮氣氛圍下向2-溴-4-甲基噻唑(0.041 g,0.23 mmol)於1,4-二噁烷:H2
O (4:1,6 ml)中之溶液中依序添加碳酸鈉(50 mg,0.50 mmol)、二氯化1,1'-雙(二苯膦基)二茂鐵-鈀(II)二氯甲烷錯合物(19 mg,0.02 mmol)及(3-甲基-2-((2-甲基-4-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環戊-2-基)苯氧基)甲基)苯基)胺基甲酸甲酯(0.10 g,0.20 mmol)。在100℃下攪拌反應物12 h。將反應混合物用乙酸乙酯(50 mL)稀釋,且用水(3 × 20 mL)洗滌,經硫酸鈉乾燥,且在減壓下蒸發至乾。粗化合物藉由管柱層析純化,獲得呈灰白色固體狀之2-((2-甲基-4-(4-甲基噻唑-2-基)苯氧基)甲基)-3-甲氧基苯基胺基甲酸甲酯(49 mg,產率:53.4%)。1
H NMR (CDCl3
): δ 7.77-7.74 (m, 3H), 7.44 (bs, 1H), 7.28 (t, J = 8.2 Hz 1H), 7.02-6.98 (m, 2H), 6.81 (d, J = 8.0 Hz 1H), 5.13 (s, 2H), 3.74 (s, 3H), 2.48 (s, 3H), 2.41 (s, 3H), 2.26 (s, 3H)。 本發明之代表性化合物在下表1至3中例示,但本發明不限於此等化合物。 除在製備實例1至9中獲得之化合物外,表1至3中所示的化合物藉由與製備實例1至9中所描述之方法或實施方式中所描述之方法類似的方法製造。 表1至3中之縮寫如下所指示。 F:氟,Cl:氯,Br:溴,Me:甲基,Et:乙基,iPr:異丙基,t-Bu:第三丁基,CF3
:三氟甲基,Ph:苯基,NO2
:硝基,CN:氰基,OMe:甲氧基。表1:屬於式(1A)之合成的化合物之細節及1
H NMR:
表2:屬於式(1B)之合成的化合物之細節及1
H NMR:
表3:屬於式(1C)之合成的化合物之細節及1
H NMR:
下文給出調配實例,其中份數指代重量份。 調配實例1 (可乳化濃縮物) 將10份各本發明之化合物溶解於45份Solvesso®
150及35份N-甲基吡咯啶酮中。向其中添加10份乳化劑(商標名:Sorpol®
3005X,由Toho Kagaku Co., Ltd.製造)。將此等成分混合同時攪拌,由此製造10%可乳化濃縮物。 調配實例2 (可濕潤散劑) 將20份各本發明之化合物添加至2份十二烷基硫酸鈉、4份木質素磺酸鈉、20份含水合成氧化矽之細粉及54份黏土的混合物中。將此等成分藉由果汁混合器混合同時攪拌,由此製造20%可濕潤散劑。 調配實例3 (顆粒) 將5份各本發明之化合物與2份十二烷基苯磺酸鈉、10份膨潤土及83份黏土混合,隨後充分攪拌。添加適合量之水,且進一步攪拌混合物。混合物藉由粒化機粒化且風乾,製造5%顆粒。 調配實例4 (粉塵) 將1份各本發明之化合物溶解於適合量之丙酮中。向溶液中添加5份含水合成氧化矽之細粉、0.3份酸性磷酸異丙酯(PAP)及93.7份黏土,隨後藉由果汁混合器混合及攪拌。丙酮藉由蒸發自其中移除,製造1%散劑調配物。 調配實例5 (可流動製劑) 將20份各本發明之化合物與20份含水3份聚氧伸乙基三苯乙烯基苯基醚磷酸及三乙醇胺乙基0.2份Rhodorsil®
426R (由RhodiaChimie製造)混合。混合物藉由研磨機(商標名:DYNO-Mill,且由Willy A. Bachofen AG製造)使用濕式方法粉碎,且進一步與60份含水8份丙二醇及0.32份三仙膠(xanthan gum)混合,由此製造20%水中之懸浮液。 測試實例在下文給出以證明本發明之化合物適用作殺真菌劑之活性成分。 測試實例在下文給出以證明本發明之化合物適用作用於殺真菌劑之活性成分。測試實例 1 ( 對單絲殼白粉菌 , 胡瓜進行殺真菌測試 )
將本發明之化合物之溶液(500 ppm)噴灑至新鮮健康兩週齡的胡瓜植物上。將植物風乾且用新製備之孢子懸浮液(1 × 106
cfu孢子/ml)接種。將接種植物隨後置放於溫室(25℃,濕度為60%及16L8D)中 疾病面積速率在接種12天後進行量測,且化合物之活性經展示為根據以下等式計算之預防性值。預防性值= {1-(治療中之疾病面積速率) / (對照的疾病面積速率)} × 100。 呈現50%或更大之預防性值的化合物如下: 化合物編號:1A-1、1A-2、1A-3、1A-4、1A-5、1A-6、1A-9、1A-10、1A-12、1A-13、1A-14、1A-15、1A-16、1A-17、1A-18、1A-22、1A-25、1A-28、1A-29、1A-30、1A-31、1A-32、1A-33、1A-34、1A-35、1A-36、1A-37、1A-38、1A-39、1A-40、1A-41、1A-42、1A-43、1A-44、1A-45、1A-46、1A-47、1A-48、1A-49、1A-50、1A-51、1B-1、1B-2、1C-1、1C-2。測試實例 2 ( 對灰葡萄孢菌 ( Botrytis cinerea ) 之殺真菌測試 )
將本發明之化合物之溶液(500 ppm及200 ppm)在至少三葉階段時噴灑至新鮮健康胡瓜植物上。切割經治療植物之子葉,且將其葉子安放在塑料盤上之潮濕拭紙上。使用微量吸管將50 µl孢子懸浮液(1×106
cfu孢子/ml)滴在葉子中間。且隨後將小片脫脂棉安放在孢子液滴上,且再次將50 µl孢子懸浮液滴在該片上。葉子保持在室溫(20℃)下。 真菌之輻向生長在接種五天後進行量測,且化合物之活性經展示為根據以下等式計算之預防性值。預防性值= {1-(經治療的輻向生長) / (對照組的輻向生長)} × 100 在500 ppm之處理濃度下呈現50%或更大之預防性值的化合物如下: 化合物編號:1A-1、1A-2、1A-3、1A-4、1A-5、1A-6、1A-9、1A-10、1A-12、1A-13、1A-14、1A-15、1A-16、1A-17、1A-18、1A-22、1A-23、1A-25、1A-29、1A-30、1A-33、1A-34、1A-37、1A-38、1A-39、1A-40、1A-41、1A-42、1A-46、1A-47、1A-48、1A-49、1A-50、1A-51、1B-1、1B-2、1C-1、1C-2。 在200 ppm之處理濃度下呈現50%或更大之預防性值的化合物如下: 化合物編號:1A-1、1A-2、1A-3、1A-4、1A-5、1A-6、1A-9、1A-10、1A-12、1A-13、1A-14、1A-15、1A-17、1A-18、1A-25、1A-29、1A-30、1A-33、1A-37、1A-38、1A-39、1A-40、1A-41、1A-47、1A-48、1A-49、1A-50、1A-51、1B-1、1B-2、1C-1、1C-2。測試實例 3 ( 對致病疫黴 ( Phytophthora infestans ) 之殺真菌測試 )
將本發明之化合物之溶液(500 ppm)在至少三葉階段時噴灑至新鮮健康番茄植物上。將植物風乾且用新製備之孢子囊懸浮液(1 × 106
cfu遊走孢子/ml)接種。接種植物隨後置放於露水室(20℃且濕度為100%)中。接種一天後,將植物轉移至恆溫室(20℃,濕度為80%,且16L8D)中。 疾病面積速率在接種5天後進行量測,且化合物之活性經展示為根據以下等式計算之預防性值。預防性值= {1-(治療中之疾病面積速率) / (對照的疾病面積速率)} × 100。 呈現50%或更大之預防性值的化合物如下: 化合物編號:1A-4、1A-5、1A-12、1A-15、1A-17、1A-29、1A-35、1A-36、1A-37、1A-40、1A-49、1C-1、1C-2。測試實例 4 ( 對 稻瘟病菌 ( Pyricularia grisea ) 之殺真菌測試 )
本發明之化合物之溶液(500 ppm)噴灑至新鮮健康兩週齡的栗植物上。將植物風乾且用新製備之孢子懸浮液(1 × 106
cfu孢子/ml)接種。接種植物隨後置放於露水室(25℃且濕度為100%)中。接種一天後,將植物轉移至恆溫室(25℃,濕度為80%,且16L8D)中。 疾病面積速率在接種5-7天後進行量測,且化合物之活性經展示為根據以下等式計算之預防性值。預防性值= {1-(治療中之疾病面積速率) / (對照的疾病面積速率)} × 100。 呈現50%或更大之預防性值的化合物如下: 化合物編號:1A-1、1A-2、1A-3、1A-4、1A-5、1A-6、1A-7、1A-9、1A-10、1A-11、1A-12、1A-13、1A-14、1A-15、1A-17、1A-18、1A-19、1A-20、1A-22、1A-23、1A-25、1A-26、1A-29、1A-30、1A-33、1A-35、1A-36、1A-37、1A-38、1A-39、1A-40、1A-41、1A-42、1A-43、1A-44、1A-45、1A-46、1A-47、1A-48、1A-49、1A-50、1A-51、1B-1、1B-2、1C-1、1C-2。 (注意) 如上所述,本發明藉由本發明之較佳實施例說明。然而,應理解本發明之範疇應僅由權利要求解釋。應理解,本文中所引用之專利、專利申請案及文獻以引用之方式併入本文中,如同其含量具體言之描述於本文中。本申請主張印度專利局(印度智慧財產權)之2017年1月30日申請之印度專利申請案第201711003382號的優先權,該案之全部內容以引用之方式併入本文中。 產業可利用性 本發明之胺基甲酸酯化合物針對植物疾病具有控制作用,且適用作植物控制劑之活性成分。Hereinafter, the present invention will be described in more detail with reference to examples, but the technical scope of the present invention is not limited to the examples. Throughout the specification, unless expressly stated otherwise, the singular expression should be understood to encompass the concept in the plural. Therefore, singular items (for example, in the case of English, "a", "the", and the like) are also understood to encompass the concept in the plural. Moreover, the terms used herein are to be understood as being used in the ordinary meanings of the art unless specifically stated otherwise. Therefore, unless otherwise defined, all terms and technologies used herein have the same meaning as the terms commonly understood by those skilled in the art. In the case of conflicts, this specification (including definitions) is preferred.Carbamate compound or salt thereof
The present invention provides a urethane compound represented by the formula (1) or a salt thereof for use in agriculture and horticulture.Where R1
, R2
, R3
, R4
, R5
, R6
, R7
, R8
, X, X1
, Y, Z, l, m and n are as defined above. Subsequently, the terms in the present specification are described below. In the present invention, the number of substituents of the group defined by "optionally substituted" or "substituted" is not particularly limited, if the group is substitutable and is one or plural. In addition, unless otherwise indicated, the description of each group is also applied when the group is a moiety of one or the other group. "C1 - 6
"Alkyl" means a straight or branched saturated hydrocarbon group having from one to six carbon atoms. "C2 - 6
"Alkenyl" means a straight or branched chain unsaturated hydrocarbon group having from two to six carbon atoms and containing from 1 to 3 double bonds. "C2 - 6
"Alkynyl" means a straight or branched chain unsaturated hydrocarbon group having two to six carbon atoms and containing one triple bond. "C3 - 8
"Cycloalkyl" means a cycloalkyl group having three to eight carbon atoms and includes those cycloalkyl groups having a partially bridged structure. "C1 - 6
"Alkoxy" means "C1 - 6
Alkoxy", and "C1 - 6
"Alkyl" part and "C described above"1 - 6
The alkyl group has the same definition. "Aryl" means a monocyclic or polycyclic aromatic hydrocarbon. "Heterocycle" means a saturated, unsaturated or aromatic heterocyclic group having at least one of nitrogen, oxygen, phosphorus and/or sulfur atoms in the ring and which may be bonded at any substitutable position. "Heteroaryl" means an aromatic heterocyclic group having at least one of nitrogen, oxygen and/or sulfur atoms in the ring and which may be bonded at any substitutable position, wherein the ring member atoms of the heteroaryl group are excluded The carbon atom includes 1, 2, 3 or 4 hetero atoms selected from N, O and S. Specific examples of the groups as used in the present specification are shown below. Examples of the halogen include, but are not particularly limited to, fluorine, chlorine, bromine, iodine, and the like. C1 - 6
Examples of alkyl groups include, but are not particularly limited to, C1 - 6
a linear or branched alkyl group such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, t-butyl, n-pentyl, n-hexyl and the like Group. C1 - 6
Examples of the haloalkyl group include, but are not particularly limited to, C substituted with 1 to 9, preferably 1 to 5 halogen atoms.1 - 6
A linear or branched alkyl group such as fluoromethyl, chloromethyl, bromomethyl, iodomethyl, difluoromethyl, 2,2-difluoroethyl, trifluoromethyl, 2,2,2- Trifluoroethyl, pentafluoroethyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, heptafluoroisobutyl and the like. C1 - 6
Examples of alkoxy groups include, but are not particularly limited to, C1 - 6
a linear or branched alkoxy group such as methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy, tert-butoxy and Its similar group. C1 - 6
Examples of the haloalkoxy group include, but are not particularly limited to, C substituted with 1 to 9, preferably 1 to 5, halogen atoms.1 - 6
Linear or branched alkoxy such as fluoromethoxy, chloromethoxy, bromomethoxy, iodomethoxy, difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoro Ethoxy, pentafluoroethoxy, 3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, heptafluoroisobutoxy and the like. C1 - 6
Alkoxy C1 - 6
Examples of the alkyl group include not particularly limited to C1 - 6
Linear or branched alkyl group via C1 - 6
a linear or branched alkoxy-substituted alkoxyalkyl group such as methoxymethyl, ethoxymethyl, n-propoxymethyl, isopropoxymethyl, n-butoxymethyl, Isobutoxymethyl, second butoxymethyl, tert-butoxymethyl, methoxyethyl, ethoxyethyl, methoxy-n-propyl, methoxy-n-butyl And similar groups. C1 - 6
Haloalkoxy C1 - 6
Examples of the alkyl group include, but are not particularly limited to, a linear or branched alkoxyalkyl group substituted with 1 to 9, preferably 1 to 5 halogen atoms, such as fluoromethoxymethyl, chloromethoxymethyl , bromomethoxymethyl, iodomethoxymethyl, difluoromethoxymethyl, trifluoromethoxymethyl, 2,2,2-trifluoroethoxymethyl and the like . C3 - 8
Examples of the cycloalkyl group include, but are not particularly limited to, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cycloheptyl group, a cyclooctyl group, and the like. C3 - 8
Cycloalkyl C1 - 6
Examples of the alkyl group include, but are not particularly limited to, a cyclopropylmethyl group, a cyclobutylethyl group, a cyclopentylmethyl group, a cyclohexylmethyl group, and the like. C1 - 6
Examples of alkylcarbonyl groups include, but are not particularly limited to, C1 - 6
a linear or branched alkylcarbonyl group such as methylcarbonyl (ethenyl), ethylcarbonyl (propyl), n-propylcarbonyl (butylidene), isopropylcarbonyl (isobutyl), n-butylcarbonyl ( Pentamidine), isobutylcarbonyl (isoamyl), t-butylcarbonyl, tert-butylcarbonyl and the like. C1 - 6
Examples of the haloalkylcarbonyl group include, but are not particularly limited to, C substituted with 1 to 9, and preferably 1 to 5, halogen atoms.1 - 6
a linear or branched alkylcarbonyl group such as fluoromethylcarbonyl, chloromethylcarbonyl, bromomethylcarbonyl, iodomethylcarbonyl, dichloromethylcarbonyl, trichloromethylcarbonyl, difluoromethylcarbonyl, trifluoro Methylcarbonyl, chlorodifluoromethylcarbonyl, bromodifluoromethylcarbonyl, dichlorofluoromethylcarbonyl, 2,2,2-trichloroethylcarbonyl, 2,2,2-trifluoroethylcarbonyl, five Fluoroethyl carbonyl and the like. C1 - 6
Examples of alkoxycarbonyl groups include, but are not particularly limited to, C1 - 6
a linear or branched alkoxycarbonyl group such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, second butoxycarbonyl , a third butoxycarbonyl group and the like. C1 - 6
Examples of the haloalkyloxycarbonyl group include, but are not particularly limited to, C substituted with 1 to 9, preferably 1 to 5, halogen atoms.1 - 6
a straight or branched alkoxycarbonyl group such as fluoromethoxycarbonyl, chloromethoxycarbonyl, bromomethoxycarbonyl, iodomethoxycarbonyl, dichloromethoxycarbonyl, trichloromethoxycarbonyl, difluoro Methoxycarbonyl, trifluoromethoxycarbonyl, 2,2,2-trifluoroethoxymethyl, pentafluoroethoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 4,4, 4-Trifluorobutoxycarbonyl, heptafluoroisopropoxycarbonyl and the like. Cyano C1 - 6
Examples of the alkyl group include, but are not particularly limited to, C substituted by a cyano group1 - 6
Linear or branched alkyl group, such as cyanomethyl, cyanoethyl, cyano-n-propyl, cyano-isopropyl, cyano-n-butyl, cyano-isobutyl, cyano- Second butyl, cyano-t-butyl, cyano-n-hexyl and the like. Cyano C1 - 6
Examples of alkoxy groups include C substituted by a cyano group1 - 6
a linear or branched alkoxy group such as cyanomethoxy, cyanoethoxy, cyano-n-propoxy, cyano-isopropoxy, cyano-n-butoxy, cyano-iso Butoxy, cyano-second butoxy, cyano-tert-butoxy, cyano-hexyloxy and the like. C2 - 6
Examples of the alkenyl group include, but are not particularly limited to, a vinyl group, an allyl group, a 2-butenyl group, a 3-butenyl group, a 1-methallyl group, and the like. C2 - 6
Examples of the haloalkenyl group include, but are not particularly limited to, 2,2-dichlorovinyl, 2,2-dibromovinyl, 2,2-difluorovinyl, 3,3-difluoro-2-allyl 4,4-Difluoro-3-butenyl, 4,4,4-trifluoro-2-butenyl and the like. C2 - 6
Examples of alkynyl groups include, but are not particularly limited to, ethynyl, 2-propynyl (propargyl), 1-methyl-2-propynyl, 1-butynyl, 2-butynyl, 3-butyl Alkynyl groups and the like. C2 - 6
Examples of the haloalkynyl group include, but are not particularly limited to, a fluoroethynyl group, a bromoethynyl group, a chloroethynyl group, an iodoethynyl group, a 3,3,3-trifluoro-1-propynyl group, and the like. Cyano C2 - 6
Examples of alkenyl groups include, but are not particularly limited to, 2-cyanovinyl, 2,2-dicyanovinyl, 3-cyano-2-allyl, 3,3-dicyano-2-ene Base, 4-cyano-3-butenyl, 4,4-dicyano-3-butenyl, 4,4,4-tricyano-2-butenyl and the like. Cyano C2 - 6
Examples of the alkynyl group include, but are not particularly limited to, a cyanoethynyl group, a 3-cyano-1-propynyl group, and the like. C1 - 6
Examples of alkanesulfonyl groups include, but are not particularly limited to, C1 - 6
Linear or branched alkanesulfonyl, such as methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n-butylsulfonyl, isobutylsulfonyl, second butanesulfonate Base, tributyl sulfonyl group and the like. C1 - 6
Examples of the halosulfonyl group include, but are not particularly limited to, fluoromethanesulfonyl, chloromethanesulfonyl, bromomethylsulfonyl, iodomethylsulfonyl, chloromethanesulfonyl, trichloromethanesulfonyl. ,difluoromethanesulfonyl, trifluoromethanesulfonyl, chlorodifluoromethanesulfonyl, bromodifluoromethanesulfonyl, dichlorofluoromethanesulfonyl, 2,2,2-trichloroethanesulfonate Base, 2,2,2-trifluoroethanesulfonyl, pentafluoroethanesulfonyl and C substituted by 1 to 9, and preferably 1 to 5 halogen atoms1 - 6
Linear or branched alkanesulfonyl. C1 - 6
Examples of the alkylsulfinyl group include, but are not particularly limited to, C1 - 6
A linear or branched alkyl sulfinylene group, such as methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n-butylsulfinyl , isobutylsulfinyl, t-butylsulfinyl, tert-butylsulfinyl and the like. C1 - 6
Examples of the haloalkylsulfinyl group include, but are not particularly limited to, C substituted with 1 to 9, and preferably 1 to 5 halogen atoms.1 - 6
Linear or branched alkyl sulfinylene, such as fluoromethylsulfinyl, chloromethylsulfinyl, bromomethylsulfinyl, iodomethylsulfinyl, dichloromethyl Sulfonyl, trichloromethylsulfinyl, difluoromethylsulfinyl, trifluoromethylsulfinyl, chlorodifluoromethylsulfinyl, bromodifluoromethylsulfinyl , dichlorofluoromethylsulfinyl, 2,2,2-trichloroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, pentafluoroethylsulfinyl and Its similar group. C1 - 6
Examples of alkylthio groups include, but are not particularly limited to, C1 - 6
a linear or branched alkylthio group such as methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, second butylthio, tert-butylthio and Its similar group. C1 - 6
Examples of the haloalkylthio group include, but are not particularly limited to, C substituted with 1 to 9, and preferably 1 to 5, halogen atoms.1 - 6
Linear or branched alkylthio such as fluoromethylthio, chloromethylthio, bromomethylthio, iodomethylthio, dichloromethylthio, trichloromethylthio, difluoromethylthio, trifluoro Methylthio, chlorodifluoromethylthio, bromodifluoromethylthio, dichlorofluoromethylthio, 2,2,2-trichloroethylthio, 2,2,2-trifluoroethylthio, five Fluoroethylthio groups and the like. C3 - 8
Examples of the cycloalkylsulfonyl group include, but are not particularly limited to, a cyclopropanesulfonyl group, a cyclobutsulfonyl group, a cyclopentylsulfonyl group, a cyclohexylsulfonyl group, and the like. C3 - 8
Examples of the cycloalkylsulfinyl group include, but are not particularly limited to, a cyclopropylsulfinyl group, a cyclobutylsulfinyl group, a cyclopentylsulfinyl group, a cyclohexylsulfinyl group, and the like. . C3 - 8
Examples of the cycloalkylthio group include, but are not particularly limited to, a cyclopropylthio group, a cyclobutylthio group, a cyclopentylthio group, a cyclohexylthio group, and the like. C3 - 8
Cycloalkyl C1 - 6
Examples of the alkanesulfonyl group include, but are not particularly limited to, cyclopropylmethylsulfonyl, 2-cyclopropylethylsulfonyl, 3-cyclopropylpropanesulfonyl, cyclohexylmethanesulfonyl, and the like. group. C3 - 8
Cycloalkyl C1 - 6
Examples of the alkylsulfinyl group include, but are not particularly limited to, cyclopropylmethylsulfinyl, 2-cyclopropylethylsulfinyl, 3-cyclopropylsulfinyl, cyclohexyl. Methyl sulfinylene and its like. C3 - 8
Cycloalkyl C1 - 6
Examples of the alkylthio group include, but are not particularly limited to, a cyclopropylmethylthio group, a 2-cyclopropylethylthio group, a 3-cyclopropylpropylthio group, a cyclohexylmethylthio group, and the like. C1 - 6
Alkoxy C1 - 6
Examples of alkylthio groups include, but are not particularly limited to, C1 - 6
Linear or branched alkylthio group via C1 - 6
a linear or branched alkoxy-substituted alkoxyalkylthio group, such as methoxymethylthio, ethoxymethylthio, n-propoxymethylthio, isopropoxymethylthio, n-butyl Oxymethylthio group, second butoxymethylthio group, tert-butoxymethylthio group, 2-methoxyethylthio group and the like. C2 - 6
Examples of the alkenyloxy group include, but are not particularly limited to, a vinyloxy group, a 1-propenyloxy group, an isopropenyloxy group, an allyloxy group, a 2-butenyloxy group, a 3-butenyloxy group, a 1-methylene group. Propyloxy and the like. C2 - 6
Examples of the haloalkoxy group include, but are not particularly limited to, 2,2-dichloroethyleneoxy, 2,2-dibromoethenyloxy, 2,2-difluoroethyleneoxy, 3,3-difluoro-2 - allyloxy, 4,4-difluoro-3-butenyloxy, 4,4,4-trifluoro-2-butenyloxy and the like. C2 - 6
Examples of alkynyloxy groups include, but are not particularly limited to, ethynyloxy, 2-propynyloxy, 1-methyl-2-propynyloxy, 1,1-dimethyl-2-propynyloxy, 1 - butynyloxy, 2-butynyloxy, 3-butynyloxy and the like. C2 - 6
Examples of haloalkynyloxy groups include, but are not particularly limited to, fluoroethynyloxy, bromoethynyloxy, chloroethynyloxy, iodoethynyloxy, 3,3,3-trifluoro-1-propynyloxy and the like. Group. C1 - 6
Examples of alkylsulfonyloxy groups include, but are not particularly limited to, C1 - 6
Linear or branched alkanesulfonyl group, such as methylsulfonyloxy, ethylsulfonyloxy, n-propylsulfonyloxy, isopropylsulfonyloxy, n-butylsulfonyloxy, iso Butylsulfonyloxy, t-butylsulfonyloxy, tert-butylsulfonyloxy and the like. C1 - 6
Examples of the alkylsulfinyloxy group include, but are not particularly limited to, C1 - 6
A linear or branched alkylsulfinyloxy group, such as methylsulfinyloxy, ethylsulfinyloxy, n-propylsulfinyloxy, isopropylsulfinyloxy, n-butyl A sulfinyloxy group, an isobutylsulfinyloxy group, a t-butylsulfinyloxy group, a tert-butylsulfinyloxy group, and the like. Examples of the substituted or unsubstituted amino group include, but are not particularly limited to, an amine group, a monoalkylamino group, a dialkylamino group, a monodecylamino group, and the like. Examples of alkyl groups include the C mentioned above1 - 6
Alkyl groups and the like. Examples of sulfhydryl groups include the C mentioned above1 - 6
Alkoxycarbonyl, haloalkyloxycarbonyl, arylcarbonyl and the like. Examples of the aryl group include, but are not particularly limited to, a phenyl group, a 1-naphthyl group, a 2-naphthyl group, and the like. Aryl C1 - 6
Examples of the alkyl group include, but are not particularly limited to, a benzyl group, a phenethyl group, a phenyl-n-propyl group, and the like. These aryl C1 - 6
The alkyl group may be further substituted in both the alkyl group and the aryl group. Examples of the aryloxy group include, but are not particularly limited to, a phenoxy group, a 1-naphthyloxy group, a 2-naphthyloxy group, and the like. Aryl C1 - 6
Examples of alkoxy groups include, but are not particularly limited to, benzyloxy, phenylethoxy, phenyl-n-propoxy, phenyl-n-butoxy, 1-naphthylmethoxy, 2-naphthylmethoxy Base and its like. Examples of the heteroaryloxy group include, but are not particularly limited to, a pyridyloxy group, a pyrimidinyloxy group, a pyrazolyloxy group, and the like. Heteroaryl C1 - 6
Examples of the alkoxy group include, but are not particularly limited to, a pyridylmethoxy group, a pyridylethoxy group, a pyrimidinylethoxy group, a pyrazolylmethoxy group, and the like. Examples of the arylsulfonyl group include, but are not particularly limited to, a benzenesulfonyl group, a 1-naphthalenesulfonyl group, a 2-naphthalenesulfonyl group, and the like. Examples of the arylsulfinyl group include, but are not particularly limited to, a phenylsulfinylene group, a 1-naphthylsulfinyl group, a 2-naphthylsulfinyl group, and the like. Examples of the arylthio group include, but are not particularly limited to, a phenylthio group, a 1-naphthylthio group, a 2-naphthylthio group, and the like. Examples of the arylsulfonyloxy group include, but are not particularly limited to, a phenylsulfonyloxy group, a 1-naphthylsulfonyloxy group, a 2-naphthylsulfonyloxy group, and the like. Examples of the arylsulfinyloxy group include, but are not particularly limited to, a phenylsulfinyloxy group, a 1-naphthylsulfinyloxy group, a 2-naphthylsulfinyloxy group, and the like. Aryl C1 - 6
Examples of the alkylthio group include, but are not particularly limited to, benzylthio, phenethylthio, phenyl-n-propylthio, phenyl-n-butylthio, 1-naphthylthio, 2-naphthylthio. And similar groups. Examples of heteroaryl groups include, but are not particularly limited to, thienyl, furyl, pyrrolyl, oxazolyl, isoxazolyl, thiazolyl, isothiazolyl, pyrazolyl, imidazolyl, oxadiazolyl, thiadipine Azyl, triazolyl, tetrazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, tetrazinyl, indolyl, isodecyl, oxazolyl, quinazolinyl , carbazolyl, benzoxazolyl, benzoisoxazolyl, benzothiazolyl, benzisothiazolyl, benzimidazolyl, quinolyl, isoquinolyl, pyridoindoleyl, hydrazine A phenyl group, a pyridazinyl group, a quinoxalinyl group, a fluorenyl group, a phenothiazine group, a benzofuranyl group, a decyl group, a benzothienyl group, and the like. All aryl and heteroaryl groups mentioned above may be further substituted as appropriate. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5). Examples of the heterocyclic group include, but are not particularly limited to, thienyl, furyl, tetrahydrofuranyl, dioxolanyl, dioxanyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, oxazolyl, iso Oxazolyl, oxazolyl, oxazolidinyl, isoxazolinyl, thiazolyl, isothiazolyl, thiazolinyl, thiazolidinyl, isothiazolinyl, pyrazolyl, pyrazolyl, imidazole , dihydroimidazolyl, tetrahydroimidazolyl, oxadiazolyl, oxadiazolyl, thiadiazolyl, triazolyl, triazolinyl, triazolyl, tetrazolyl, tetrazoline Base, pyridyl, dihydropyridyl, tetrahydropyridyl, piperidinyl, oxazinyl, dihydrooxazinyl, N-morpholinyl, thiazinyl, dihydrothiazinyl, thia N-morpholine Base, pyridazinyl, dihydropyridazinyl, tetrahydropyridazinyl, hexahydroazinyl, oxadiazinyl, dihydrooxadiazinyl, tetrahydrooxazinyl, thiadiazolyl, thiazepine Azinyl, dihydrothiazinyl, tetrahydrothiazinyl, pyrimidinyl, dihydropyrimidinyl, tetrahydropyrimidinyl, hexahydropyrimidinyl, pyrazinyl, dihydropyrazinyl, tetrahydropyrazinyl , piperazinyl, triazinyl, Dihydrotriazinyl, tetrahydrotriazinyl, hexahydrotriazinyl, tetrazinyl, dihydrotetrazinyl, fluorenyl, indanyl, isodecyl, oxazolyl, quinazoline , dihydroquinazolyl, tetrahydroquinazolyl, oxazolyl, benzoxazolyl, benzoxazolinyl, benzisoxazolyl, benzisoxazolinyl, benzothiazolyl, Benzoisothiazolyl, benzisothiazolinyl, benzimidazolyl, oxazolinyl, quinolyl, dihydroquinolinyl, tetrahydroquinolyl, isoquinolinyl, dihydroisoquinolinyl , tetrahydroisoquinolyl, pyridoindoleyl, tetrahydrobenzoxazinyl, porphyrinyl, dihydroporphyrinyl, tetrahydroporphyrinyl, pyridazinyl, dihydropyridazinyl, tetrahydrogen Pyridazinyl, quinoxalinyl, dihydroquinoxalinyl, tetrahydroquinoxalinyl, fluorenyl, dihydrobenzotriazinyl, dihydrobenzotetrazinyl, phenothiazine furyl, benzene And furyl, decyl, benzothienyl and the like. Such heterocyclic groups include those substituted with a pendant oxy or thioketo group at any substitutable position. All of the heterocyclic compounds mentioned above may be further substituted as appropriate. Examples of the number of substituents include, but are not particularly limited to, 1 to 20 (preferably 1 to 10, and more preferably 1 to 5). Examples of "substituted" or "substituent" include, but are not particularly limited to, halogen, nitro, cyano, hydroxy, formamyl, C.1 - 6
Alkyl, C1 - 6
Haloalkyl, C1 - 6
Alkoxy, C1 - 6
Haloalkoxy, C1 - 6
Alkoxy C1 - 6
Alkyl, C1 - 6
Haloalkoxy, C1 - 6
Alkyl, C3 - 8
Cycloalkyl, C3 - 8
Cycloalkyl C1 - 6
Alkyl, C1 - 6
Alkylcarbonyl, C1 - 6
Haloalkylcarbonyl, arylcarbonyl, aryloxycarbonyl, C1 - 6
Alkoxycarbonyl, C1 - 6
Haloalkoxycarbonyl, C1 - 6
Cyanoalkyl, C1 - 6
Cyanoalkoxy, C2 - 6
Alkenyl, C2 - 6
Haloalkenyl, C2 - 6
Alkynyl, C2 - 6
Haloalkynyl, C1 - 6
Alkylsulfonyl, C1 - 6
Haloalkylsulfonyl, C1 - 6
Alkylsulfinyl, C1 - 6
Haloalkylsulfinyl, C1 - 6
Alkylthio, C1 - 6
Haloalkylthio, C3 - 8
Cycloalkylsulfonyl, C3 - 8
Cycloalkylsulfinyl, C3 - 8
Cycloalkylthio, C3 - 8
Cycloalkyl C1 - 6
Alkylsulfonyl, C3 - 8
Cycloalkyl C1 - 6
Alkylsulfinyl, C3 - 8
Cycloalkyl C1 - 6
Alkylthio, C1 - 6
Alkoxy C1 - 6
Alkylsulfonyl, C1 - 6
Alkoxy C1 - 6
Alkylsulfinyl, C1 - 6
Alkoxy C1 - 6
Alkylthio, C2 - 6
Alkenyloxy, C2 - 6
Haloalkenyloxy, C2 - 6
Alkynyloxy, C2 - 6
Haloalkynyloxy, C1 - 6
Alkylsulfonyloxy, C1 - 6
Haloalkylsulfonyloxy, C1 - 6
Alkyl sulfinyloxy, C1 - 6
Haloalkylsulfinyloxy, OCN, SCN, SF5
Substituted or unsubstituted amine, aryl, aryl C1 - 6
Alkyl, aryloxy, aryl C1 - 6
Alkoxy, arylsulfonyl, arylsulfinyl, arylthio, aryl C1 - 6
Alkylsulfonyl, aryl C1 - 6
Alkylsulfinyl, aryl C1 - 6
Alkylthio, heterocyclic, heterocyclic C1 - 6
Alkyl, heterocyclic oxy and the like. In these, preferred substituents are halogen, nitro, cyano, C1 - 6
Alkyl, C1 - 6
Haloalkyl, C1 - 6
Alkoxy, C1 - 6
Haloalkoxy, C1 - 6
Alkylsulfonyl, C1 - 6
Haloalkylsulfonyl, C1 - 6
Alkylsulfinyl, C1 - 6
Haloalkylsulfinyl, C1 - 6
Alkylthio, C1 - 6
Haloalkylthio, substituted or unsubstituted amino, aryl and heterocyclic, and more preferred substituents are fluoro, chloro, nitro, methyl, ethyl, trifluoromethyl, methoxy and Fluoromethoxy. Preferably, the substituted aryl group is a halogen-substituted aryl group, via C1 - 6
Alkyl substituted aryl, via C1 - 6
Haloalkyl substituted aryl, halogen and C1 - 6
Haloalkyl substituted aryl, via C1 - 6
Alkoxy-substituted aryl, via C1 - 6
Haloalkoxy substituted aryl group and C1 - 6
An alkylthio substituted aryl group. More preferably substituted aryl is chloro substituted aryl, fluoro substituted aryl, trifluoromethyl substituted aryl, chloro and trifluoromethyl substituted aryl, trifluoromethoxy Substituted aryl and methoxy substituted aryl and methylthio substituted aryl. Preferably, the substituted heteroaryl group is a halogen-substituted heteroaryl group, via C1 - 6
Alkyl substituted heteroaryl, via C1 - 6
Haloalkyl substituted heteroaryl, halogen and C1 - 6
Haloalkyl substituted heteroaryl, via C1 - 6
Alkoxy substituted heteroaryl, via C1 - 6
Haloalkoxy substituted heteroaryl and via C1 - 6
Alkylthio substituted heteroaryl. More preferred substituted aryl groups are chloro substituted heteroaryl, fluoro substituted heteroaryl, trifluoromethyl substituted heteroaryl, chloro and trifluoromethyl substituted heteroaryl, Trifluoromethoxy substituted heteroaryl and methoxy substituted heteroaryl and methylthio substituted heteroaryl. Preferred substituted heterocyclic groups are halogen-substituted heterocyclic rings, via C1 - 6
Alkyl substituted heterocyclic ring, via C1 - 6
Haloalkyl substituted heterocycle, via C1 - 6
Alkoxy substituted heterocycle, via C1 - 6
Haloalkoxy substituted heterocyclic ring and C1 - 6
Alkylthio substituted heterocycle. More preferably substituted heterocyclic groups are chlorine-substituted heterocyclic rings, fluorine-substituted heterocyclic rings, trifluoromethyl-substituted heterocyclic rings, trifluoromethoxy-substituted heterocyclic rings, substituted by methoxy groups. A heterocyclic ring and a heterocyclic group substituted with a methylthio group. The salt of the compound represented by the formula (1) may be any type of salt as long as it is agriculturally acceptable. Examples of the salt include: inorganic acid salts such as hydrochlorides, sulfates, nitrates and the like; organic acid salts such as acetates, methanesulfonates and the like; alkali metal salts such as sodium salts and potassium salts Salts and the like; alkali earth metal salts such as magnesium salts, calcium salts and the like; quaternary ammonium salts such as dimethylammonium, triethylammonium and the like; and the like. In an embodiment, X and X1
Indicates oxygen or sulfur; Y represents oxygen or sulfur; Z represents oxygen or sulfur; l is an integer from 0 to 2; m is an integer from 0 to 3; and n is an integer from 0 to 4. In the compound (1) of the present invention, preferred compounds are those in which R1
Is the following compounds: hydrogen, halogen, nitro, C1 - 6
Alkyl, C1 - 6
Haloalkyl, C1 - 6
Alkylcarbonyl, cyano C1 - 6
An alkyl group, optionally substituted aryl group, and more preferably compound (1) is wherein R1
It is a compound of hydrogen, chlorine, bromine, methyl, chloromethyl, trifluoromethyl, methoxycarbonyl, ethoxycarbonyl or cyanomethyl. In the compound (1) of the present invention, preferred compounds are those in which R2
For hydrogen or C1 - 6
a compound of an alkyl group, and more preferably a compound (1) is wherein R2
A compound that is a methyl group. In the compound (1) of the present invention, preferred compounds are those in which R3
For hydrogen, halogen or C1 - 6
a compound of an alkyl group, and more preferably a compound (1) is wherein R3
A compound that is hydrogen. In the compound (1) of the present invention, preferred compounds are those in which R4
For hydrogen or C1 - 6
a compound of an alkyl group, and more preferably a compound (1) is wherein R4
A compound that is hydrogen. In the compound (1) of the present invention, preferred compounds are those in which R5
For hydrogen or C1 - 6
a compound of an alkyl group, and more preferably a compound (1) is wherein R5
A compound that is hydrogen. In the compound (1) of the present invention, preferred compounds are those in which R6
For hydrogen, halogen, C1 - 6
Alkyl or C1 - 6
a compound of an alkoxy group, and more preferably a compound (1) wherein R6
A compound of hydrogen, chlorine, methyl or methoxy. In the compound (1) of the present invention, preferred compounds are those in which R7
For hydrogen, C1 - 6
Alkyl or C1 - 6
a compound of an alkylcarbonyl group, and more preferably a compound (1) wherein R7
It is a compound of the following: hydrogen, methyl, ethyl, isopropyl, ethyl fluorenyl, propyl fluorenyl or isobutyl fluorenyl. In the compound (1) of the present invention, preferred compounds are those in which R8
For C1 - 6
a compound of an alkyl group, and more preferably a compound (1) is wherein R8
A compound that is a methyl group. In the compound (1) of the present invention, preferred compounds are those wherein X is oxygen or sulfur, and more preferably compound (1) is a compound wherein X is oxygen. In the compound (1) of the present invention, a preferred compound is wherein X1
a compound which is oxygen or sulfur, and more preferably compound (1) is X1
A compound that is oxygen. In the compound (1) of the present invention, preferred compounds are compounds wherein Y oxygen or sulfur, and more preferably compound (1) is a compound wherein Y is oxygen. In the compound (1) of the present invention, preferred compounds are those wherein Z is oxygen or sulfur, and more preferably compound (1) is a compound wherein Z is sulfur. Among these, a more preferred compound of the present invention is the following compound or a salt thereof, wherein R1
For hydrogen, halogen, nitro, C1 - 6
Alkyl, C1 - 6
Haloalkyl, C1 - 6
Alkylcarbonyl or cyano C1 - 6
Alkyl; R2
For hydrogen or C1 - 6
Alkyl; R3
For hydrogen, halogen or C1 - 6
Alkyl; R4
For hydrogen or C1 - 6
Alkyl; R5
For hydrogen or C1 - 6
Alkyl; R6
For hydrogen, halogen, C1 - 6
Alkyl or C1 - 6
Alkoxy; R7
For hydrogen, C1 - 6
Alkyl or C1 - 6
Alkylcarbonyl; R8
For C1 - 6
Alkyl; X and X1
Independently represents oxygen or sulfur; Y represents oxygen or sulfur; Z represents oxygen or sulfur; l is an integer from 0 to 2; m is an integer from 0 to 3; and n is an integer from 0 to 4. A more particularly preferred compound of the invention is a compound or a salt thereof, wherein R1
For hydrogen, halogen, C1 - 6
Alkyl or C1 - 6
Haloalkyl; R2
Is hydrogen or methyl; R3
For hydrogen; R4
For hydrogen; R5
For hydrogen; R6
Is hydrogen, chlorine, methyl or methoxy; R7
Is hydrogen, methyl, ethyl, isopropyl, acetyl, propyl or isobutyl); R8
Methyl; X and X1
Independently represents oxygen; Y represents oxygen; Z represents oxygen; l is an integer from 0 to 2; m is an integer from 0 to 3; and n is an integer from 0 to 4. The present invention also provides a process for producing a carbamate represented by the formula (1) or a salt thereof.Where R1
, R2
, R3
, R4
, R5
, R6
, R7
, R8
, X, X1
, Y, Z, l, m and n are as defined above. The urethane compound represented by the formula (1) can be easily produced according to the following Reaction Schemes 1 to 4, but is not limited thereto. The urethane compound represented by the formula (1D) can be obtained by subjecting a 2-substituted five-membered heterocyclic compound (2a) to a boron compound (3) as described in the reaction scheme 1, a base and Prepared by the reaction in the presence of a solvent: Reaction Scheme 1Where R1
, R2
, R3
, R4
, R5
, R6
, R8
, X, X1
, Y, Z, l, m and n are as defined above. A represents a halogen, a methanesulfonyloxy group, a p-toluenesulfonyloxy group or a trifluoromethanesulfonyloxy group. R9
Represents hydrogen, C1 - 6
Alkyl (substituent can form two adjacent R9
-CH2
CH2
-, -C(CH3
)2
-C(CH3
)2
-or-CH2
-CH2
-CH2
-). The foregoing reaction can be carried out in the presence of a transition metal catalyst. As the transition metal catalyst, a generally known transition metal catalyst can be widely used, and examples of the transition metal catalyst include a palladium compound such as palladium (II) acetate, ruthenium (triphenylphosphine) palladium (0), and dichloride (three) Phenylphosphine) palladium (II), tris(diphenylmethyleneacetone) dipalladium and [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and methylene chloride And its analog, preferably ruthenium (triphenylphosphine) palladium (0). The amount of the palladium catalyst to be used is usually 0.01 to 1.0 mol, preferably 0.05 to 0.1 mol per 1 mol of the compound (3). The amount of the compound (2a) to be used is usually 0.5 to 5 mol, preferably 1.0 to 2.0 mol per 1 mol of the compound (3). The foregoing reaction can be carried out in the absence or presence of a base. In the above, the reaction is preferably carried out in the presence of a base. As the base, generally known bases can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and the like; alkali metal hydroxides , such as sodium hydroxide, potassium hydroxide and the like; inorganic bases such as alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, butanol Potassium and its analogues; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine and The analogues and analogs thereof are preferably sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and sodium hydride. Any of these bases or a combination of two or more types thereof is used. The amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol per 1 mol of the compound (3). The foregoing reaction is carried out in a suitable solvent or in the absence of any solvent. When the foregoing reaction is carried out in a solvent, the solvent is not limited as long as the solvent is inactive with respect to the aforementioned reaction. Examples of such a solvent include: a solvent based on a fatty acid or an alicyclic hydrocarbon such as n-hexane, cyclohexane, n-heptane, and the like; a solvent based on an aromatic hydrocarbon such as benzene, chlorobenzene, toluene, xylene, and the like An analog thereof; a solvent based on a halogenated hydrocarbon such as dichloromethane, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; an ether-based solvent such as diethyl ether, tetrahydrofuran (THF), 1, 4-dioxane, dimethoxyethane and the like; ester solvents such as methyl acetate, ethyl acetate and the like; acetonitrile; a solvent based on decylamine such as N,N-dimethyl Indoleamine (DMF), N,N-dimethylacetamide, N-methyl-2-pyrrolidone and the like; and a solvent based on hydrazine, such as dimethyl hydrazine, cyclobutyl fluorene and Analog; H2
O; acetic acid, preferably dimethoxyethane and ethanol-H2
O and toluene-H2
O mixed solvent. Any of these solvents may be used alone, or two or more combinations of the two types may be used as necessary. The amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters per 1 mol of the compound (3). The reaction temperature of the foregoing reaction is not particularly limited, and is usually in the range between -10 ° C and the boiling point of the solvent used, and is preferably from 0 to 120 ° C. The reaction time varies depending on, for example, the reaction temperature, and the reaction usually ends in about 0.5 to 24 hours. The urethane compound represented by the formula (1E) can be obtained by reacting a 5-substituted five-membered heterocyclic compound (2b) with a boron compound (3) as described in Reaction Scheme 2, a base and Prepared by the reaction in the presence of a solvent: Reaction Scheme 2Where R1
, R2
, R3
, R4
, R5
, R6
, R8
, X, X1
, Y, Z, l, m and n are as defined above. A represents a halogen, a methanesulfonyloxy group, a p-toluenesulfonyloxy group or a trifluoromethanesulfonyloxy group. R9
Represents hydrogen, C1 - 6
Alkyl (substituent can form two adjacent R9
-CH2
CH2
-, -C(CH3
)2
-C(CH3
)2
-or-CH2
-CH2
-CH2
-). The foregoing reaction can be carried out in the presence of a transition metal catalyst. As the transition metal catalyst, a generally known transition metal catalyst can be widely used, and examples of the transition metal catalyst include a palladium compound such as palladium (II) acetate, ruthenium (triphenylphosphine) palladium (0), and dichloride (three) Phenylphosphine) palladium (II), tris(diphenylmethyleneacetone) dipalladium and [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and methylene chloride And its analog, preferably ruthenium (triphenylphosphine) palladium (0). The amount of the palladium catalyst to be used is usually 0.01 to 1.0 mol, preferably 0.05 to 0.1 mol per 1 mol of the compound (3). The amount of the compound (2b) to be used is usually 0.5 to 5 mol, preferably 1.0 to 2.0 mol per 1 mol of the compound (3). The foregoing reaction can be carried out in the absence or presence of a base. In the above, the reaction is preferably carried out in the presence of a base. As the base, generally known bases can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and the like; alkali metal hydroxides , such as sodium hydroxide, potassium hydroxide and the like; inorganic bases such as alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, butanol Potassium and its analogues; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine and The analogues and analogs thereof are preferably sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and sodium hydride. Any of these bases or a combination of two or more types thereof is used. The amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol, per 1 mol of the compound (3). The foregoing reaction is carried out in a suitable solvent or in the absence of any solvent. When the foregoing reaction is carried out in a solvent, the solvent is not limited as long as the solvent is inactive with respect to the aforementioned reaction. Examples of such a solvent include: a solvent based on a fatty acid or an alicyclic hydrocarbon such as n-hexane, cyclohexane, n-heptane, and the like; a solvent based on an aromatic hydrocarbon such as benzene, chlorobenzene, toluene, xylene, and the like An analog thereof; a solvent based on a halogenated hydrocarbon such as dichloromethane, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; an ether-based solvent such as diethyl ether, tetrahydrofuran (THF), 1, 4-dioxane, dimethoxyethane and the like; ester solvents such as methyl acetate, ethyl acetate and the like; acetonitrile; a solvent based on decylamine such as N,N-dimethyl Indoleamine (DMF), N,N-dimethylacetamide, N-methyl-2-pyrrolidone and the like; and a solvent based on hydrazine, such as dimethyl hydrazine, cyclobutyl fluorene and Analog; H2
O; acetic acid, preferably dimethoxyethane and ethanol-H2
O and toluene-H2
O mixed solvent. Any of these solvents may be used alone, or two or more combinations of the two types may be used as necessary. The amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters per 1 mol of the compound (3). The reaction temperature of the foregoing reaction is not particularly limited, and is usually in the range between -10 ° C and the boiling point of the solvent used, and is preferably from 0 to 120 ° C. The reaction time varies depending on, for example, the reaction temperature, and the reaction usually ends in about 0.5 to 24 hours. The urethane compound represented by the formula (1F) can be obtained by reacting a 4-substituted five-membered heterocyclic compound (2c) with a boron compound (3) as described in Reaction Scheme 3, a base and Prepared by reacting in the presence of a solvent: Reaction Scheme 3Where R1
, R2
, R3
, R4
, R5
, R6
, R8
, X, X1
, Y, Z, l, m and n are as defined above. A represents a halogen, a methanesulfonyloxy group, a p-toluenesulfonyloxy group or a trifluoromethanesulfonyloxy group. R9
Represents hydrogen, C1 - 6
Alkyl (substituent can form two adjacent R9
-CH2
CH2
-, -C(CH3
)2
-C(CH3
)2
-or-CH2
-CH2
-CH2
-). The foregoing reaction can be carried out in the presence of a transition metal catalyst. As the transition metal catalyst, a generally known transition metal catalyst can be widely used, and examples of the transition metal catalyst include a palladium compound such as palladium (II) acetate, ruthenium (triphenylphosphine) palladium (0), and dichloride (three) Phenylphosphine) palladium (II), tris(diphenylmethyleneacetone) dipalladium and [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and methylene chloride And its analog, preferably ruthenium (triphenylphosphine) palladium (0). The amount of the palladium catalyst to be used is usually 0.01 to 1.0 mol, preferably 0.05 to 0.1 mol per 1 mol of the compound (3). The amount of the compound (2c) to be used is usually 0.5 to 5 mol, preferably 1.0 to 2.0 mol per 1 mol of the compound (3). The foregoing reaction can be carried out in the absence or presence of a base. In the above, the reaction is preferably carried out in the presence of a base. As the base, generally known bases can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and the like; alkali metal hydroxides , such as sodium hydroxide, potassium hydroxide and the like; inorganic bases such as alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, butanol Potassium and its analogues; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine and The analogues and analogs thereof are preferably sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and sodium hydride. Any of these bases or a combination of two or more types thereof is used. The amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol, per 1 mol of the compound (3). The foregoing reaction is carried out in a suitable solvent or in the absence of any solvent. When the foregoing reaction is carried out in a solvent, the solvent is not limited as long as the solvent is inactive with respect to the aforementioned reaction. Examples of such a solvent include: a solvent based on a fatty acid or an alicyclic hydrocarbon such as n-hexane, cyclohexane, n-heptane, and the like; a solvent based on an aromatic hydrocarbon such as benzene, chlorobenzene, toluene, xylene, and the like An analog thereof; a solvent based on a halogenated hydrocarbon such as dichloromethane, 1,2-dichloroethane, chloroform, carbon tetrachloride, and the like; an ether-based solvent such as diethyl ether, tetrahydrofuran (THF), 1, 4-dioxane, dimethoxyethane and the like; ester solvents such as methyl acetate, ethyl acetate and the like; acetonitrile; a solvent based on decylamine such as N,N-dimethyl Indoleamine (DMF), N,N-dimethylacetamide, N-methyl-2-pyrrolidone and the like; and a solvent based on hydrazine, such as dimethyl hydrazine, cyclobutyl fluorene and Analog; H2
O; acetic acid, preferably dimethoxyethane and ethanol-H2
O and toluene-H2
O mixed solvent. Any of these solvents may be used alone, or two or more combinations of the two types may be used as necessary. The amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters per 1 mol of the compound (3). The reaction temperature of the foregoing reaction is not particularly limited, and is usually in the range between -10 ° C and the boiling point of the solvent used, and is preferably from 0 to 120 ° C. The reaction time varies depending on, for example, the reaction temperature, and the reaction usually ends in about 0.5 to 24 hours. The compound (3) used in this step can be produced according to a known method (for example, the method is described in WO2016/114165, WO2016/114164, WO2016/114162 and WO2016/114161). The urethane compound represented by the formula (1) can be produced by reacting the reagent (4) with the compound (1G) in the presence of a catalyst, a base and a solvent as mentioned in Reaction Scheme 4: Reaction Scheme 4Where R1
, R2
, R3
, R4
, R5
, R6
, R7
, R8
, X, X1
, Y, Z, l, m, and n are as defined above, and G represents a leaving group. The ratio between the compound (1G) and the reagent (4) used in the reaction is not particularly limited, and may be appropriately selected from a wide range. The amount of the reagent (4) to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 2.0 mol per 1 mol of the compound (1 G). The foregoing reaction can be carried out in the absence or presence of a base. In the above, the reaction is preferably carried out in the presence of a base. As the base, generally known bases can be widely used, and examples of the base include: alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate and the like; alkali metal hydroxides , such as sodium hydroxide, potassium hydroxide and the like; inorganic bases such as alkali metal hydrides such as sodium hydride and potassium hydride and the like; alkali metal alkoxides such as sodium methoxide, sodium ethoxide, butanol Potassium and its analogues; organic bases such as pyridine, triethylamine, diethylamine, dimethylamine, methylamine, imidazole, benzimidazole, diisopropylethylamine, 4-dimethylamine pyridine, piperidine and The analogs thereof and the like are preferably an alkali metal carbonate and an alkali metal hydride, more preferably sodium carbonate, potassium carbonate, potassium hydrogencarbonate, sodium hydrogencarbonate or sodium hydride. Any one of these bases or a combination of two or more of these types is used. The amount of the base to be used is usually 1.0 to 5.0 mol, preferably 1.0 to 3.0 mol per 1 mol of the compound (1 G). The foregoing reaction can be carried out by further adding a radical initiator. Examples of the radical initiator include, but are not particularly limited to, a sulfite adduct such as sulfurous acid, sulfite, Rongalite (a compound name, sodium formaldehyde sulfoxylate), and the like. A base and a radical initiator can be used in combination. When a radical initiator is used, the amount of the radical initiator to be used is usually from 0.1 to 10.0 mol, preferably from 0.1 to 5.0 mol, per 1 mol of the compound (1 G). The foregoing reaction is carried out in a suitable solvent. Examples of the solvent include: a solvent based on a fatty acid or an alicyclic hydrocarbon such as n-hexane, cyclohexane, n-heptane, and the like; a solvent based on an aromatic hydrocarbon such as benzene, chlorobenzene, toluene, xylene, and the like a solvent based on a halogenated hydrocarbon such as dichloromethane, 1,2-dichloroethane, chloroform, carbon tetrachloride and the like; an ether-based solvent such as diethyl ether, THF, 1,4-dioxane And analogs thereof; ester-based solvents such as methyl acetate, ethyl acetate and the like; guanamine-based solvents such as acetonitrile; DMF, N,N-dimethylacetamide, N-methyl- 2-pyrrolidone and its analogues; dimethyl sulfoxide and its analogs, solvents based on hydrazine; polar solvents such as alcohol-based solvents such as cyclobutyl hydrazine, methanol, ethanol, isopropanol and the like ; water; and its analogues. Any of these solvents may be used alone, or two or more combinations of the two types may be used as necessary. The amount of the solvent to be used is usually 1.0 to 20 liters, preferably 1.0 to 10 liters per 1 mol of the compound (1 G). The reaction temperature varies depending on the starting compound, the reagent, the solvent and the like, but it is usually -40 ° C to reflux temperature in the reaction system, preferably 0 to 100 ° C. The reaction time varies depending on the compound, the reagent, the solvent and the reaction temperature, and the like, but is usually from 5 minutes to 48 hours, preferably from 10 minutes to 24 hours. The compound represented by the formula (1) obtained by the present process shown in Schemes 1 to 4 is easily separated from the reaction mixture, and can be separated by a typical separation method and purification method (for example, filtration, solvent extraction, distillation, Recrystallization, column chromatography, etc.) to purify. Although the form of the compound used in the present invention may be the compound of the present invention itself, the compound of the present invention is usually prepared by mixing the compound of the present invention with a solid carrier, a liquid carrier, a gas carrier, a surfactant, and the like, and is necessary. Adding an adhesive, a dispersing agent and a stabilizer to prepare a wettable powder, a water-dispersible granule, a flowable substance, a granule, a dry flowable substance, an emulsifiable concentrate, an aqueous solution, an oil solution, an aerosol, an aerosol, a micro Capsules and others, in such formulations, typically comprise from 0.1 to 99% by weight, preferably from 0.2 to 90% by weight of the compound of the invention. Examples of solid carriers include clays in the form of fine powders or particulates (eg, kaolin, diatomaceous earth, synthetic hydrated ceria, Fubasami clay, bentonite, and acid clay), talc, or other inorganic minerals (eg, sericite, Quartz powder, sulfur powder, activated carbon, calcium carbonate and hydrated cerium oxide), and examples of the liquid carrier include water, alcohols (for example, methanol and ethanol), ketones (for example, acetone and methyl ethyl ketone), Aromatic hydrocarbons (eg, benzene, toluene, xylene, ethylbenzene, and methylnaphthalene), aliphatic hydrocarbons (eg, n-hexane, cyclohexane, and kerosene), esters (eg, ethyl acetate and butyl acetate) ), nitriles (eg, acetonitrile and isobutyronitrile), ethers (eg, dioxane and diisopropyl ether), guanamines (eg, N,N-dimethylformamide (DMF) and Dimethylacetamide), halogenated hydrocarbons (for example, dichloroethane trichloroethylene and carbon tetrachloride) and others. Examples of the surfactant include alkyl sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers and polyoxyethylated compounds thereof, polyethylene glycol ethers, polyol esters, and sugars. Alcohol derivatives. Examples of other adjuvants for use in the formulation include adhesives, dispersants, and stabilizers, specifically casein, gelatin, polysaccharides (eg, starch, gum arabic, cellulose derivatives, and alginic acid), Lignin derivatives, bentonite, sugar, water-soluble synthetic polymers (for example, polyvinyl alcohol, polyvinylpyrrolidone and polyacrylic acid), PAP (isopropyl acid phosphate), BHT (2,6-di- Tributyl-4-methylphenol), BHA (a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol), vegetable oil, mineral oil, fatty acid or Its fatty acid esters and others. The method of administering a compound of the present invention is not particularly limited as long as the form of administration is a form by which the compound of the present invention can be administered, and includes, for example, administration to a plant, such as leaf application; administration to a field for cultivating a plant, Such as immersion treatment; and application to contamination, such as seed sterilization. The dosage administered varies depending on weather conditions, dosage form, timing of administration, method of administration, area to be administered, target disease, target crop, etc., but usually at every 1,000 m2
The area to be applied is in the range of 1 to 500 g, and preferably 2 to 200 g. Emulsifying concentrates, wettable powders or suspension concentrates and the like are usually applied by dilution with water. In this case, the concentration of the compound of the present invention is usually in the range of 0.0005 to 2% by weight, and preferably 0.005 to 1% by weight, after dilution. Dust formulations or granule formulations and the like are usually applied by themselves without dilution. In the application to the seed, the amount of the compound of the present invention is usually in the range of 0.001 to 100 g, and preferably 0.01 to 50 g per 1 kg of the seed. Herein, examples of places where pests survive include rice fields, fields, tea gardens, orchards, non-farm fields, houses, seedling trays, seedling boxes, seedling soils, and nursery beds. Further, in another embodiment, for example, the compound of the present invention can be administered to the interior (inside of the body) or the outside (body surface) of the vertebrate mentioned below to parasitize the vertebrate in a systemic or non-systemic manner. Live or parasite. Examples of methods of internal medicine include oral administration, anal administration, colonization, administration by subcutaneous, intramuscular or intravenous injection. Examples of external pharmaceutical methods include transdermal administration. Furthermore, the compounds of the invention may be ingested by livestock animals to eliminate the appearance of sanitary insects in animal waste. When the compound of the present invention is administered to an animal such as livestock animals and pets on which the pest is parased, the dose varies depending on the administration method and the like, but it is generally desirable to administer the compound of the present invention such that the active ingredient (the compound of the present invention or The dose of the salt thereof is generally in the range of 0.1 mg to 2,000 mg per 1 kg of animal body weight, and preferably in the range of 0.5 mg to 1,000 mg. The compounds of the present invention are useful as agents for controlling plant diseases in farmland such as fields, rice fields, lawns, orchards. The compounds of the present invention can control diseases occurring in farmland or in other fields used to grow the following "plants". Crops: corn, rice, wheat, barley, rye, oats, sorghum, cotton, soybeans, peanuts, buckwheat, beets, rapeseed, sunflower, sugar cane, tobacco and others; vegetables: solanaceous vegetables (solanaceous vegetable) For example, eggplant, tomato, sweet pepper, pepper and potato), cucurbitaceous vegetable (for example, courgette, pumpkin, zucchini, watermelon and melon), cruciferous vegetable (for example, Japan) Japanese radish, white phthalocyanine, horseradish, broccoli, Chinese cabbage, kale, leaf mustard, broccoli, cauliflower, asteraceous vegetable (asteraceous vegetable) For example, burdock, crown daisy, artichoke and lettuce, liliaceous vegetable (eg, green onion, onion, garlic, and asparagus), ammiaceous vegetable (ammiaceous vegetable) For example, carrots, parsley, celery and parsnips, chenopodiaceous vegetables (for example, spinach and red wine (Swiss chard)), and labiatae ( Lamiaceous vegetable) (for example, Perilla frutescens, mint and basil, strawberry, sweet potato, Dioscorea japonica, colocasia and others; flower: ornamental plant leaf plant: fruit: pear fruit (pomaceous) fruits (eg, apples, pears, Japanese pears, Chinese quince and citrus), stone fruits (eg, peach, plum, nectarine, plum (Prunus mume), cherry fruit, apricot, and dried plum (prune) ), citrus fruits (eg, Citrus unshiu, orange, lemon, lime, and grapefruit), nuts (eg, chestnuts, walnuts, hazelnuts, almonds, pistachios, Cashew nut and macadamia nut, berry fruits (eg, bilberry, cranberry, blackberry and raspberry), grapes, kaki persimmon, olive, Japanese plum, banana, coffee, Date palm, coconut and others; trees other than fruits and trees: tea mulberry, flowering plants, roadside trees (eg, ash, birch, dogwood, eucalyptus) , Ginkgo biloba, snow Green (lilac), maple (maple), Quercus, poplar, Judas tree, Liquidambar formosana, plane tree, zelkova, Japanese arborvitae, fir wood, hemlock, juniper, Pinus, Picea, and Taxus cuspidata; and others. The "plant" mentioned above includes genetically modified crops. Pests for which the compounds of the invention have control effects include plant pathogens such as filamentous fungus, as well as harmful arthropods such as harmful insects and harmful aphids, and nemathelminths such as nematodes, and in particular This includes but is not limited to the following examples. Rice diseases: blast (Magnaporthe grisea), brown spot (Cochliobolus miyabeanus), sheath blight (Rhizobacter serrata) (Rhizoctonia solani)), rice bakanae disease (Gibberella fujikuroi) and downy mildew (Sclerophthora macrospora); wheat disease: powdery mildew (powdery mildew) (Erysiphe graminis), fusarium blight (Fusarium graminearum, F. avenaceum, F. culmorum, snow mold) Microdochium nivale), rust (Puccinia striiformis, P. graminis, P. recondita), snow mould (C. oxysporum) Micronectriella nivale)), typhulasnow blight (Typhula sp.), loose smut (Ustilago tritici), smut ( Stinking smut) (Tilletia caries, wheat dwarf smut (T. contro) Versa)), wheat sheath blight (eyespot) (Pseudocercosporella herpotrichoides), leaf blotch (Septoria tritici), glume blotch (wheat leaf spot) Diseased fungi (Stagonospora nodorum), brown spot (Pyrenophora tritici-repentis), rhizoctonia seeding blight (Rhizobacter serrata) and all diseases (Geumannomyces graminis); Barley disease: powdery mildew (grass powder), sickle blight (Fusarium graminearum, Fusarium oxysporum, Fusarium oxysporum, snow mold blight), rust ( Stripe rust, rod rust, barley rust (P. hordei), smut (Ustilago nuda), browning (scald) (Rhynchosporium secalis), net Net blotch (Pyrenophora teres), spot blotch (Cochliobolus sativus), leaf stripe (Pyrenophora) Graminea)), Ramularia disease (Ramularia c) Ollo-cygni)) and Rhizoctonia seed plague (Rh. rhizogenes); corn disease: rust (Puccinia sorghi), southern rust (Puccinia polysora), Northern leaf blight (Setosphaeria turcica), southern leaf blight (Cochliobolus heterostrophus), anthracnose (Colletotrichum graminicola), gray leaf spot (gray leaf) Spot) (Cercospora zeae-maydis), wheat sheath blight (Kabatiella zeae) and phaeosphaeria leaf spot (Phaeosphaeria maydis) Cotton disease: anthracnose (anthrax cotton), gray mold (Ramularia areola), alternaria leaf spot (Alternaria macrospora, cotton bollworm (A. gossypii) Coffee disease: rust (Hemileia vastatrix); rapeseed disease: sclerotinia rot (Sclerotinia sclerotiorum), black spot ( Alternaria alternata (Alternaria brassicae)) and black leg (Phoma lingam); citrus disease: melanose (Diaporthe citri), scab ( Scab) (Elsinoe fawcettii) and fruit rot (Penicillium digitatum, P. italicum); apple disease: blight blight (Monilinia mali), canker (Valsa ceratosperma), powdery mildew (Podosphaera leucotricha), broad bean leaf spot (alternaria leaf spot) (Alternaria alternata apple pathotype), scab (Venturia inaequalis) and bitter rot (Colletotrichum acutatum); pear disease: Scab disease (Venturia nashicola, V. pirina), plant black spot (Alternaria alternata Japanese pear pathotype) and rust ( Pear rust (Gymnosporangium haraeanum); peach disease : brown rot (Monilinia fructicola), scab (Cladosporium carpophilum) and Phalaopsis rot (Phomopsis sp.) )); grape disease: anthracnose (Elsinoe ampelina), ripe rot (Glomerella cingulata), powdery mildew (Uncinula necator), Rust (Phakopsora ampelopsidis), black rot (Guignardia bidwellii) and downy mildew (Plasmopara viticola); Japan Persimmon diseases: anthracnose (Gloeosporium kaki) and leaf spot (Cercospora kaki, Mycosphaerella nawae); disease of the gourd family: anthracnose (melon anthrax) Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), gummy stem blight (Didymella bryoniae), target spot (multiple rods) Corynespora cassiicola), Fusarium wilt disease Wilt) (Fusarium oxysporum, downy mildew (Pseudoperonospora cubensis), phytophthora rot (Phytophthora sp.) and tripping Damping-off (Pythium sp.); tomato disease: early blight (Alternaria solani), leaf mold (Cladosporium) Fulvum), leaf mold (Pseudocercospora fuligena) and late blight (Phytophthora infestan); eggplant disease: brown spot (Phomopsis vexans) And powdery mildew (Erysiphe cichoracearum); Cruciferous vegetable diseases: Alternaria leaf spot (Alternaria japonica), white spot (short tail) Cercosporella brassicae), clubroot (Plasmodiophora parasitica), downy mildew (Peronospora parasitica); green onion disease: rust (Puccinia allii) Soybean disease: purple spot (Ceramicus sclerotium), round Sphaceloma scad (Esinoe glycines), pod and stem blight (Diaporthe phaseolorum var. sojae), rust (soybean rust), target spot disease (multi-spore Mildew, anthracnose (Colletotrichum glycines/C. truncatum), Rhizoctonia aerial blight (Rhizobacter pylori), Septoria brown spot (Soybean brown spot) Helicobacter pylori and frog eye leaf spot; Bean disease: anthracnose (Anthracnose edulis); Peanut disease: Early leaf spot (Cercospora personata), Late leaf spot (Cercospora arachidicola) and southern blight (Sclerotium rolfsii); pea disease: powdery mildew (white powder); potato disease: early blight (potato summer) Alternaria solani, late blight (potato rot), and verticillium wilt (verticillium albo-atrum, V. dahliae, blackened) Verticillium (V. nigrescens); Strawberry disease: powdery mildew (Strawberry powdery mildew); Tea tree disease: net blister blight (Exobasidium reticulatum), white scab (Elsinoe leucospila) ), gray blight (Pestalotiopsis sp.) and anthracnose (Colletotrichum theae-sinensis); tobacco disease: brown spot (Alternaria alternata), white powder Disease (Bacillus white fungus), anthracnose (tobacco anthracnose), downy mildew (Peronospora tabacina) and black stalk (Phytophthora nicotianae); beet disease: tail Phytophthora leaf spot (C. cerevisiae), leaf blight (Thanatephorus cucumeris), root rot (Thanatephorus cucumeris) (R. solani) and genus root rot (beet) Aphanomyces cochlioides; Rose disease: black spot disease (Diplocarpon rosae) and powdery mildew (Sphaerotheca pannosa); chrysanthemum disease: leaf blight (wild chrysanthemum Septoria chrysanthemi-indici) and Rust (Puccinia horiana); Onion disease: Botrytis blight (B. ssoidea, B. squamosa) , gray mold neck rot (Botrytis allii) and small bacterial rot (Botrytis squamosa); various crop diseases: gray mold (G. cinerea) and Sclerotinia sclerotiorum Sclerotinia rot (Sclerotium); Japanese radish disease: Alternaria brassica (Alternaria brassicicola); turf grass disease: dollar spot (Dollar spot) Sclerotinia homoeocarpa, brown spots and large spots (Rhizobacter serrata); and banana diseases: Sigatoka disease (G. sinensis, G. sphaeroides). Hemiptera: Delphacidae (eg, Laodelphax striatellus, brown planthopper or white-backed planthopper); Deltocephalinae (eg pseudo-black-tailed spider mites or two-point black) Eucalyptus (Aphis gossypii); Aphididae (eg, cotton aphid, peach aphid, rapeseed meal, Macrosiphum euphorbiae, potato scorpion, scorpion scorpion, Toxoptera citricidus); Pentatomidae) (eg, southern rice genus, Riptortus clavatus, Leptocorisa chinensis, Eysarcoris parvus, Halyomorpha mista or Lygus lineolaris )); Aleyrodidae (such as Trialeurodes vaporariorum or Bemisia argentifolii); Coccoidea (such as Aonidiella aurantii, pear) Comstockaspis perniciosa, Unaspis citri, Ceroplastes rubens or Icerya purchasi; Tingidae, Psyllidae Bed bugs (temperate bed bugs (Cimex) Lectularius)) and others. Lepidoptera: Coleoptera (eg, Chilo suppressalis, Tryporyza incertulas, Cnaphalocrocis medinalis, Notarcha derogata, Plodia interpunctella) , Asian corn borer (Ostrinia furnacalis), Hellula undalis (Pediasia teterrellus), Noctuidae (such as Spodoptera litura, Spodoptera exigua), sticky night Moth (Pseudaletia separata), Mamestra brassicae, Agrotis ipsilon, Plusia nigrisigna, Trichoplusia spp., Heliothis Spp.) or Helicoverpa spp.; Pieridae (eg, Pieris rapae), Tortricidae (eg, Adoxophyes spp., peach) Heartworm (Grapholita molesta), Cydia pomonella, Leguminivora glycinivorella, Matsumuraeses azukivora, Adoxophyes orana fasciata, Adoxophyes Sp .), Homona magnanima, Archips fuscocupreanus, Cydia pomonella; Graculillariidae (eg Caloptilia theivora, Phyllodon moth) Ringoniella)); Carposinidae (eg Carposina niponensis); Lyonetiidae (eg Lyonetia spp.; Lymantriidae (eg Lymantria) Spp.) or Euproctis spp.; Yponomeutidae (eg Plutella xylostella); Gelechiidae (eg Pectinophora gossypiella or potato tuber moth (Phthorimaea operculella) )); genus Moth (such as Hyphantria cunea); Tineidae (such as Tinea translucens or Tineola bisselliella); and others; Thysanoptera: Thysanoptera (such as Frankliniella occidentalis, Thrips palmi, Scirthothrips dorsalis, Thrips tabaci, Frankliniella intonsa, smoky brown flower (Frankliniella fusca); Diptera: Musca domestica, Culex pipiens pallens, Tabanus trigonus, Hylemya antiqua, Hylemya platura , Anopheles sinensis, Agromyza oryzae, Hydrellia griseola, Chlorops oryzae, Dacus cucurbitae, Ceratitis capitata Liriomyza trifolii and others; Coleoptera: Epilachna vigintioctopunctata, Aulacophora femoralis, Phyllotreta striolata, Oulema Oryzae), Echinocnemus squameus, Lissorhoptrus oryzophilus, Anthonomus grandis, Callosobruchus chinensis, Sphenophorus venatus, Japanese Lijin tortoise Popillia japonica), Anomala cuprea, Diabrotica spp., potato beetle (Leptinotarsa decemlineata), Agriotes spp., Yankee (Lasioderma serricorne), Anthrenus verbasci, Tribolium castaneum, Lyctus brunneus, Anoplophora malasiaca, Tomicus piniperda And others; Orthoptera: Locusta migratoria, Gryllotalpa africana, Oxya yezoensis, Oxya japonica and others; Hymenoptera: Aedalia Rosae), Acromyrmex spp., Solenopsis spp. and others; Nematodes: Aphelenchoides besseyi, Nothotylenchus acris, Soybean Heterodera glycines), Meloidogyne incognita, Pratylenchus, Nacobbus aberrans and others; Blattariae: Blattella germanica, Black-brown Periplaneta fuliginosa), Periplaneta americana, Periplaneta brunnea, Blatta orientalis and others; 蜱螨目:Tetranychidae ( Such as Tetranychus urticae, Panonychus citri or Oligonychus spp.; Eriophyidae (eg Aculops pelekassi); Tarsonemidae (eg Polyphagotarsonemus latus); Tenuipalpidae; Tuckerellidae; Acaridae (eg Tyrophagus putrescentiae) (Pyroglyphidae) (such as Dermatophagoides farinae or Dermatophagoides pteronyssinus); Cheyletidae (such as Cheyletus eruditus, Cheyletus malaccensis or Cheyletus moorei); Dermanyssidae; and others. Formulations comprising a compound of the invention or a salt thereof can also be used in the field of treating livestock diseases or the livestock industry, and for example can eliminate parasitism in vertebrates (such as humans, cows, sheep, pigs, poultry, dogs, cats and Live or hygienic on the inside and/or outside of the fish) to maintain public health. Examples of pests include the genus Ixodes spp. (e.g., Ixodes scapularis), Boophilus spp. (e.g., Boophilus microplus), and the genus Amblyomma spp. ), Hyalomama spp., Rhipicephalus spp. (such as Rhipicephalus sanguineus), Haemaphysalis spp. (such as Haemaphysalis longicornis) )), dermacentor spp., Ornithodoros spp. (eg Ornithodoros moubata), Dermanyssus gallinae, Ornithonyssus sylviarum, 疥螨Genus (Sarcoptes spp.) (eg, Sarcoptes scabiei), Psoroptes spp., Chorioptes spp., Demodex spp., subgenus Eutrombicula spp.), Ades spp. (eg Aedes albopictus), Anopheles spp., Culex spp., Culicoides spp. ), Musca spp., Hypoderma spp., Gasterophilus spp., Haematobia spp., Tabanus spp., Simulium spp., Triatoma spp., Phthiraptera (eg Damalina spp.), Lidognathus spp. ), Haematopinus spp., Ctenocephalides spp. (eg Ctenocephalides felis), Xenopsylla spp., monomorium pharaonis and nematodes (nematodes/hairworm) (eg, Nippostrongylus brasiliensis, Trichostrongylus axei, Trichostrongylus colubriformis, Trichinella spp. (eg Trichinella) Spiralis)), Haemonchus contortus, Nematodirus spp. (eg Nematodirus battus), Ostertagia circumcincta, Cooper nematode ( Cooperia spp.), Hymenolepis nana and others. The urethane (1) of the present invention is used as an active ingredient of, for example, a fungicide. The urethane (1) of the present invention can be used in a desired form such as an oil, an emulsion, a wettable powder, a flowable preparation, a granule, a powder, an aerosol, a fumigant or the like. In this case, the content of the urethane (1) of the present invention is not limited and may be suitably selected from a wide range according to various conditions such as a form of preparation, a disease type to be treated, a plant species, and a disease. Severity, application site, application time, application method, combined use of chemicals (insecticides, nematicides, acaricides, fungicides, herbicides, plant growth control agents, synergists, Soil conditioners, etc.), the amount and type of fertilizer, etc. The content is usually from about 0.01 to about 95% by weight based on the total amount of the fungicidal preparation. A fungicidal preparation containing the urethane (1) of the present invention as an active ingredient can be produced according to a known method. For example, the urethane (1) of the present invention can be mixed with a carrier such as a solid carrier, a liquid carrier, a gaseous carrier or the like. Surfactants and other adjuvants for preparation may be added as appropriate. Suitable carriers can be any of the carriers known in the art. Examples of suitable solid carriers are fine particles or granules of clay (kaolin clay, diatomaceous earth, synthetic hydrated ceria, bentonite, fubasami clay, acid clay and the like), talc, ceramics, other inorganic minerals. Stone, quartz, sulfur, activated carbon, calcium carbonate, hydrated cerium oxide, etc.) and the like. Suitable liquid carriers are, for example, water, alcohols (such as methanol, ethanol, etc.), ketones (such as acetone, methyl ethyl ketone, etc.), aromatic hydrocarbons (such as benzene, toluene, xylene, ethylbenzene, Methylnaphthalene, etc.), aliphatic hydrocarbons (such as hexane, cyclohexane, kerosene, light oil, etc.), esters (such as ethyl acetate, butyl acetate, etc.), nitriles (such as acetonitrile, isobutyronitrile) Etc.), ethers (such as diisopropyl ether, dioxane, etc.), guanamines (such as N,N-dimethylformamide, N,N-dimethylacetamide, etc.), halogenated hydrocarbons (such as dichloromethane, trichloroethane, carbon tetrachloride, etc.), dimethylformamide, soybean oil, cottonseed oil, vegetable oil, and the like. Examples of suitable gaseous carriers (propellants) are butane gas, LPG (liquefied petroleum gas), dimethyl ether, carbon dioxide, and the like. Examples of suitable surfactants are alkyl ester sulfates, alkyl sulfonates, alkyl aryl sulfonates, alkyl aryl ethers, polyoxyethylated products thereof, polyethylene glycol ethers, polyol esters, Sugar alcohol compounds and the like. Examples of suitable adjuvants for the preparation are fixatives such as casein, gelatin, polysaccharides (starch powder, gum arabic, cellulose compounds, alginic acid, etc.), lignin compounds, bentonite, sugars, synthetic water-soluble polymerizations. (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid, etc.) and its analogues; stabilizers such as PAP (isopropyl isopropyl phosphate), BBH (2,6-di-t-butyl-4-methyl) Phenol), BHA (a mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol), vegetable oils, mineral oils, fatty acids, esters thereof and the like. The fungicidal preparation of the present invention thus obtained can be used as it is or diluted with water. The preparation can be prepared by mixing with any of an insecticide, a nematicide, an acaricide, a fungicide, a herbicide, a plant growth controlling agent, a synergist, a soil conditioner, and the like. The formulations of the invention can be administered simultaneously with other formulations. When the preparation of the present invention is used as a fungicide for use in agriculture and horticulture, the amount of the preparation of the present invention is not limited and may be suitably selected from a wide range according to various conditions such as the concentration of the active ingredient, the form of the preparation. , the type of disease to be treated, the type of plant, the severity of the disease or sputum, the time of administration, the method of application, the chemicals used in combination (insecticides, nematicides, miticides, fungicides, herbicides) , plant growth control agents, synergists, soil conditioners, etc.), the amount and type of fertilizer, and so on. This amount is usually every 100 m2
The area is from about 0.001 to about 100 g. When a water-diluted emulsion, a wettable powder, a flowable preparation or the like is used, the concentration of the fungicidal or acaricidal preparation is from about 0.1 to about 1000 ppm, preferably from about 1 to 500 ppm. The particles, microparticles or the like are applied as they are without dilution. The compounds of the invention are characterized by excellent fungicidal activity and a wide range of activities. The compounds are useful for controlling plant diseases attributable to pathogenic fungi and resistant pathogenic fungi. Examples of such pathogenic fungi include those which cause or are tolerant to the treatment of the following diseases: rice plant rice blast, rice plant sheath blight, gray mold on tomato, apple powdery mildew, apple genus Persimmon powdery mildew, grape powdery mildew, barley powdery mildew, wheat powdery mildew, squash powdery mildew, squash gray mold, tomato late blight, potato blight and its analogues. EXAMPLES The present invention will describe in more detail the preparation examples, formulation examples, and test examples. The invention is described in more detail with respect to the following reference examples, manufacturing examples, formulation examples, and test examples. However, the invention is not limited to these examples. Further, changes may be made without departing from the scope of the invention. Preparation Example 1 Preparation of methyl 2-((2-methyl-4-(4-(trifluoromethyl)thiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A- 1) (1) 1-(2-Nitrobenzyloxy)-4-bromo-2-toluene to 4-bromo-2-methylphenol (0.93 g, 5.0 mmol) and (2-nitrogen) under nitrogen atmosphere Triphenylphosphine (1.9 g, 7.5 mmol) was added to a cooled solution of phenyl)methanol (1.0 g, 6.5 mmol) in anhydrous THF (10 ml), followed by the slow addition of diethyl azodicarboxylate (0.78 g, 7.5 Mm). The resulting mixture was then stirred at room temperature for 12 h. The reaction mixture was then poured into cold distilled water and extracted with ethyl acetate (3×EtOAc). The combined organic layers were washed with EtOAc (EtOAc)EtOAc. The residue was purified by column chromatography (EtOAc:EtOAc:1
H NMR (CDCl3
): δ 8.18 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 7.6 Hz, 1H), 7.70 (t, J = 8.4 Hz, 1H), 7.51 (t, J = 7.6 Hz, 1H) , 7.31-7.30 (m, 1H), 7.27-7.24 (m, 1H), 6.74 (d, J = 8.4 Hz, 1H), 5.46 (s, 2H), 2.30 (s, 3H). (2) 2-((4-Bromo-2-methylphenoxy)methyl)aniline added cuprous chloride (0.74 g, 7.5 mmol) to 1-(2-nitrobenzyloxy)- A solution of 4-bromo-2-toluene (1.2 g, 3.7 mmol) in MeOH (10 mL). Sodium borohydride (0.69 g, 18.7 mmol) was then added portionwise to this mixture. The resulting mixture was then stirred at room temperature for 2 h. The reaction mixture was then quenched with EtOAc (EtOAc)EtOAc The organic layer was washed with EtOAc (EtOAc m. It was then used in the next step without further purification.1
H NMR (DMSO-d 6
): δ 7.33-7.30 (m, 2H), 7.18-7.17 (m, 1H), 7.04-7.00 (m, 2H), 6.68-6.66 (m, 1H), 6.55 (t, J = 7.2 Hz, 1H) , 5.06 (bs, 2H), 4.95 (s, 2H), 2.16 (s, 3H). (3) Methyl 2-((4-bromo-2-methylphenoxy)methyl)phenylcarbamate to 2-((4-bromo-2-methylphenoxy)methyl)aniline (0.90 g, 3.1 mmol) pyridine (0.74 g, 9.3 mmol). Methyl chloroformate (0.43 g, 4.6 mmol) was then slowly added to this mixture. The resulting mixture was then stirred at room temperature for 12 h. The reaction mixture was then poured into cold water and extracted with dichloromethane (3× 80 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and evaporated The title compound (0.75 g, yield: 69%).1
H NMR (DMSO-d 6
): δ 9.01 (bs, 1H), 7.49-7.45 (m, 2H), 7.36-7.30 (m, 3H), 7.18 (t, J = 7.6 Hz, 1H), 6.93 (d, J = 8.4 Hz, 1H ), 5.12 (s, 2H), 3.65 (s, 3H), 2.17 (s, 3H). (4) 2-((2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy) A Methyl phenylaminocarbamate to methyl 2-((4-bromo-2-methylphenoxy)methyl)phenylcarbamate (0.75 g, 2.1 mmol) and potassium acetate under nitrogen atmosphere (0.42 g, 4.3 mmol) of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and dichloride in a mixture of 1,4-dioxane (5.0 ml) A complex of methane (0.09 g, 0.10 mmol) followed by bis(pinadol) diboron (0.81 g, 3.2 mmol). The resulting mixture was then refluxed for 3 h. The reaction mixture was then diluted with ethyl acetate. The organic layer was washed with EtOAc EtOAc EtOAc. It was then used in the next step without any further purification.1
H NMR (CDCl3
): δ 8.01 (bs, 1H), 7.66-7.59 (m, 3H), 7.39-7.35 (m, 1H), 7.30-7.29 (m, 1H), 7.10-7.06 (m, 1H), 6.96 (d, J = 8.0 Hz, 1H), 5.11 (s, 2H), 3.74 (s, 3H), 2.25 (s, 3H), 1.33 (s, 12H). (5) Methyl 2-((2-methyl-4-(4-(trifluoromethyl)thiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A-1) To 2-bromo-4-(trifluoromethyl)thiazole (0.058 g, 0.25 mmol) and potassium carbonate (0.070 g, 0.5 mmol) in 1,4-dioxane (5 ml) To the mixture was added hydrazine (triphenylphosphine) palladium (0) (0.014 g, 0.01 mmol) followed by 2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3) Methyl 2-dioxaborolan-2-yl)phenoxy)methyl)phenylcarbamate (0.1 g, 0.25 mmol). The resulting mixture was then refluxed for 3 h. The reaction mixture was then diluted with ethyl acetate (50 mL). The organic layer was washed with distilled water, dried over sodium sulfate, filtered and evaporated The title compound (0.060 g, yield: 47%).1
H NMR (CDCl3
): δ 8.00 (bs, 1H), 7.81-7.77 (m, 2H), 7.66 (s, 1H), 7.51 (bs, 1H), 7.39 (t, J = 7.2 Hz, 1H), 7.33 (d, J = 7.6 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.00 (d, J = 8.8 Hz, 1H), 5.16 (s, 2H), 3.77 (s, 3H), 2.31 (s, 3H ). Preparation Example 2 Preparation of methyl 2-((4-(4-chlorothiazol-2-yl)-2-methylphenoxy)methyl)phenylcarbamate (1A-2) to 2 under nitrogen atmosphere Add ruthenium (triphenylphosphine) palladium (0) to a mixture of 4-dichlorothiazole (0.06 g, 0.39 mmol) and potassium carbonate (0.11 g, 0.78 mmol) in 1,4-dioxane (5.0 ml) (22 mg, 0.02 mmol) followed by 2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-) Phenyloxy))) Methyl phenylcarbamate (0.15 g, 0.39 mmol). The resulting mixture was then refluxed for 3 h. The reaction mixture was then diluted with ethyl acetate (50 mL). The organic layer was washed with distilled water, dried over sodium sulfate, filtered and evaporated The crude product was purified by EtOAc EtOAc (EtOAc:EtOAc: Methyl phenoxy)methyl)phenylcarbamate (0.050 g, yield: 33%).1
H NMR (CDCl3
): δ 7.99 (bs, 1H), 7.77 (s, 1H), 7.75-7.72 (m, 1H), 7.53 (bs, 1H), 7.41-7.37 (m, 1H), 7.32 (d, J = 7.6 Hz) , 1H), 7.11 (t, J = 7.6 Hz, 1H), 7.01-6.98 (m, 2H), 5.14 (s, 2H), 3.77 (s, 3H), 2.30 (s, 3H). Preparation Example 3 Preparation of methyl 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A- 39) (1) 2-(4-Methoxy-3-methylphenyl)-4-methylthiazole to 2-bromo-4-methylthiazole (1.0 g, 5.6 mmol) in DMF under nitrogen atmosphere :H2
Sodium carbonate (1.19 g, 0.0112 mol) was added to the solution in O (10:1, 3.0 ml), followed by the addition of 1,1'-bis(diphenylphosphino)ferrocene-palladium(II) dichloride. Dichloromethane (0.457 g, 5.6 mmol). 4-methoxy-3-methylphenylAcid (1.38 g, 8.41 mmol) was added to the reaction mixture, which was then stirred at 100 ° C for 12 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude product was purified by EtOAc EtOAc (EtOAc) .1
H NMR (CDCl3
): δ 7.73-7.71 (m, 2H), 6.84 (d, J = 9.2 Hz, 1H), 6.79-6.78 (m, 1H), 3.87 (s, 3H), 2.48 (s, 3H), 2.26 (s , 3H). (2) 2-Methyl-4-(4-methylthiazol-2-yl)phenol 2-(4-methoxy-3-methylphenyl)-4-methylthiazole (0.8 g, 3.6 A solution of mmol in HBr (10 ml) and acetic acid (5.0 ml) was refluxed at 120 ° C for 24 h. After the reaction was completed, the reaction mixture was treated with a saturated sodium hydrogen carbonate solution until the pH became about 10. This was extracted with EtOAc (3×50 mL)EtOAc. ). It was then used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.73 (s, 1H), 7.64-7.62 (m, 1H), 6.80-6.78 (m, 2H), 5.07 (bs, 1H), 2.48 (s, 3H), 2.29 (s, 3H). (3) 2-(Bromomethyl)-1-chloro-3-nitrobenzene to 1-chloro-2-methyl-3-nitrobenzene (1.0 g, 5.8 mmol) in carbon tetrachloride (30) N-bromobutaneimine (1.03 g, 5.8 mmol) was added to the solution in ml), followed by the addition of benzamidine peroxide (0.071 g, 0.29 mmol). The reaction mixture was refluxed at 80 ° C for 6 h. The reaction mixture was then cooled to room temperature and filtered. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by EtOAc EtOAcjjjjjj1
H NMR (CDCl3
): δ 7.87-7.85 (m, 1H), 7.70-7.68 (m, 1H), 7.43 (t, J = 8.0 Hz, 1H), 4.87 (s, 2H). (4) 2-(4-((2-Chloro-6-nitrobenzyloxy)-3-methylphenyl)-4-methylthiazole to 2-methyl-4-(4-methyl) Potassium carbonate (0.7 g, 5.1 mmol) was added to a solution of thiazol-2-yl)phenol (0.7 g, 3.4 mmol) in acetonitrile (10 mL) followed by 2-(bromomethyl)-1-chloro-3 - nitrobenzene (0.85 g, 3.4 mol), and the reaction mixture was refluxed for 3 h at 80 ° C. The reaction mixture was diluted with ethyl acetate (70 mL) and washed with water (3×100 mL) Drying and evaporation to dryness. 4-methylthiazole (0.80 g, yield: 62%).1
H NMR (CDCl3
): δ 7.75-7.72 (m, 3H), 7.70-7.67 (m, 1H), 7.47 (t, J = 8.0 Hz, 1H), 6.93 (d, J = 9.2 Hz, 1H), 6.79-6.78 (m , 1H), 5.49 (s, 2H), 2.48 (s, 3H), 2.17 (s, 3H). (5) 3-Chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)aniline to 2-(4-(2-) at 0 °C Addition of cuprous chloride (0.63 g) to a solution of chloro-6-nitrobenzyloxy)-3-methylphenyl)-4-methylthiazole (0.80 g, 2.1 mmol) in methanol (20 ml) 6.3 mmol) followed by sodium borohydride (0.24 g, 6.4 mmol). The reaction mixture was stirred at room temperature for 3 h. The reaction mixture was filtered and evaporated with w~~~~~~~~~~~~~~~~~~~ g, crude product). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.75-7.71 (m, 2H), 7.09-7.04 (m, 2H), 6.83-6.79 (m, 2H), 6.61 (d, J = 8.0 Hz, 1H), 5.34 (s, 2H), 4.27 (bs, 2H), 2.48 (s, 3H), 2.16 (s, 3H). (6) Methyl 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A-39) To 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)aniline (0.60 g, 1.7 mmol) in dichloromethane (10 ml Pyridine (0.20 g, 2.5 mmol) was added to the solution, followed by methyl chloroformate (0.20 g, 2.1 mmol). The reaction mixture was stirred at room temperature for 3 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to afford 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)benzene as a yellow solid. Methyl carbazate (0.50 g, yield: 71%).1
H NMR (CDCl3
): δ 7.96 (d, J = 8.0 Hz, 1H), 7.90 (bs, 1H), 7.77 (s, 1H), 7.74-7.71 (m, 1H), 7.29 (t, J = 8.4 Hz, 1H), 7.16-7.14 (m, 1H), 7.05 (d, J = 8.8 Hz, 1H), 6.80 (d, J = 1.2 Hz, 1H), 5.40 (s, 2H), 3.77 (s, 3H), 2.49 (s , 3H), 2.30 (s, 3H). Preparation Example 4 Preparation of methyl 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl(methyl)carbamate (compound) 1A-43) Methyl (3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamate at 0 ° C Sodium hydride (6.0 mg, 0.26 mmol) was added to a solution of EtOAc (EtOAc (EtOAc) The reaction mixture was stirred at room temperature for 3 h. EtOAc (EtOAc)EtOAc. Purification by column chromatography gave 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)benzene as a yellow viscous oil Methyl (meth)carbamate (40 mg, yield: 55%).1
H NMR (CDCl3
): δ 7.75-7.73 (m, 2H), 7.45-7.43 (m, 1H), 7.36 (t, J = 8.0 Hz, 1H), 7.15-7.11 (m, 1H), 6.98 (d, J = 9.2 Hz) , 1H), 6.79 (d, J = 1.2 Hz, 1H), 5.12 (d, J = 10.0 Hz, 1H), 5.03 (d, J = 10.0 Hz, 1H), 3.76-3.22 (m, 6H), 2.49 (s, 3H), 2.20 (s, 3H). Preparation Example 5 Preparation of (3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamic acid methyl ethyl decyl ester ( Compound 1A-46) methyl 3-chloro-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenylcarbamate at 0 ° C (90 mg, 0.22 mmol) of sodium hydride (8 mg, 0.33 mmol). After 10 minutes, ethyl chloroform (22 mg, 0.30 mmol) was added to the reaction mixture and then stirred at room temperature for 3 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to give (3-chloro-2-(4-methyl-4-(4-methylthiazol-2-yl)phenoxy) Methyl ethyl phenyl methacrylate (50 mg, yield: 50%).1
H NMR (CDCl3
): δ 7.75-7.74 (m, 1H), 7.71-7.69 (m, 1H), 7.50 (d, J = 7.6 Hz, 1H), 7.38 (t, J = 8.0 Hz, 1H), 7.06 (d, J = 8.0 Hz, 1H), 6.90 (d, J = 8.4 Hz, 1H), 6.79 (s, 1H), 3.53 (s, 3H), 2.61 (s, 3H), 2.48 (s, 3H), 2.20 (s , 3H). Preparation Example 6 Preparation of methyl 2-((2-methyl-4-(thiazol-5-yl)phenoxy)methyl)phenylcarbamate (Compound 1B-1) to 5-bromine under nitrogen atmosphere Thiazole (0.15 g, 0.91 mmol) in 1,4-dioxane: H2
Potassium phosphate (0.38 g, 1.8 mmol) was added to the solution in O (5:1, 6.0 mL), followed by hydrazine (triphenylphosphine) palladium (50 mg, 0.04 mmol). 2-((2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)methyl) Methyl phenylcarbamate (0.65 g, 1.6 mmol) was added to the reaction mixture, which was then stirred at 100 ° C for 12 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to give methyl 2-((2-methyl-4-(thiazol-5-yl)phenoxy)methyl)phenylcarbamate as a yellow viscous oil. (0.20 g, yield: 62%).1
H NMR (DMSO-d 6
): δ 8.70 (s, 1H), 8.01-7.96 (m, 2H), 7.62 (bs, 1H), 7.41-7.37 (m, 3H), 7.32 (d, J = 7.2 Hz, 1H), 7.12 (t , J = 7.2 Hz, 1H), 6.99-6.96 (m, 1H), 5.13 (s, 2H), 2.99 (s, 3H), 2.30 (s, 3H). Preparation Example 7 Preparation of methyl 2-((2-methyl-4-(thiazol-4-yl)phenoxy)methyl)phenylcarbamate (Compound 1C-1) to 4-bromo in a nitrogen atmosphere Thiazole (0.1 g, 0.61 mmol) in 1,4-dioxane: H2
Potassium phosphate (0.26 g, 1.2 mmol) was added to a solution of O (5:1, 6 mL), followed by hydrazine (triphenylphosphine) palladium (35 mg, 0.031 mmol). 2-((2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)methyl) Methyl phenylcarbamate (0.38 g, 0.97 mmol) was added to the reaction mixture, which was then stirred at 100 ° C for 12 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to give methyl 2-((2-methyl-4-(thiazol-4-yl)phenoxy)methyl)phenylcarbamate as a yellow viscous oil. (0.15 g, yield: 69%).1
H NMR (DMSO-d 6
): δ 9.14 (s, 1H), 9.03 (bs, 1H), 7.97 (s, 1H), 7.80-7.77 (m, 1H), 7.50 (d, J = 8.0 Hz, 2H), 7.41-7.30 (m , 2H), 7.20-7.17 (m, 1H), 7.04 (d, J = 8.4 Hz, 1H), 5.18 (s, 2H), 3.66 (s, 3H), 2.24 (s, 3H). Preparation Example 8 Preparation of methyl 2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)-3-methoxyphenylcarbamate (Compound 1A- 38) (1) 2-(Bromomethyl)-1-methoxy-3-nitrobenzene to 1-methoxy-2-methyl-3-nitrobenzene (2 g, 12.0 mmol) N-bromobutaneimine (2.56 g, 14.4 mmol) was added to a solution of carbon tetrachloride (20 ml), followed by the addition of benzamidine peroxide (0.14 g, 0.6 mmol). The reaction mixture was refluxed at 80 ° C for 6 h. The reaction mixture was cooled to room temperature and filtered. The filtrate was diluted with EtOAc (EtOAc) (EtOAc)EtOAc. The crude product was purified by EtOAc EtOAcjjjjjj1
H NMR (CDCl3
): δ 7.74-7.72 (m, 1H), 7.61-7.58 (m, 1H), 7.12 (t, J = 8.0 Hz, 1H), 4.91 (s, 2H), 4.01 (s, 3H). (2) 1-(2-Methoxy-6-nitrobenzyloxy)-4-bromo-2-toluene to 4-bromo-2-methylphenol (1.0 g, 5.3 mmol) in acetonitrile (10 ml Potassium carbonate (1.1 g, 6.4 mmol) was added to the solution, followed by 2-(bromomethyl)-1-methoxy-3-nitrobenzene (1.58 g, 6.4 mol), and the reaction mixture was Reflow at 80 ° C for 3 h. The reaction mixture was diluted with EtOAc EtOAc m. The crude product was purified by column chromatography eluting eluting elut elut eluting : 83.8%).1
H NMR (CDCl3
): δ 7.47-7.39 (m, 2H), 7.24-7.21 (m, 2H), 7.16-7.14 (m, 1H), 6.79 (d, J = 9.2 Hz, 1H), 5.34 (s, 2H), 3.93 (s, 3H), 2.07 (s, 3H). (3) 2-((4-Bromo-2-methylphenoxy)methyl)-3-methoxyaniline to 1-(2-methoxy-6-nitrobenzyloxy) at 0 ° C Add copper chloride (0.21 g, 2.1 mmol) to a solution of 4-bromo-2-toluene (0.5 g, 1.4 mmol) in methanol (10 ml), followed by sodium borohydride (0.18 g, 5.0 (mmol), and the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was diluted with EtOAc EtOAc EtOAc. It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.24-7.22 (m, 2H), 7.09 (t, J = 8.4 Hz, 1H), 6.95 (d, J = 9.2 Hz, 1H), 6.35-6.33 (m, 2H), 5.20 (s, 2H ), 4.13 (bs, 2H), 3.83 (s, 3H), 2.17 (s, 3H). (4) Methyl 2-((4-bromo-2-methylphenoxy)methyl)-3-methoxyphenylcarbamate to 2-((4-bromo-2-methylphenoxy) Add pyridine (98 mg, 1.2 mmol) to a solution of methyl)-3-methoxyaniline (0.2 g, 0.62 mmol) in dichloromethane (5.0 ml), followed by methyl chloroformate (70 mg , 0.74 mmol). The reaction mixture was stirred at room temperature for 3 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude product was purified by EtOAc EtOAc EtOAc EtOAc g, yield: 59%).1
H NMR (CDCl3
): δ 7.82 (bs, 1H), 7.64 (d, J = 8.4 Hz, 1H), 7.29 (t, J = 8.4 Hz, 1H), 7.27-7.22 (m, 2H), 6.91 (d, J = 8.4 Hz, 1H), 6.65 (d, J = 8.4 Hz, 1H), 5.28 (s, 2H), 3.86 (s, 3H), 3.76 (s, 3H), 2.21 (s, 3H). (5) 2-((2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy) A Methyl 3-methoxyphenylcarbamate to 2-((4-bromo-2-methylphenoxy)methyl)-3-methoxyphenylaminocarboxylic acid under nitrogen atmosphere Methyl ester (0.15 g, 0.4 mmol) and potassium acetate (77 mg, 0.8 mmol) in 1,4-dioxane: H2
To a mixture of O (5:1, 6 ml) was added hydrazine (triphenylphosphine) palladium (45 mg, 0.04 mmol) followed by bis(pinadol) diboron (0.15 g, 0.6 mmol). The reaction was then refluxed at 85 ° C for 12 h. After cooling to room temperature, the~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ The crude compound was purified by column chromatography to yield 2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxy) as a yellow viscous oil. Methyl boroborolan-2-yl)phenoxy)methyl)-3-methoxyphenylcarbamate (0.09 g, yield: 53%).1
H NMR (CDCl3
): δ 7.88 (bs, 1H), 7.64-7.60 (m, 3H), 7.28 (t, J = 8.4 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H), 6.64 (d, J = 8.0) Hz, 1H), 5.30 (s, 2H), 3.86 (s, 3H), 3.74 (s, 3H), 2.24 (s, 3H), 1.26 (s, 9H). (6) Methyl 2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)-3-methoxyphenylcarbamate (Compound 1A-38) To 2-bromo-4-methylthiazole (0.041 g, 0.23 mmol) in 1,4-dioxane: H under nitrogen atmosphere2
Sodium carbonate (50 mg, 0.50 mmol) and 1,1'-bis(diphenylphosphino)ferrocene-palladium(II) dichloride were added sequentially to the solution in O (4:1,6 ml). Methyl chloride complex (19 mg, 0.02 mmol) and 2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan) Methyl-2-yl)phenoxy)methyl)-3-methoxyphenylcarbamate (0.10 g, 0.2 mmol). The reaction was stirred at 100 ° C for 12 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to afford 2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)-3-methoxy Methyl phenylaminocarbamate (49 mg, yield: 53.4%).1
H NMR (CDCl3
): δ 7.85 (bs, 1H), 7.73 (s, 1H), 7.71-7.68 (m, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.30 (t, J = 8.0 Hz, 1H), 7.08 (d, J = 8.4 Hz, 1H), 6.79 (d, J = 1.2 Hz, 1H), 6.66 (d, J = 8.0 Hz, 1H), 5.33 (s, 2H), 3.88 (s, 3H), 3.76 (s, 3H), 2.48 (s, 3H), 2.29 (s, 3H). Preparation Example 9 Preparation of methyl 3-methyl-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A) -15) (1) (2-Methyl-6-nitrophenyl)methanol to 2-methyl-6-nitrobenzoic acid (2.0 g, 12.0 mmol) in dichloromethane (20 ml) Ethyl ruthenium chloride (3.47 g, 30.0 mmol) was added dropwise to the solution, followed by the addition of dimethylformamide (0.2 mL). The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was evaporated to dryness under reduced pressure. Anhydrous THF was added thereto at 0 ° C to prepare a clear solution, followed by sodium borohydride (1.2 g, 36.0 mmol). The reaction mixture was stirred at room temperature for 1 h. It was quenched with water and extracted with ethyl acetate (3×50 mL) with NH4
The solution was washed with EtOAc (3 mL, EtOAc). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.69 (d, J = 8.0 Hz 1H), 7.45 (d, J = 7.60 Hz 1H 1H), 7.34 (t, J = 8.0 Hz, 1H), 4.69 (d, J = 7.2 Hz, 2H), 2.64 (t, J = 7.6 Hz 1H), 2.55 (s, 3H) (2) (2-Amino-6-methylphenyl)methanol at 0 ° C to 2-methyl-6-nitrophenyl) Copper chloride (1.7 g, 15.0 mmol) and sodium borohydride (1.8 g, 40.0 mmol) were added sequentially to a solution of methanol (1.0 g, 5.0 mmol) in methanol (10 ml). The reaction mixture was stirred at 0 ° C for 1 h. The reaction mixture was diluted with EtOAc (EtOAc) (EtOAc (EtOAc) 6-Methylphenyl)methanol (0.70 g, crude product). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.01 (t, J = 7.6 Hz, 1H), 6.58 (t, J = 7.6 Hz 2H), 4.76 (s, 2H), 233 (s, 3H). (3) Methyl (2-(hydroxymethyl)-3-methylphenyl)carbamate to 2-amino-6-methylphenyl)methanol (0.70 g, 0.62 mmol) Pyridine (20 mg, 0.32 mmol) and methyl chloroformate (48 mg, 0.32 mmol) were added sequentially to a solution of 5.0 ml. The reaction mixture was stirred at room temperature for 1 h. The reaction mixture was diluted with EtOAc (EtOAc (EtOAc)EtOAc. Methyl)methyl-3-phenylphenyl)carbamate (0.50 g, crude). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.59 (s, 1H), 7.56 (d, J = 8.4 Hz, 1H), 7.20 (t, J = 8 Hz, 1H), 6.96 (d, J = 7.6 Hz, 1H), 4.74 (d, J = 5.2 Hz, 2H), 3.78 (s, 3H), 2.40 (s, 3H). (4) (2-(Hydroxymethyl)-3-methylphenyl)carbamic acid methyl ester at 0 ° C to (2-(hydroxymethyl)-3-methylphenyl) carbamic acid Add a solution of the ester (0.50 g, 0.62 mmol) in dichloromethane (5 mL The reaction mixture was stirred at 0 ° C for 1 h. The reaction mixture was diluted with EtOAc (EtOAc (EtOAc)EtOAc. Methyl (bromomethyl)-3-methylphenyl)carbamate (0.55 g, crude). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.57 (bs, 1H), 7.22 (d, J = 8 Hz, 1H), 6.99 (d, J = 7.6 Hz, 1H), 6.68 (s, 1H), 4.54 (s, 2H), 3.80 ( s, 3H), 2.41 (s, 3H). (5) Methyl 2-((4-bromo-2-methylphenoxy)methyl)-3-methylphenyl)carbamate to 4-bromo-2-methylphenol at 0 ° C ( 0.40 g, 5.3 mmol) of potassium carbonate (0.59 g, 10.6 mmol) and methyl (2-(bromomethyl)-3-methylphenyl)carbamate were added sequentially to a solution of acetonitrile (10 ml) (0.55 g, 5.3 mmol). The reaction mixture was refluxed at 80 ° C for 3 h. After chilling at rt EtOAc (EtOAc)EtOAc. Methyl 2-((4-bromo-2-methylphenoxy)methyl)-3-methylphenyl)carbamate (0.54 g, crude). It was used as such in the next step without any further purification.1
H NMR (CDCl3
): δ 7.75 (bs, 1H), 7.39 (bs, 1H), 7.30-7.26 (m, 3H), 7.03-6.97 (m, 1H), 6.85 (t, J = 4.8, 1H), 5.06 (s, 2H), 3.74 (s, 3H), 2.38 (s, 3H), 2.18 (s, 3H). (6) (3-Methyl-2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) Methyl phenoxy)methyl)phenyl)carbamate to (2-((4-bromo-2-methylphenoxy)methyl)-3-methylphenyl)amine under nitrogen atmosphere Methyl carbamic acid (0.150 g, 0.4 mmol) and potassium acetate (77 mg, 0.8 mmol) in 1,4-dioxane: H2
To a mixture of O (5:1, 6 ml) was added hydrazine (triphenylphosphine) palladium (45 mg, 0.04 mmol) followed by bis(pinadol) diboron (0.15 g, 0.6 mmol). The reaction was then refluxed at 85 ° C for 12 h. After cooling to room temperature, the~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ The crude compound was purified by column chromatography to afford (3-methyl-2-((2-methyl-4-(4,4,5,5,4-tetramethyl-1,3, Methyl 2-dioxaborolan-2-yl)phenoxy)methyl)phenyl)carbamate (0.09 g, yield: 53%).1
H NMR (CDCl3
): δ 7.76 (d, J = 5.6 Hz 1H), 7.68 (d, J = 8.4 Hz 1H), 7.64 (s, 1H), 7.47 (bs, 1H), 7.28-7.24 (m, 1H), 6.99 ( t, J = 8.4 Hz, 2H), 5.11 (s, 2H), 3.72 (s, 3H), 2.39 (s, 3H), 2.21 (s, 3H), 1.34 (s, 12H). (7) Methyl 3-methyl-2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)phenyl)carbamate (Compound 1A- 15) 2-Bromo-4-methylthiazole (0.041 g, 0.23 mmol) in 1,4-dioxane: H under nitrogen atmosphere2
Sodium carbonate (50 mg, 0.50 mmol) and 1,1'-bis(diphenylphosphino)ferrocene-palladium(II) dichloride were added sequentially to the solution in O (4:1,6 ml). Chloromethane complex (19 mg, 0.02 mmol) and (3-methyl-2-((2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-di) Methyl oxaborolan-2-yl)phenoxy)methyl)phenyl)carbamate (0.10 g, 0.20 mmol). The reaction was stirred at 100 ° C for 12 h. The reaction mixture was diluted with EtOAc (EtOAc)EtOAc. The crude compound was purified by column chromatography to afford 2-((2-methyl-4-(4-methylthiazol-2-yl)phenoxy)methyl)-3-methoxy Methyl phenylaminocarbamate (49 mg, yield: 53.4%).1
H NMR (CDCl3
): δ 7.77-7.74 (m, 3H), 7.44 (bs, 1H), 7.28 (t, J = 8.2 Hz 1H), 7.02-6.98 (m, 2H), 6.81 (d, J = 8.0 Hz 1H), 5.13 (s, 2H), 3.74 (s, 3H), 2.48 (s, 3H), 2.41 (s, 3H), 2.26 (s, 3H). Representative compounds of the invention are illustrated in the following Tables 1 to 3, but the invention is not limited to such compounds. Except for the compounds obtained in Preparation Examples 1 to 9, the compounds shown in Tables 1 to 3 were produced by a method similar to that described in the methods or embodiments described in Preparation Examples 1 to 9. The abbreviations in Tables 1 to 3 are indicated below. F: fluorine, Cl: chlorine, Br: bromine, Me: methyl, Et: ethyl, iPr: isopropyl, t-Bu: tert-butyl, CF3
:trifluoromethyl, Ph: phenyl, NO2
: nitro, CN: cyano, OMe: methoxy. Table 1: Details of the compounds belonging to the synthesis of formula (1A) and1
H NMR:
Table 2: Details of the compounds belonging to the synthesis of formula (1B) and1
H NMR:
Table 3: Details of the compounds belonging to the synthesis of formula (1C) and1
H NMR:
The formulation examples are given below, in which the parts refer to parts by weight. Formulation Example 1 (Emulsible concentrate) 10 parts of each of the present compounds were dissolved in 45 parts of Solvesso®
150 and 35 parts of N-methylpyrrolidone. Add 10 parts of emulsifier to it (trade name: Sorpol®
3005X, manufactured by Toho Kagaku Co., Ltd.). These components were mixed while stirring, thereby producing a 10% emulsifiable concentrate. Formulation Example 2 (wettable powder) 20 parts of each of the compounds of the present invention were added to 2 parts of sodium lauryl sulfate, 4 parts of sodium lignin sulfonate, 20 parts of fine powder of aqueous synthetic cerium oxide, and a mixture of 54 parts of clay. in. These ingredients were mixed by a juice mixer while stirring, thereby producing a 20% wettable powder. Formulation Example 3 (Particles) Five parts of each of the present compounds were mixed with 2 parts of sodium dodecylbenzenesulfonate, 10 parts of bentonite and 83 parts of clay, followed by thorough stirring. A suitable amount of water is added and the mixture is further stirred. The mixture was granulated by a granulator and air dried to produce 5% granules. Formulation Example 4 (Dust) One part of each of the compounds of the present invention was dissolved in a suitable amount of acetone. To the solution were added 5 parts of a fine powder of aqueous synthetic cerium oxide, 0.3 parts of isopropyl acid phosphate (PAP) and 93.7 parts of clay, followed by mixing and stirring by a juice mixer. Acetone was removed from it by evaporation to make a 1% powder formulation. Formulation Example 5 (Flowable Formulation) 20 parts of each of the present compounds and 20 parts of water 3 parts of polyoxyethylidenetrisylphenyl ether phosphate and triethanolamine ethyl 0.2 part of Rhodorsil®
426R (made by RhodiaChimie) mixed. The mixture was pulverized by a wet method (trade name: DYNO-Mill, manufactured by Willy A. Bachofen AG), and further mixed with 60 parts of water containing 8 parts of propylene glycol and 0.32 parts of xanthan gum, This produces a suspension in 20% water. Test examples are given below to demonstrate that the compounds of the invention are useful as fungicide active ingredients. Test examples are given below to demonstrate that the compounds of the invention are suitable for use as active ingredients for fungicides.Test case 1 ( Monochamus , Cucumber for fungicidal test )
A solution of the compound of the invention (500 ppm) was sprayed onto fresh, healthy two week old courgette plants. The plants are air dried and freshly prepared spore suspension (1 × 106
Cfu spores/ml) were inoculated. The inoculated plants were then placed in a greenhouse (25 ° C, humidity 60% and 16 L8D). The disease area rate was measured 12 days after inoculation, and the activity of the compound was shown to be a preventive value calculated according to the following equation. Prophylactic value = {1 - (area rate of disease in treatment) / (control disease area rate)} × 100. Compounds exhibiting a prophylactic value of 50% or greater are as follows: Compound No.: 1A-1, 1A-2, 1A-3, 1A-4, 1A-5, 1A-6, 1A-9, 1A-10, 1A -12, 1A-13, 1A-14, 1A-15, 1A-16, 1A-17, 1A-18, 1A-22, 1A-25, 1A-28, 1A-29, 1A-30, 1A-31 , 1A-32, 1A-33, 1A-34, 1A-35, 1A-36, 1A-37, 1A-38, 1A-39, 1A-40, 1A-41, 1A-42, 1A-43, 1A -44, 1A-45, 1A-46, 1A-47, 1A-48, 1A-49, 1A-50, 1A-51, 1B-1, 1B-2, 1C-1, 1C-2.Test case 2 ( Botrytis cinerea ( Botrytis Cinerea ) Fungicidal test )
A solution of the compound of the invention (500 ppm and 200 ppm) was sprayed onto fresh healthy courgette plants at least at the three leaf stage. The cotyledons of the treated plants are cut and the leaves are placed on a moist wipe on a plastic tray. 50 μl spore suspension (1×10) using a micropipette6
Cfu spores/ml) drip in the middle of the leaves. Then, a small piece of cotton wool was placed on the spore droplets, and 50 μl of the spore suspension was again dropped on the sheet. The leaves were kept at room temperature (20 ° C). The radial growth of the fungus was measured five days after inoculation, and the activity of the compound was shown to be a preventive value calculated according to the following equation. Prophylactic value = {1 - (radiated growth by treatment) / (radiation growth of control group)} × 100 Compounds exhibiting a prophylactic value of 50% or greater at a treatment concentration of 500 ppm are as follows: Compound number :1A-1, 1A-2, 1A-3, 1A-4, 1A-5, 1A-6, 1A-9, 1A-10, 1A-12, 1A-13, 1A-14, 1A-15, 1A -16, 1A-17, 1A-18, 1A-22, 1A-23, 1A-25, 1A-29, 1A-30, 1A-33, 1A-34, 1A-37, 1A-38, 1A-39 , 1A-40, 1A-41, 1A-42, 1A-46, 1A-47, 1A-48, 1A-49, 1A-50, 1A-51, 1B-1, 1B-2, 1C-1, 1C -2. Compounds that exhibit a prophylactic value of 50% or greater at a treatment concentration of 200 ppm are as follows: Compound number: 1A-1, 1A-2, 1A-3, 1A-4, 1A-5, 1A-6, 1A- 9, 1A-10, 1A-12, 1A-13, 1A-14, 1A-15, 1A-17, 1A-18, 1A-25, 1A-29, 1A-30, 1A-33, 1A-37, 1A-38, 1A-39, 1A-40, 1A-41, 1A-47, 1A-48, 1A-49, 1A-50, 1A-51, 1B-1, 1B-2, 1C-1, 1C- 2.Test case 3 ( Phytophthora infestans ( Phytophthora Infestans ) Fungicidal test )
A solution of the compound of the invention (500 ppm) was sprayed onto fresh healthy tomato plants at least at the three leaf stage. The plants are air dried and freshly prepared sporangia suspension (1 × 106
Cfu travels spores/ml) inoculation. The inoculated plants were then placed in a dew chamber (20 ° C and humidity 100%). One day after the inoculation, the plants were transferred to a thermostatic chamber (20 ° C, humidity 80%, and 16 L8D). The disease area rate was measured 5 days after inoculation, and the activity of the compound was shown to be a prophylactic value calculated according to the following equation. Prophylactic value = {1 - (area rate of disease in treatment) / (control disease area rate)} × 100. Compounds exhibiting a prophylactic value of 50% or greater are as follows: Compound No.: 1A-4, 1A-5, 1A-12, 1A-15, 1A-17, 1A-29, 1A-35, 1A-36, 1A -37, 1A-40, 1A-49, 1C-1, 1C-2.Test case 4 ( Correct Magnaporthe oryzae ( Pyricularia Grisea ) Fungicidal test )
A solution of the compound of the invention (500 ppm) was sprayed onto fresh, healthy two week old chestnut plants. The plants are air dried and freshly prepared spore suspension (1 × 106
Cfu spores/ml) were inoculated. The inoculated plants were then placed in a dew chamber (25 ° C and humidity 100%). One day after the inoculation, the plants were transferred to a thermostatic chamber (25 ° C, humidity 80%, and 16 L8D). The disease area rate was measured 5-7 days after inoculation, and the activity of the compound was shown to be a preventive value calculated according to the following equation. Prophylactic value = {1 - (area rate of disease in treatment) / (control disease area rate)} × 100. Compounds exhibiting a prophylactic value of 50% or greater are as follows: Compound No.: 1A-1, 1A-2, 1A-3, 1A-4, 1A-5, 1A-6, 1A-7, 1A-9, 1A -10, 1A-11, 1A-12, 1A-13, 1A-14, 1A-15, 1A-17, 1A-18, 1A-19, 1A-20, 1A-22, 1A-23, 1A-25 , 1A-26, 1A-29, 1A-30, 1A-33, 1A-35, 1A-36, 1A-37, 1A-38, 1A-39, 1A-40, 1A-41, 1A-42, 1A -43, 1A-44, 1A-45, 1A-46, 1A-47, 1A-48, 1A-49, 1A-50, 1A-51, 1B-1, 1B-2, 1C-1, 1C-2 . (Note) As described above, the present invention has been described by way of preferred embodiments of the present invention. However, it should be understood that the scope of the invention should be construed only by the claims. It is to be understood that the patents, patent applications, and documents cited herein are hereby incorporated by reference in their entirety in their entirety in their entirety herein The present application claims priority to Indian Patent Application No. 201711003382, filed on Jan. 30,,,,,,,,,,,,, Industrial Applicability The urethane compound of the present invention has a controlling action against plant diseases and is suitable as an active ingredient of a plant controlling agent.